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ABSTRACT 
 
Both the pharmaceutical industry and regulatory bodies have created a demand for improved 
product quality and more effective manufacturing processes. And this demand extends also to 
products manufactured by freeze-drying. Freeze-drying is a commonly used manufacturing 
process which can enhance the stability of biopharmaceuticals. A thorough understanding of 
the product and process plays a key role in improving both product quality and process 
efficiency. The Quality by Design (QbD) concept reinforced with Process Analytical Technology 
(PAT) was developed as a tool to increase product and process understanding. The vial 
monitoring PAT techniques such as Raman and near-infrared (NIR) spectroscopies are 
currently the only methods available to elucidate product-specific physical and chemical 
phenomena occurring during freeze-drying process. However, previous studies have mainly 
applied these techniques for qualitative monitoring of only single vial in laboratory scale 
freeze-drying process. 
The aim of this work was to develop and evaluate quantitative Raman and NIR 
spectroscopic methods for in-line freeze-drying process monitoring. First, the feasibility of 
noninvasive Raman spectroscopy for monitoring the microscale freeze-drying process was 
evaluated. The Raman spectroscopic process data were multivariately analyzed to characterize 
the evolution of the solid-state forms of the model formulation under different process 
conditions. The results of the study demonstrated the applicability of the in-line Raman 
spectroscopic method to estimate the solid-state ratios of the sample in a semiquantitative 
manner and to evaluate the influence of the applied process parameters. Furthermore, the use 
of microscale freeze-drying equipment reduced the sample volume and shortened the required 
process time, allowing a rapid and environmentally sustainable process analysis. 
The second part of the study involved the development and validation of the noninvasive 
multipoint NIR spectroscopy method for the monitoring of laboratory scale freeze-drying 
process. The NIR spectroscopic process data were multivariately analyzed to achieve an in-line 
determination of the moisture content of the model formulation. The results of the study 
demonstrated that this new quantitative, in-line multipoint NIR spectroscopic method could 
make valid moisture content estimates of the samples in the latter stages of the freeze-drying 
process. These results indicate that method could be applied to detect process end point to the 
desired residual moisture content. Furthermore, the multipoint feature enhanced the 
representativity of the analysis by allowing the measurement of even those samples located in 
extreme positions within the freeze-dryer.  
As a conclusion, Raman and NIR spectroscopic methods are capable of achieving a 
quantitative elucidation of product-specific phenomena occurring during a freeze-drying 
process. 
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TIIVISTELMÄ 
 
Lääketeollisuuden ja lääkealan viranomaisten pyrkimyksenä on lääkkeiden laadun 
parantaminen ja valmistusprosessien tehostaminen. Tämä pyrkimys koskee myös 
kylmäkuivausmenetelmää, joka on yleisesti käytetty valmistusprosessi biologisten 
lääkeaineiden säilyvyyden parantamiseksi. Lääkkeiden laadun parantamisen ja tehokkaampien 
valmistusprosessien edellytyksenä on tuotteiden ja prosessien läpikotainen ymmärtäminen. 
Tuote- ja prosessiymmärryksen lisäämiseksi on esitetty prosessianalyyttisten teknologioiden 
(PAT) käyttöönottoa osana niin kutsuttua Quality by Design (QbD) konseptia. Yksittäisten 
tuotteiden monitorointiin käytettävät PAT-työkalut, kuten Raman spektroskopia ja lähi-
infrapunaspektroskopia (NIR), ovat ainoita analyysimenetelmiä joilla voidaan saada 
tuotekohtaista tietoa kylmäkuivausprosessin aikana näytteessä tapahtuvista kemiallisista ja 
fysikaalisista ilmiöistä. Aikaisemmat tutkimukset aiheesta ovat kuitenkin pääosin käyttäneet 
näitä menetelmiä vain yhden näytteen kvalitatiiviseen prosessimonitorointiin 
laboratoriomittakaavassa. 
Tämän työn tavoitteena oli kehittää ja arvioida kvantitatiivisten Raman ja NIR  
-spektroskopioihin perustuvien menetelmien käytettävyyttä kylmäkuivausprosessin in-line 
monitoroinnissa. Työn ensimmäisessä osassa selvitettiin Raman spektroskopian soveltuvuutta 
mikroskaalan kylmäkuivausprosessin monitorointiin. Tutkimuksessa käytetyn 
malliformulaation kiinteän tilan olomuodot eri prosessiolosuhteissa pyrittiin karakterisoimaan 
spektroskopisesta Raman prosessidatasta käyttäen monimuuttuja-analyysiä. Kehitetyn Raman-
spektroskopisen menetelmän avulla näytteen kiinteän tilan olomuodot kyettiin määrittämään 
puoli-kvantitatiivisesti eri prosessiolosuhteissa. Lisäksi, mikroskaalan kylmäkuivausprosessin 
käyttö vähensi tarvittavaa näytetilavuutta ja lyhensi prosessin ajallista kestoa täten 
mahdollistaen nopean ja ympäristöystävällisen prosessianalyysin. 
Työn toisessa osassa kehitettiin ja validoitiin monipiste NIR-spektroskopiaan perustuva 
menetelmä laboratoriomittakaavan kylmäkuivausprosessin monitorointiin. NIR-
spektroskopinen prosessidata analysoitiin monimuuttujamenetelmällä tutkittujen näytteiden 
kosteuspitoisuuden määrittämiseksi. Kehitetyllä NIR-spektroskopisella menetelmällä kyettiin 
luotettavasti määrittämään näytteiden kosteuspitoisuus kylmäkuivausprosessin 
loppuvaiheessa. Menetelmää voidaan mahdollisesti käyttää prosessin päätepisteen 
määrittämiseen haluttuun tuotteiden jäännöskosteuspitoisuuteen. Lisäksi, monipistelaitteiston 
käyttö mahdollisti kylmäkuivaimen eri puolilla sijainneiden näytteiden samanaikaisen 
mittauksen täten parantaen analyysin luotettavuutta.  
Yhteenvetona, Raman ja NIR -spektroskopiaan perustuvat menetelmät mahdollistavat 
kvantitatiivisen ja näytekohtaisen kylmäkuivausprosessianalyysin. 
 
Luokitus: QV 778 
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1 Introduction 
One current trend in the global health care market has been the massive growth in the 
numbers of biopharmaceuticals. In the United States of America alone, the sales of the 
biopharmaceuticals amounted to 63.6 billion US dollars in 2012 with a significant 18.2% 
increase over 2011 sales (Aggarwal 2014). The situation is similar also all around the world, 
it has been estimated that the annual sales of the biopharmaceuticals will approach 200 
billion US dollars worldwide in 2014 with an annual growth rate of 15% (Langer 2014). This 
growth has been fuelled especially by developments in certain product areas as antibiotics, 
oncolytics and vaccines. The common factor for these products is the treatment of diseases 
with high unmet needs or a high prevalence (Trappler 2013; Aggarwal 2014).  
Meanwhile, freeze-drying has evolved into being one of the main downstream 
processing methods with which to improve the stability of biopharmaceuticals (Trappler 
2013). This global trend of escalating demand for biopharmaceuticals will most likely 
increase the volume of the products being manufactured by freeze-drying. As the market 
value of the biopharmaceutical products increases, there will be an economically driven 
requirement for better quality products in order to reduce financial losses caused by batch 
rejections or recalls (Trappler 2013). Moreover, as the required volume of the 
biopharmaceuticals continues to expand, this will trigger a demand to improvements in the 
process efficiency in the pharmaceutical industry (Langer 2014). It has been claimed that the 
current trend points clearly towards enhanced process efficiency and product quality 
assurance by means of improved control of the freeze-drying process (Trappler 2013).  
Along with the economical incentive, the pharmaceutical regulatory authorities such as 
U.S. Food and Drug Administration (FDA) have also issued demands to improve the 
quality in order to ensure both the safety and the efficacy of the drug product (FDA 2004a). 
In the context of freeze-drying, as with any other pharmaceutical production method, the 
demand for better quality products is achieved through enhanced product and process 
understanding. Consequently, new applications of sophisticated analytical technologies are 
required to measure and elucidate product and process related phenomena. In their PAT 
initiative, the FDA encouraged and gave guidance to the pharmaceutical companies to 
initiate voluntary implementation of science- and risk-based quality assessment 
technologies into their manufacturing processes (FDA 2004b). 
Since both regulatory and economical requirements are the driving forces for the 
enhanced product quality, there is a clear demand for these new PAT technologies. After 
the release of the PAT initiative in 2004, a growing number of publications have described 
the development and evaluation of novel process analyzers for freeze-drying process 
monitoring (Patel and Pikal 2009; Barresi and Fissore 2011; Jameel and Kessler 2012). These 
analyzers are commonly designated as either batch or vial monitoring techniques i.e. 
whether their respective measurement principle covers the property attributable to all 
samples within the freeze-drying batch or individual sample vials within the batch. The 
major advantage of the batch techniques over the vial techniques is the higher 
representativity of the analysis; an average value of the common property for the whole 
batch is obtained with a single measurement. However, high representativity of the 
analysis also includes a downside, i.e. the individual product information cannot be 
obtained during the measurement. Furthermore, the batch techniques are susceptible to 
produce erroneous observations if there are heterogeneous process conditions. In contrast, 
the vial monitoring techniques can be used to deliver product-specific information during 
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the freeze-drying process. However, the results of the vial techniques are subject to reduced 
reliability since the sample under observation might not be representative of all of the 
samples in a particular batch (Patel and Pikal 2009). 
Raman and NIR spectroscopic methods are optical measurement technologies belonging 
to the vial techniques for freeze-drying process monitoring. They have a well established 
background in various qualitative or quantitative analyses undertaken in several different 
pharmaceutical manufacturing processes (Rantanen 2007; Räsänen and Sandler 2007; De 
Beer et al. 2011b). Raman and NIR spectroscopies can achieve rapid, noninvasive and 
nondestructive real-time measurements during the pharmaceutical freeze-drying process 
without the need for any sample preparation (Presser 2003; De Beer et al. 2007; Romero-
Torres et al. 2007; De Beer et al. 2009a). Furthermore, incorporation of the spectroscopic 
methods into the freeze-drying process can be facilitated by the possibility to use fiber optic 
cables and probes. The area and location of the measurement spot on the sample can be 
adjusted depending on the intended purpose of analysis and technologies available. Both 
Raman and NIR spectroscopic methods provide a range of product-specific chemical and 
physical information that can be analyzed and used to enhance product and process 
understanding.  
Despite the potential of Raman and NIR spectroscopies, very few in-line freeze-drying 
process monitoring applications of these methods have been reported so far. Most 
commonly, these in-line spectroscopic applications have been incorporated into only 
laboratory scale freeze-drying equipment. In laboratory scale freeze-drying, the applied 
sample volumes are typically a few milliliters resulting in process times that can be counted 
in days (Tang and Pikal 2004). Instead, the application of smaller scale freeze-drying 
equipment would lead to more environmentally-friendly chemistry by reducing the 
amount of sample to microlites and shortening the processing time to hours (Nail et al. 
1994). At present, all of the published studies have utilized both Raman and NIR 
spectroscopies as a single-vial technique for in-line process monitoring. This capability of 
being only able to monitor a single sample has been generally considered as the main 
limitation to the introduction of Raman and NIR spectroscopic methods as PAT tools for 
freeze-drying process monitoring (Patel and Pikal 2009; De Beer et al. 2011b). The 
utilization of multipoint spectroscopic methods has been postulated as a way to resolving 
the issue of low representavity of the analysis (De Beer et al. 2011a). Moreover, in most of 
the published reports, the process phenomena have been descriptively evaluated using 
only a qualitative analysis of the spectroscopic process data. However, applying a 
quantitative approach would expand the level of product and process understanding. The 
quantitative information of the property of interest can be extracted from the spectroscopic 
data by adopting suitable multivariate data analysis (MVDA) methods.  
In this PhD thesis, applications of noninvasive Raman and NIR spectroscopic methods 
for the in-line freeze-drying process monitoring were evaluated. Specifically, the value of 
Raman spectroscopy was examined for use in microscale freeze-drying equipment. 
Subsequently, multipoint NIR spectroscopy was incorporated into the laboratory scale 
freeze-dryer. In these installations, the spectroscopic data were analyzed both qualitatively 
and (semi)quantitatively in order to clarify the physical and chemical phenomena occurring 
in the individual samples during the freeze-drying process. The critical quality attributes 
(CQAs) of the freeze-dried product (i.e. stability, moisture content) are dependent on these 
phenomena. The ultimate aim of the study was to deepen our understanding of the product 
and the process. 
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2 Background of the Study 
The background of the study will provide a general insight into the scope of this thesis. The 
text will give the reader an understanding of the basic principles of the freeze-drying 
process and how it can be monitored. In addition, the fundamentals of the Raman and NIR 
spectroscopies will be introduced as well as the data analysis tools that were used in the 
experimental part of the thesis. The content of background of the study is organized as 
follows. First, the freeze-drying process and the quality of the freeze-dried products are 
discussed in chapters 2.1 and 2.2, respectively. Chapters 2.3 and 2.4 present the state of the 
art of techniques applicable for freeze-drying process monitoring. The operational 
principles, advantages and disadvantages of these methods are discussed. Chapter 2.5 
summarizes the main characteristics of the reported techniques and justifies the application 
of the Raman and NIR spectroscopies for freeze-drying process monitoring. Chapters 2.6 
and 2.7 provide the basic theory of these spectroscopies and data analysis tools that were 
used in the experimental part of the thesis, respectively. 
2.1 FREEZE-DRYING 
Down the ages, drying has been an important way to preserve food and other perishable 
biological material via the removal of water (Oetjen and Haseley 2004; Day and Stacey 2007; 
Rey and May 2010). Many of the forms of drying require high temperature, but there is one 
form that can be conducted at very low temperatures: freeze-drying. Freeze-drying, also 
known as lyophilization, is based on sublimation phenomenon, i.e. the phase transition 
from a solid directly to a gas. The freeze-drying method was adapted by indigenous 
peoples already in prehistoric times. For example, Incas dried frozen meat in the light of 
sun in the rarefied atmosphere of plateaus of the Andes and Eskimos dried fish and meat in 
the air at very low temperatures (Adams 2007; Rey 2010). The first ‘official’ freeze-drying 
experiments have been reported to date back to the year 1890, when the method was 
applied to preserve parts of organs (Neumann 1952). In the pharmaceutical context, the 
feasibility of freeze-drying was first demonstrated at the beginning of 20th century as a way 
of preserving sera and vaccines (d’Arsonval and Bordas 1906). At that time, the 
development of the method was mainly delayed due the primitive nature of the 
refrigeration and vacuum technologies (Day and Stacey 2007). A few decades later, driven 
by the World War II, freeze-drying saw its first industrial scale application in the 
production of dried blood plasma and penicillin (Flosdorf 1949). Since then freeze-drying 
has been frequently used in both the pharmaceutical and food industries (Day and Stacey 
2007). The method has also been adapted by U.S. Army and the National Aeronautics and 
Space Administration (NASA) for the production of dried food (Tuomy 1971; Casaburri 
and Gardner 1999). 
In the field of pharmaceutics, freeze-drying is mainly used to improve the stability of 
heat-labile biopharmaceuticals (e.g. monoclonal antibodies, proteins, vaccines, enzymes) by 
converting liquid formulations into solids (Pikal 1994; Wang 2000; Pikal 2002; Costantino 
and Pikal 2004). In addition, freeze-drying is widely used as a downstream processing 
method in the purification of proteins, in the preparation of protein reagents and in the 
production of proteins for therapeutic and diagnostic applications (Matejtschuk 2007). 
However, freeze-drying is not necessarily the first-choice option in the formulation of 
biopharmaceuticals. It is a complex, high-cost unit operation and the process can even take 
up weeks to reach completion (Pikal 1990a; Nail et al. 2002; Oetjen and Haseley 2004; Tang 
and Pikal 2004). Furthermore, the formulation development is complex since the product is 
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exposed to a variety of stresses during processing (e.g. freezing and drying) and storage 
(Pikal 1990b; Carpenter et al. 1997; Wang 2000; Pikal 2002; Oetjen and Haseley 2004; 
Schwegman et al. 2005). In summary, it can be stated that freeze-drying tends to be avoided 
in pharmaceutical formulation development, if possible at all. 
The liquid dosage form is usually preferred due to its easier production, affordable 
manufacturing costs, enhanced user convenience and acceptance (Carpenter et al. 1997; 
Franks 1998; Costantino and Pikal 2004; Wiggenhorn et al. 2005; Siew 2014). The main 
drawbacks of liquid dosage forms are their poor long-term stability and inconvenient 
handling during storage and shipment (Carpenter and Chang 1996; Carpenter et al. 1997; 
Tang and Pikal 2004). The stability of the biopharmaceuticals in an aqueous state can be 
compromised by both chemical (e.g. oxidation and deamidation) and/or physical (e.g. 
aggregation and precipitation) degradation (Capelle et al. 2007). External disturbances such 
as changes in the product temperature or pH and exposure to denaturants (e.g. arginine, 
guanidine hydrochloride) can easily cause irreversible denaturation of a protein (Jaenicke 
1991; Tang and Pikal 2005). Furthermore, degradation of the protein can result in the 
appearance of undesirable by-products that may compromise not only the clininal efficacy 
of the drug product but also increase the risk of adverse side effects (Thornton 1993; 
Manning et al. 2010). Therefore, the storage of the aqueous formulations usually requires 
controlled conditions such as constant temperature and humidity in order to slow down 
degradation reactions. Unfortunately, these storage conditions might not be possible to 
control during shipping. In addition, during shipment the product is susceptible to 
agitation, also a driving force for denaturation (Carpenter and Chang 1996; Carpenter et al. 
1997).  
Since stability is a paramount prerequisite of a pharmaceutical drug product, freeze-
drying provides a good alternative for production in order to fulfill the predefined quality 
criteria of the product (Carpenter et al. 1997; Franks 1998). The basic function of freeze-
drying is the removal of solvent, most commonly water, under low temperature and low 
pressure. From the stability point of view, water is a damaging component; it provides a 
medium for molecular movement and it permits conformational perturbations (Carpenter 
and Chang 1996; Pikal 2010). Since freeze-drying is a low temperature drying process, it is 
well suited for the drying of heat-labile biopharmaceuticals. In general, a formulation can 
be dried approximately to 1%-m/m of residual moisture (RM) at temperatures not higher 
than +30°C (Carpenter et al. 1997; Pikal 2002). Moreover, the freeze-dried drug can be dosed 
as accurately as a liquid formulation (Oetjen and Haseley 2004). The result of a successful 
freeze-drying process is the formation of an elegant, highly porous solid matrix allowing 
rapid reconstitution and the safe final use of the end product (Oetjen and Haseley 2004). In 
addition, the freeze-dried products can be stored even at ambient temperatures without 
compromising the efficacy or safety of the drug. The improved storage stability in the 
freeze-dried solid results from the inhibition or at least the greatly reduced degradative 
reactions (Carpenter et al. 1997; Carpenter et al. 2010). The shipment of the solid products is 
also more convenient than liquids since the products have reduced mass and highly 
controlled ambient conditions are not necessarily required (Carpenter et al. 1997).  
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Figure 2.1. Production chart of an injectable freeze-dried pharmaceutical. Both the drug product 
and diluent are prepared during manufacturing. 
 
Figure 2.1 illustrates an example of the production of an injectable freeze-dried 
pharmaceutical. The final product consists of freeze-dried drug and its diluent (e.g. sterile 
water for injection (SWFI) for reconstitution. First, the drug solution is prepared, filtered 
and filled into the vials. The vials are loaded into the freeze-dryer, freeze-dried and 
stoppered. After the freeze-drying process the vials are sealed and labeled for storage. 
Immediately prior to use, the freeze-dried cake is reconstituted with the diluent to be 
administered e.g. via injection. 
2.1.1 Process Steps 
The initial drug solution can be prepared in water, in organic or mineral solvent (e.g. 
carbon dioxide, dioxane, diethyl amine) or in mixed cosolvent (e.g. tert-butanol/water) (Rey 
2010; Teagarden et al. 2010a). Since water is the most common solvent in freeze-dried 
pharmaceuticals, only freeze-drying of aqueous solutions will be discussed here. Removal 
of water from the frozen product is achieved by means of sublimation and desorption 
during three main process steps; freezing, primary drying and secondary drying. The freeze-
drying process is controlled by three main variables; shelf temperature (
s
T ), chamber 
pressure (
c
p ) and time (t). These are well accepted as critical process parameters (CPP) of 
freeze-drying (FDA 1993). CPP is ‘a process parameter whose variability has an impact on a 
critical quality attribute and therefore should be monitored or controlled to ensure the 
process produces the desired quality’ (ICH 2009). 
The process can be viewed as a series of isothermal periods and ramps of the shelf 
temperature under controlled chamber pressure and time (Trappler 2013). The progress of 
the freeze-drying process is illustrated in Figure 2.2 using the phase diagram of water. 
Briefly, the first step is freezing (1.) where the temperature is reduced and liquid water 
freezes into ice. Once freezing is completed, the primary drying starts with a decrease in the 
pressure (2.) and increase in the temperature (3.), enabling sublimation of ice. After all of 
the ice has been sublimated, the secondary drying begins with a gradual increase in the 
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temperature which initiates desorption of the remaining unfrozen water. All of these steps 
have their own specific features that affect the quality of the end product. The following 
text will discuss these three main process steps in more detail.  
 
 
Figure 2.2. Visualization of freezing and primary drying steps using phase diagram of water. 
First, the sample is frozen in freezing step (1.). Freezing step is followed by decrease in the 
pressure (2.) and increase in the temperature (3.) in order to initiate sublimation of ice to a 
water vapor. Point A refers to the triple point of water.  
 
Freezing 
Although freezing is simple in concept, it is the most complex process step in freeze-drying 
and it exhibits many crucial effects on the subsequent process steps and product quality 
characteristics (Liu 2006; Andrieu and Vessot 2011; Siew 2014). These include primary and 
secondary drying rates, the extent and type of crystallization of the solutes, protein 
aggregation and denaturation, storage stability, surface area of the porous matrix, 
reconstitution time and inter- and intra-batch consistency (Searles et al. 2001b; Searles 2010). 
During freezing, the physical state of the sample is converted from a liquid phase into a 
solid. The primary purpose of the freezing step is the solidification of the solvent via the 
formation of ice. The second objective is related to the solidification of the solutes, that 
should crystallize or form an amorphous glass matrix (Pikal 2002). The main feature of the 
freezing step is that it dictates the morphology, number and size of the formed ice crystals 
(Knight 1967; Searles et al. 2001a). 
During the freezing step, water never freezes at its thermodynamic freezing point, 
f
T  
(0°C) (Nail et al. 2002). Instead, supercooling of water always exists to some extent and ice 
crystallizes typically in the temperature range from -10 to -20°C (Pikal 1990a; Akyurt et al. 
2002; Patapoff and Overcashier 2002; Pikal 2002; Liu 2006; Searles 2010). In good 
manufacturing practice (GMP) production, the supercooling may reach temperatures as 
low as -30°C or even lower (Konstantinidis et al. 2011). The temperature difference between 
the 
f
T  and the actual temperature at which the first ice crystals are formed, is called the 
degree of supercooling (Nail et al. 2002; Rambhatla et al. 2004). The degree of supercooling is 
dependent upon the formulation properties (e.g. solute concentration, container type) and 
process conditions (e.g. cooling rate) (Pikal 1990a; Pikal et al. 2002). It can be stated that the 
degree of supercooling is the most important individual parameter in the freezing step 
since it determines the number, size and morphology of the formed ice crystals (Knight 
1967; Searles et al. 2001a; Pikal 2002; Hottot et al. 2007; Petzold and Aguilera 2009). The 
higher the degree of supercooling, the higher the number and the smaller are the ice 
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crystals that are formed (Pikal 2002). During drying, a higher degree of supercooling results 
in a slower primary drying rate due to the smaller pore size and the thicker porous network 
within the sample. As a consequence, the primary drying time is increased by 
approximately 3% for each 1°C decrease in the ice nucleation temperature (Searles et al. 
2001a). Thus, a more effective freeze-drying process can be obtained with a lower degree of 
supercooling and larger ice crystal size (Searles et al. 2001a; Searles 2010; Konstantinidis et 
al. 2011; Awotwe-Otoo et al. 2013; Geidobler and Winter 2013). Further, the mean degree of 
supercooling for a given formulation is usually higher in production scale freeze-drying 
than in the laboratory scale, leading to problems during the scale-up of the process 
(Rambhatla et al. 2004). 
The nucleation of ice can occur via homogeneous nucleation or heterogeneous nucleation 
(Franks and Auffret 2008). Homogeneous nucleation is observed usually in a pure water 
system without any foreign particles. In this situation, the water molecules go through 
substantial supercooling (from -39 to -48°C) before there is the spontaneous formation of 
the clusters that generate ice nuclei (Oetjen and Haseley 2004; Moore and Molinero 2011). 
Instead, the heterogeneous nucleation of ice is induced by the impurities that act as 
nucleation sites and lower the degree of supercooling (Akyurt et al. 2002; Oetjen and 
Haseley 2004; Franks and Auffret 2008). The following text will focus only on 
heterogeneous nucleation of ice since this is observed in the majority of the aqueous 
pharmaceutical solutions (Pikal et al. 2002; Franks and Auffret 2008). The supercooling is a 
non-equilibrium and metastable state of water and ice nucleation occurs when the 
activation energy has been reached (Akyurt et al. 2002). In a supercooled liquid, the water 
molecules tend to form hydrogen bonds and initial clusters that break up rapidly (Petzold 
and Aguilera 2009). As the temperature of the supercooled liquid is lowered, there is an 
increased probability that these hydrogen bonds will endure. At some point during the 
freezing step, termed as primary nucleation, the formed hydrogen bonds last long enough 
and the first ice nuclei start to appear. During the standard cooling protocol, the nucleation 
of ice is a heterogeneous event that is initiated by impurities that act as ice nucleation sites 
(Jennings 1999). These impurities exist even in a sterile environment and these include the 
inner walls of the vial, particulate contaminants and the sites on macromolecules (e.g. 
proteins) present in the formulation (Blond 1988; Wilson et al. 2003). Moreover, ice 
nucleation is a stochastic event, causing variations in the degree of supercooling among 
samples (Franks 1998; Searles et al. 2001a; Liu 2006). Once a critical mass of nuclei has been 
reached, secondary nucleation follows and ice crystallization occurs over the surrounding 
liquid volume with a velocity in the order of mm/s (Searles et al. 2001a; Akyurt et al. 2002). 
The final phase of freezing is solidifcation. During solidification, the ice crystals grow in size 
and the heat of crystallization is transferred from the solidification interface to the freeze-
dryer shelf through the solidified sample layer and the bottom of the container (Searles et 
al. 2001a; Searles 2010). During crystallization, the temperature of the sample increases 
momentarily since the crystallization is an exothermic process. Once the whole sample has 
become solidified, the temperature of the sample approaches the temperature of the 
surrounding atmosphere. The postnucleation rate of ice crystal growth, termed as the 
freezing rate, is clearly dependent upon the degree of supercooling and the effectiveness of 
removal of the generated heat of crystallization (Jennings 1999; Patapoff and Overcashier 
2002). The freezing rate needs to be distinguished from the cooling rate which is the rate at 
which the sample container is cooled. As a rough generalization, a slower cooling rate 
results in a faster freezing rate and vice versa (Jennings 1999; Kasper and Friess 2011). Due to 
the heterogeneous and stochastic nature of nucleation, the samples within the same batch 
undergo unequal degrees of supercooling and display different pore size distributions, 
leading to intra-batch heterogeneity (Hatley and Mant 1993; Searles et al. 2001a; Pikal et al. 
2002). Furthermore, factors such as changes in the particulate content or vial condition can 
cause batch-to-batch variability (Searles 2010). 
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Moreover, the freezing phenomenon can occur by two basic mechanisms, depending on 
whether the sample experiences the supercooling globally or locally (Searles et al. 2001a; 
Searles 2010). Global supercooling is a state in which the entire sample reaches a similar level 
of supercooling and secondary nucleation progresses through the whole liquid volume 
followed by solidification of the nucleated sample. In contrast, during local supercooling, 
only a small portion of the total sample volume is supercooled to the temperature at which 
the primary and secondary nucleations occur. In a local supercooling event, large thermal 
gradients exist within the sample and it goes through directional solidification in which the 
nucleation and solidification fronts move into the non-nucleated liquid in close proximity 
to each other (Searles et al. 2001a; Searles 2010). Due to directional solidification, the degree 
of supercooling varies within the sample, resulting in different ice crystal sizes in the 
different regions. Global supercooling is the more preferable of these two mechanisms as it 
results in more homogeneous ice crystal size distribution within the various parts of the 
sample. Global supercooling is usually obtained if one uses typical freeze-drying 
containers, fill volumes and cooling rates (~1°C/min) (Searles 2010). Local supercooling 
occurs typically with fast cooling rates (e.g. liquid nitrogen immersion) and/or high fill 
volumes of the sample (Searles 2010).  
Although water plays a major role in the freezing step, it is not only formulation 
component that needs to be considered. Solutes may crystallize or form an amorphous 
glassy solid via vitrification (Nail et al. 2002). The freezing behaviour of solutes can be 
explained in a simplified fashion using a supplemented phase diagram for binary mixtures 
of water and solutes (Figure 2.3). 
 
 
Figure 2.3. Supplemented phase diagram of a binary system of water (w) and solute (s). Black 
drawings refer to crystallization of solute and grey drawings refer to vitrification of solute. Tm 
and Tg denote to the melting temperature and the glass transition temperature, respectively. 
Crystallization of solute occurs when the eutectic concentration Ce is reached in the eutectic 
temperature Te. In vitrification, eutectic freezing is inhibited and the solute reaches the 
maximally freeze-concentrated state Cg’ in the glass transition temperature Tg’. Adapted with 
permission from Kasper and Friess 2011. 
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During crystallization of ice, ordered crystalline matrices of ice are formed and the 
solutes are forced to become concentrated into the interstitial spaces between the ice 
crystals where unfrozen water still exists (Nail et al. 2002). The solutes will now be in a 
freeze-concentrated state. As the temperature decreases, the solution follows the 
equilibrium freezing curve and the concentration of solutes increases as more ice becomes 
crystallized. The solution becomes more and more viscous until it reaches a critical 
concentration, in which the solution either undergoes eutectic freezing or vitrification. 
In case of crystallizing excipients (e.g. mannitol, glycine), eutectic freezing occurs when 
the eutectic concentration 
e
C  is reached as illustrated in Figure 2.3. In the corresponding 
eutectic temperature (
e
T ), the freeze-concentrated state is saturated and the solutes 
crystallize. Here, the sample consists of pure ice crystals and the interstitial spaces between 
them where the solute molecules have formed an eutectic mixture with small ice crystals 
(Nail et al. 2002; Pikal 2002). In pharmaceutical formulations, the crystallization is usually 
delayed due to the presence of other components (Franks and Auffret 2008). This causes 
supersaturation of the solute, and the creation of a non-equilibrium state that can 
potentially inhibit complete crystallization and lead to the formation of a metastable glass 
(Jennings 1999). Furthermore, crystalline solutes, such as mannitol, can exist as multiple 
crystal forms i.e. polymorphs (Franks and Auffret 2008). 
In amorphous systems, the interstitial material between ice crystals consists of the solid 
solution of solutes and unfrozen water (Nail et al. 2002). As depicted in Figure 2.3, eutectic 
freezing of amorphous excipients (e.g. sucrose, trehalose) is kinetically inhibited and the 
solution follows the equilibrium freezing curve until the maximally freeze-concentrated 
state 
g
C ’ is reached. The corresponding temperature is the glass transition temperature of 
maximally freeze-concentrated solute (
g
T ’). The 
g
T ’ is a point on the glass transition curve, 
below which the system remains as a rigid glassy solid and above it is a rubbery-like 
viscous liquid. The 
g
T ’ value of the formulation can be experimentally determined using 
differential scanning calorimetry (DSC) (Beirowski and Gieseler 2008). 
In multicomponent pharmaceutical formulations, usually both amorphous and 
crystalline phases are present (Nail et al. 2002). Due to microstructural differences, the 
drying characteristics of the crystalline and amorphous systems vary significantly. In a 
purely crystalline material, nearly all of the water is frozen and can be removed mostly via 
sublimation during primary drying. Instead, an amorphous system can contain substantial 
amount of unfrozen water, as much as 20%, that cannot be removed via sublimation. 
Consequently, this water has to be removed via diffusion during secondary drying (Franks 
and Auffret 2008). 
The heterogeneous and stochastic nucleation of ice is a problematic quality issue in 
pharmaceutical freeze-drying as it leads to both intra- and inter-batch variations 
(Costantino and Pikal 2004; Searles 2010). Furthermore, low nucleation temperatures cause 
longer drying times. For these reasons, several techniques have been developed in order to 
ensure that the nucleation will occur at an elevated temperature and to enable simultaneous 
nucleation of the entire batch. With the controlled nucleation techniques, the nucleation of all 
samples can be induced to occur simultaneously at relatively high temperatures (i.e. -5°C) 
resulting in larger ice crystals. This kind of controlled nucleation has been shown to confer 
many advantages over stochastic uncontrolled nucleation e.g. shorter primary drying time, 
reduced protein aggregation, more acceptable visual appearance, faster reconstitution time, 
more uniform RM content and decreased cracking of the vials (Bursac et al. 2009; Patel et al. 
2009; Andrieu and Vessot 2011; Konstantinidis et al. 2011; Awotwe-Otoo et al. 2013; 
Geidobler et al. 2013; Geidobler and Winter 2013; Siew 2013; Awotwe-Otoo et al. 2014). The 
main disadvantage of controlled nucleation is the increased average RM content of the 
batch as compared to a process where nucleation occurs stochastically (Konstantinidis et al. 
2011; Awotwe-Otoo et al. 2014). The methods used to control nucleation have been 
extensively reviewed (Kasper and Friess 2011; Geidobler and Winter 2013) and will not be 
discussed here. In brief, the available commercial applications are based on the ice fog 
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technique (e.g. Millrock’s FreezeBoosterTM and Linde’s Veriseq®) and the depressurization 
technique (Praxair’s ControLyoTM) (Bursac et al. 2009; Siew 2013).  
Traditionally, a thermal treatment called annealing is an additional process step that is 
applied after the freezing step. Annealing can have several functions; promotion of 
crystallization of the solutes, reduction of inter-vial heterogeneity and higher sublimation 
rates (Pikal 1990a; Searles et al. 2001b; Chouvenc et al. 2006; Searles 2010; Andrieu and 
Vessot 2011). In some cases, annealing can also reduce the reconstitution time and improve 
the visual appearance of the dry cake (Searles et al. 2001b; Searles 2010). In brief, annealing 
enlarges the size of ice crystals through Ostwald ripening, reducing the dry layer resistance 
of the product (
p
R ) encountered during primary drying. Moreover, annealing can achieve 
a more uniform mean size of the ice crystals and more homogeneous inter-vial sublimation 
kinetics between the samples. In practice, the temperature of the frozen product is 
increased between the vitreous transition temperature (i.e. 
g
T ’ or 
e
T ) and thermodynamic 
melting point (
m
T ) after the initial freezing step, held isothermally for few hours and 
recooled back to the initial freezing step temperature (Nail et al. 2002; Searles 2010; Andrieu 
and Vessot 2011). The operation of annealing is based on increased diffusional mobility due 
to melting of ice at temperatures above 
g
T ’. However, the consequences of annealing need 
to be carefully evaluated since the system remains longer in freeze-concentrated state 
where the degradative reactions can possibly occur (Pikal et al. 2002). Further, inclusion of 
annealing can decrease the desorption rate during secondary drying due to a reduction in 
the surface area of the porous matrix (Searles 2010). It has been stated that the controlled 
nucleation is the preferable option if one wishes to achieve benefits that would have 
otherwise be gained with annealing (Pikal et al. 2002).  
 
Primary Drying 
The main function of primary drying is removal of ice via sublimation. This is usually the 
most time-consuming step in the freeze-drying process and it can take several days (Tang 
and Pikal 2004). During primary drying, the ice crystals sublimate into water vapor, leaving 
behind a porous matrix consisting of the solidified excipients. The sublimation of ice starts 
from the top layer of the frozen product and proceeds towards the bottom. The moving 
front of sublimation is termed the sublimation interface. The sublimation interface does not 
progress evenly within the product. Instead, the interface is curved so that drying along the 
vial walls is faster than that occurring in the core of the sample (Pikal and Shah 1997). 
Sublimation of ice is possible in conditions where the 
c
p  is lower than the equilibrium 
vapor pressure of ice (
0
p ). The value of 
c
p  is dependent upon the equipment capacity and 
its typical operating range is 30–300 mTorr in pharmaceutical freeze-drying (Pikal 2002). 
The value of 
0
p  increases exponentially as a function of the ice temperature as shown in 
Table 2.1 (Wagner et al. 1994). As a rule of thumb, the value of 
c
p  should be set at 
approximately 1/4 to 1/3 of 
0
p  in order to achieve an optimal sublimation rate (Nail et al. 
2002). 
 
Table 2.1. Vapor pressure of ice at the different temperatures (Wagner et al. 1994). 
T
ice
 (°C) p
0
 (mTorr) 
0 4584 
-10 1949 
-20 775 
-30 285 
-40 96 
-50 30 
-60 8 
 
The product temperature at the sublimation interface (
p
T ) is the most important individual 
parameter in any freeze-drying process, especially during primary drying step. First, it 
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determines the value of 
0
p  as stated in Table 2.1. Second, the maximum allowable value of 
p
T  during primary drying is determined by the critical formulation temperature, 
e
T  for 
crystalline systems and 
g
T ’ or 
c
T  for amorphous systems. Here, 
c
T  denotes to the collapse 
temperature of the formulation that is determined using the freeze-drying microscopy 
(FDM) method (Pikal and Shah 1990). The value of 
e
T  or 
g
T ’/
c
T  defines the highest 
possible 
p
T  at which the process can be conducted without meltback or collapse of the 
product, respectively (Nail et al. 2002). Meltback refers to the melting of a frozen, crystalline 
eutectic mixture. Collapse refers to the occurrence of a viscous flow of the freeze-
concentrated solute in an amorphous system (Nail et al. 2002). Both of these phenomena 
will compromise the quality of the product and should be avoided. Thus, it is 
recommended to conduct primary drying at 3–5°C below the 
g
T ’ of the formulation (Oetjen 
and Haseley 2004).  
The formulation has a significant impact on the efficiency of the process. The length of 
the primary drying time is mainly dependent upon the fill depth, the total solid content and 
the maximum allowable product temperature of the formulation (Pikal 2002). The primary 
drying time is roughly proportional to the square of the fill depth. Furthermore, in 
conjunction with increasing total solid content also increasing dry layer thickness increases 
the value of 
p
R , resulting in longer primary drying time (Pikal 2002). From the process 
efficiency point of view, it is preferable to have a high critical formulation temperature (i.e. 
e
T  or 
g
T ’). As a rule of thumb, it has been stated that the primary drying time can be 
reduced by approximately 13% for every 1°C increase in the product temperature (Pikal 
1990a). The combination of very low product temperatures (< -40°C) and high fill depths 
(~2 cm) is rather impractical since it can take weeks to complete the primary drying step 
(Pikal 2002). 
The freeze-drying process is controlled by three process variables (i.e. 
s
T , 
c
p  and t). The 
selection of the process conditions for primary drying step is basically a balance between 
the limitations set by mass and heat transfer with the objective being to keep the 
p
T  within 
the desired range. First, the primary drying causes an issue for the mass transfer since 
approximately 1000 liters of water vapor are formed in the sublimation of each single gram 
of ice (Pikal 1990a). On its way from the product to the condenser, water vapor faces 
resistances from different sources such as the dried layer of the product (
p
R ), the stopper 
(
s
R ) and the pathway from the chamber to the condenser (Pikal et al. 1984). Although in 
reality, the effect of 
p
R  is the most significant and the others are virtually negligible, except 
for very dilute solutions (Pikal 2002). The value of 
p
R  is dependent upon the ice crystal 
structure and certain formulation characteristics such as the total solid content and fill 
depth (Pikal et al. 1984; Searles 2010). The mass transfer rate of water vapor (dm/dt) during 
primary drying can be expressed by the following equation (Pikal et al. 1983; Pikal et al. 
1984): 
 
 0 c
p s
p pdm
dt R R



.  (2.1) 
 
From Equation (2.1), it is evident that the mass transfer rate increases as the value of 
c
p  
decreases. Therefore, the driving force of sublimation is the pressure difference 
0 c
p p  
(Pikal et al. 1983). However, the sublimation rate cannot be infinitely increased by reducing 
c
p . The mass transfer is coupled to the heat transfer and it is greatly limited at pressures 
below 50 mTorr (Pikal 1985; Costantino and Pikal 2004).  
Therefore, the primary drying is also a heat transfer issue. The sublimation of ice 
requires energy, which is equivalent to the heat of sublimation of ice (
s
ΔH 670  cal/g) 
(Nail et al. 2002). During the steady state of primary drying, the rate of removal of heat 
(dQ/dt) from the product is dependent upon the mass transfer rate and heat of sublimation 
as stated in Equation (2.2) (Pikal 1990a; Franks and Auffret 2008): 
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Furthermore, the samples require a continuous supply of heat in order to maintain a 
constant temperature to allow sublimation to proceed. During the freeze-drying process, 
the input heat transfer being experienced by a single vial is dependent upon its location on 
the shelf, its contact area to the shelf and certain process parameters (i.e. 
s
T  and 
c
p ) (Pikal 
et al. 1984; Franks and Auffret 2008): 
 
  v v s b
in
dQ
A K T T
dt
 
  
 
,  (2.3) 
 
where 
v
A  is the cross-sectional area of the container (i.e. vial), 
b
T  is the product 
temperature at the bottom centre of the vial and 
v
K  is the vial heat transfer coefficient that 
is the sum of the three heat transfer mechanisms present in the freeze-drying process. Since 
the value of 
v
K  is pressure dependent, the transfer of supplied heat also varies as a 
function of pressure. As the pressure increases, the contribution of the effect of convection 
heat transfer becomes more important (Nail 1980). Furthermore, the value of 
v
K  varies 
between the vials of the same batch (Hottot et al. 2005). This phenomenon is especially 
pronounced at low 
c
p  values, causing heterogeneous heat transfer and an uneven 
sublimation rate. It has been shown that an optimal homogeneity of heat transfer can be 
achieved with 
c
p  between 100–200 mTorr (Pikal et al. 1984; Pikal 1985). 
In the freeze-drying process, the heat is transferred by three mechanisms; conduction, 
convection or radiation. Figure 2.4 illustrates the occurrence of these mechanisms during vial 
freeze-drying. 
 
 
Figure 2.4. Heat transfer mechanisms present in the freeze-drying process. The heat can be 
transferred into the sample by radiation, conduction and convection. Conduction can occur 
either through the gas molecules (gas conduction) or through the contact points to the shelf 
(contact conduction). 
 
Conduction is the transfer of heat by a molecular motion from the shelf to the container 
material and further onto the sample. Conduction can occur either through the gas 
molecules or through the contact points between the shelf and the vial by direct contact 
conduction. Convection involves heat transfer via the flow of the gas from a higher to lower 
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density. Convectional heat transfer can occur at the bottom curvature of the vial and via gas 
flow colliding with the sides of the vial. Radiation is a heat exchange occurring via emission 
of electromagnetic (EM) waves from the warmer surfaces (e.g. shelves, walls and door of 
the drying chamber) to the colder surfaces (i.e. frozen samples). In general, radiation is the 
main heat transfer mechanism present during a freeze-drying process. In vial freeze-drying, 
the radiative component constitutes approximately 50% of the total heat transfer at the 
s
T  
value of -20°C and 
c
p  range of 40–200 mTorr. Under the same conditions, the contributions 
of convection and contact conduction are approximately 40% and 10%, respectively. At 
pressures below 40 mTorr, radiative heat transfer is even more pronounced while the 
contributions of pressure-dependent heat transfer components (convection and gas 
conduction) become less important. Conversely at higher values of 
s
T , the contribution of 
contact conduction becomes more important (Ganguly et al. 2013). The effect of radiation 
can be reduced by using thermal shields (e.g. empty vials placed in the outer row of array 
or by attaching an aluminum foil onto the chamber door) and by avoiding the use of highly 
radiation emissive acrylic (i.e. Plexiglass) doors (Nail et al. 2002; Rambhatla and Pikal 2003; 
Kuu et al. 2005; Schwegman et al. 2005; Ganguly et al. 2013). 
 
Secondary Drying 
The purpose of the secondary drying is the reduction of residual water content to a low 
level, usually below 1%-m/m, in order to achieve the optimum stability of the product. 
After primary drying, when all of the ice has been sublimated, the sample still contains 
water (approximately 5–30%-m/m) that was not frozen during the initial freezing step 
(Tang and Pikal 2004; Franks and Auffret 2008). This unfrozen water can exist in several 
forms such as a thin adsorbed layer on the crystalline surfaces, hydrogen bonded to solute 
molecule(s) as a crystalline hydrate or dissolved in an amorphous solid forming solid 
solution (Pikal et al. 1990). In order to remove this water, the temperature of the product 
needs to be increased to allow water desorption from the surfaces of the porous solid 
network. In the amorphous phase of the product, water molecules must diffuse through the 
bulk amorphous layer into the surface before they can be desorbed. This is a relatively slow 
process and the heating ramp must be adjusted so that the product temperature does not 
exceed the glass transition temperature (
g
T ) of the amorphous phase of the product. Below 
g
T , the amorphous phase of the sample is a rigid glassy matrix. When the temperature of 
the sample increases towards 
g
T , the viscosity of the amorphous phase rapidly decreases 
leading to a structural collapse of the cake. Since water acts as a plastizing component in 
the formulation, the value of the 
g
T  will increase as the water content decreases. Therefore, 
once the primary drying has finished, secondary drying is initiated by slowly (~0.1–
0.2°C/min) increasing 
s
T  up to +25°C or higher in order to avoid cake collapse (Pikal et al. 
1990; Costantino and Pikal 2004; Franks and Auffret 2008).  
The RM level of the end product is predominantly determined by the applied 
temperature and time. Usually, the RM value is below 1%-m/m but the optimum value is 
product-specific and is needed to determine empirically (Pikal 2002). It has been 
demonstrated that RM decreases rapidly at the beginning of the secondary drying step and 
then reaches a plateau level that is dependent upon the temperature. The use of a higher 
drying temperature significantly reduces the level of this plateau (Pikal et al. 1990). Since 
desorption occurs from the surfaces, increasing specific surface area of the product 
generally increase the drying rate. Therefore, a lower solid content and a higher degree of 
supercooling (smaller pores) will result in shorter secondary drying times (Pikal et al. 1990). 
Furthermore, for some compounds, the specific surface area can be increased by reducing 
the fill volume (Pikal et al. 1990). Unlike the situation in primary drying, desorption of 
water during secondary drying is not dependent upon cake thickness or 
c
p  at least at 
pressures below 200 mTorr (Pikal et al. 1990). Thus, there is no need to change 
c
p  for 
secondary drying step (Tang and Pikal 2004). 
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2.1.2 Practice of Pharmaceutical Freeze-Drying 
Operation 
Progression a typical freeze-drying process is illustrated in Figure 2.5. 
  
 
Figure 2.5. Typical progress of a freeze-drying process. The lines are coloured according to 
following parameters: blue = shelf temperature, red = product temperature at the bottom of 
the sample measured with thermocouple (TC), purple = chamber pressure determined using 
capacitance manometer (CM) and green = chamber pressure determined using Pirani gauge. 
 
First, the sample containers (e.g. vials) are filled with an aqueous formulation and 
stoppers are placed on the mouth of the vial such that the water vapor can exit the product. 
Then the vials are placed onto the trays that are loaded onto the shelves of the freeze-dryer. 
After loading, the shelves are cooled (blue line in Figure 2.5) at a defined cooling rate 
(~1°C/min) to a temperature which is below the 
g
T ’ or 
e
T  of the formulation (-50...-40°C) 
and then held isothermally to allow the samples reach a thermal equilibrium. The freezing 
step is followed by primary drying. The 
c
p  (purple line in Figure 2.5) is lowered below the 
0
p  and the 
s
T  is elevated (-30...-10°C) in order to achieve conditions where sublimation can 
occur but where the 
p
T  does not rise above the 
g
T ’ or 
e
T . These conditions are maintained 
until all of the ice of the product has sublimed. The length of primary drying can vary from 
hours up to days. Once the ice sublimation has finished, the 
s
T  is elevated to the 
temperature at which desorption of water is possible (typically 0...+40°C) while maintaining 
the 
p
T  below 
g
T . The secondary drying step is relatively short compared to the total length 
of the process, usually only a couple of hours. Once the process has come to completion, the 
drying chamber is back-filled with an inert gas (e.g. nitrogen) and the vials are stoppered 
hydraulically by pressing the shelves together. After stoppering, the vials are unloaded, 
sealed, labeled, packed and stored. Depending on the route of administration, the freeze-
dried product can be used as such in the dry state or be reconstituted back into a liquid 
form (Nail et al. 2002; Pikal 2002; Oetjen and Haseley 2004; Rey 2010). 
 
Equipment 
In essence, freeze-drying is a typical pharmaceutical unit operation. A load of products, 
namely the batch, is freeze-dried at one time. Traditionally, the scale of the process is 
categorized into three levels based on their capacity and function; laboratory, pilot and 
production (Oetjen and Haseley 2004; Franks and Auffret 2008). The scale-up of the freeze-
drying process is usually performed gradually, starting from the smallest scale. In the 
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initial stages of process development, the freeze-drying of small amounts of product is 
usually carried out in a laboratory scale freeze-dryers with a shelf area ranging from 0.1 to 
0.5 2m , equivalent to a maximum batch size of a few hundreds of samples. One relatively 
new aspect emerging in the laboratory scale freeze-drying research and development 
(R&D) has been the application of microscale freeze-drying equipment (Pikal and Shah 
1990; Nail et al. 1994; Hsu et al. 1996). In the microscale technique, individual samples can 
be freeze-dried rapidly and the critical attributes can be analyzed using sample volumes as 
small as microliters. The pilot scale is an important intermediate step between the 
laboratory and the production set-ups. Here the process is refined and the first samples for 
stability studies are generally produced. In the pilot scale process, most of the associated 
operations such as filling, loading and closure of the containers are carried out manually. 
The shelf area of the pilot scale plant is approximately between 0.5 and 5 2m  with a batch 
size maximum of a couple of thousands samples. In the production scale, the shelf area can 
range from 10 up to 50 2m  and the batch size varies from 50000 to 100000 samples, or even 
more. Furthermore, many of the ancillary operations can be automated in the production 
scale according to the product requirements. For example, if working in a sterile GMP 
environment, automatic filling, loading and closure will become necessary (Oetjen and 
Haseley 2004; Franks and Auffret 2008; Schneid and Gieseler 2011; Trappler 2013). 
The design of freeze-dryers can be roughly divided into two groups, namely shelf and 
manifold types (Oetjen and Haseley 2004). In the manifold design, freeze-drying is 
performed in flasks or bottles that are located externally to the dryer in contact with the 
ambient air. Therefore, there is poor control of the process and the product variables. In 
addition, the application of manifold design is limited only up to laboratory scale (Oetjen 
and Haseley 2004). In the shelf design, the samples can be freeze-dried in different types of 
containers (see chapter 2.1.2) located on the shelves inside the freeze-dryer. The process 
control of the shelf type installation is more accurate than with the manifold design. The 
shelf design is the predominant type used in the production scale freeze-dryer plants (Nail 
et al. 2002; Oetjen and Haseley 2004; Adams 2007) and only the shelf type of freeze-dryer 
design will be discussed here. 
The main components of shelf type freeze-dryer are the drying chamber, condenser, 
compressor(s), vacuum pump(s), stoppering mechanism and operating system (Nail et al. 
2002). In addition, the cleaning installations and sample loading/unloading systems are 
intrinsic ancillary devices within larger scale equipment (Oetjen and Haseley 2004). 
Stainless steel is the most common material used in the fabrication of the freeze-dryers 
since it is sterilizable and can withstand the drastic temperature and pressure changes 
occurring during a typical freeze-drying process (Adams 2007). The drying chamber 
contains the temperature-controlled shelves where the samples are to be freeze-dried. In 
typical setting, the shelves are stacked vertically as depicted in Figure 2.6. The sample 
containers are loaded onto the shelves through the chamber door. In laboratory and pilot 
scale equipment, the chamber door can be made of either steel or transparent plexiglass. 
But in production scale plants, steel doors are more common (Oetjen and Haseley 2004). 
The function of the condenser is to collect and solidify the water vapor sublimating from 
the product during the freeze-drying process. The condenser coil is usually located 
externally in a separate chamber with a connecting duct to the drying chamber. Internal 
condenser designs also exist where the refrigerated plates or coil are located on the side 
walls of the drying chamber (Nail et al. 2002; Adams 2007). The refrigeration of the freeze-
dryer is achieved by several compressors and the depressurization is achieved by vacuum 
pumps that can evacuate the system pressure to values of 50 mTorr or even less (Nail et al. 
2002). The typical operating range is 30–300 mTorr (Pikal 2002). The system pressure is 
typically controlled by a needle valve connected to the drying chamber. An inert inlet gas 
such as sterile nitrogen is passed through the valve in order to maintain the pressure at the 
set point value (Pikal 2002). The shelves are usually attached to a hydraulic system that will 
be used to compress the shelf stack together for stoppering of the containers once the 
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process has finished (Nail et al. 2002). Figure 2.6 is a photograph of a shelf type production 
scale freeze-dryer Epsilon 2-300DS manufactured by Martin Christ (Osterode am Harz, 
Germany). 
 
 
Figure 2.6. An example of a production scale freeze-dryer with shelf type design. Martin Christ’s 
Epsilon 2-300DS with the total shelf area of 20 m2, maximum ice condenser capacity of 300 kg 
and integrated CIP and SIP facilities. Adapted with permission from Christ 2010.  
 
Cleaning is an important quality factor in the production of the freeze-dried 
pharmaceuticals. The cleaning systems such clean in place (CIP), sterilization in place (SIP) 
and vaporized hydrogen peroxide (VHP) are usually applied to pilot and production scale 
plants in order to avoid cross-contamination and guarantee an aseptic/sterile operation 
(Oetjen and Haseley 2004). The automatic sample loading/unloading system is an essential 
part of the sterile GMP freeze-drying facility. The two main concepts for the 
loading/unloading systems are automated guided vehicle (AGV) and push and pull system 
(Oetjen and Haseley 2004). In the AGV system, the vials are transported between the filling 
device, drying chamber and the closure device using an automatic transfer cart. The push 
and pull system utilizes a device for loading and unloading of the samples and a conveyor 
belt to achieve transportation of the samples (Oetjen and Haseley 2004).  
Continuous pharmaceutical freeze-drying processes have also been introduced. There 
are now prototype designs of continuous freeze-drying processing in vials (Jennings 1999) 
and frozen granules (Oetjen and Haseley 2004; Rey 2010). The main benefits of the 
continuous operation over the batch processing is the significant decrease in the drying 
time (Jennings 1999) and potentially also better and more equivalent product quality (Rey 
2010; Barresi and Fissore 2011). It has been stated that while some technical issues need yet 
to be resolved, the main required industrial solutions already exist. The main obstacle 
seems to be the need for a change in the mindset; it might be difficult to accept a new 
approach differing considerably from the traditional practice that has been conducted for 
decades (Rey 2010; Barresi and Fissore 2011). Therefore, the widespread pharmaceutical 
application of the continuous freeze-drying process still seems to be far away. 
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Container and Closure Systems 
The containers and closures have a great impact on the quality and throughput of the final 
product, so there are several points to consider when selecting an appropriate system 
(Franks 1998; DeGrazio 2010; Teagarden et al. 2010b). Table 2.2 lists the general 
requirements for freeze-drying containers and closures. 
 
Table 2.2. General requirements for the containers and closures in freeze-drying (Franks 1998; 
DeGrazio 2010; Dietrich et al. 2010; Paskiet and DeGrazio 2010; Teagarden et al. 2010b). 
Containers Closures 
Minimum vial breakage Provide maximum integrity of the product 
Dimensional tolerance consistency Complete stoppering of the whole batch 
Minimum resistance to heat transfer Inert with the formulation substances 
Chemically durable Minimum resistance to the sublimation flux 
Resistance to thermal and mechanical stresses Minimum amout of leachables/extractables 
Robustness against sterilization Minimum moisture ingress 
Inert with the formulation substances Minimum egress of gases 
Capability to complete removal of the dosage Minimum levels of silicone contaminants 
Low alkalinity Resistance to the temperature changes 
Adjustable transparency of the light Functionality for the end user 
Adjustable surface curvature of the product  
Minimum traces of impurities (e.g. metals)  
 
One most important aspect to be considered in freeze-drying containers is the minimum 
vial breakage, from both safety and effectiveness points of view. Other safety aspects for 
containers and closures are minimum drug-container interactions and maximum product 
integrity during storage (Dietrich et al. 2010). When considering the effectiveness of the 
freeze-drying process, attributes such as the minimum heat transfer resistance and the 
ability to achieve good stoppering of the batch become important (DeGrazio 2010). The 
other attributes are also accounted to match predefined quality criteria of a given product 
when selecting an optimal packaging material (Teagarden et al. 2010b).  
One detail to be considered in the filling of the containers is that they are not filled to the 
brim; e.g. for vials the maximum recommended fill volume is approximately 1/3 of the full 
capacity (Nail et al. 2002; DeGrazio 2010). This procedure achieves optimal processing by 
keeping the dry layer resistance of the product at a reasonable level and preventing vial 
breakage during the freezing step. 
In freeze-drying with the shelf type of equipment, there is a wide range of different 
containers that can be used for packaging of the product. Thus, container systems such as 
the vials, syringes, cartridges, ampoules, bulk trays, well systems, blisters and bags are 
available (Bhambhani and Medi 2010; Patel and Pikal 2011; Hibler and Gieseler 2012; 
Kasper et al. 2013b).  
Traditionally, the most commonly used container for the freeze-dried products is a glass 
tubing vial and the typical closure system of the vials is a combination of a rubber stopper 
and aluminum seal as depicted in Figure 2.7a (Bhambhani and Medi 2010; DeGrazio 2010; 
Dietrich et al. 2010; Patel and Pikal 2011). A modern glass tubing vial is the primary choice 
for the container since this has been specially designed for freeze-drying and its attributes 
can be modified to meet the specific requirements of any given application (DeGrazio 2010). 
The tubing vials possess certain quality features such as a thin wall thickness and a low 
bottom concavity to allow improved heat transfer. Moreover, the tubing vials can be 
customized to ensure minimized vial breakage and low drug-container interactions (Pikal 
1985; DeGrazio 2010; Kasper et al. 2013b). Furthermore, the tubing vials can be produced so 
that they have small nominal volumes (< 5 ml) (Hibler and Gieseler 2010). Due to the 
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aforementioned reasons, glass tubing vials now dominate the market of the small-volume 
freeze-drying container systems with a share of 50–55% (Sacha et al. 2010). 
 
 
Figure 2.7. Examples of common container systems used in freeze-drying. a) A glass tubing vial 
containing the freeze-dried product and syringe containing SWFI as a diluent. The vial closure 
system consists of a rubber stopper, an aluminum seal and a plastic flip-off cap. b) A dual-
chamber syringe containing both the diluent and the freeze-dried product (Vetter Lyo-Ject®). 
Adapted with permission from Otto 2014. 
 
Another type of the freeze-drying vial is a molded glass vial. The main notable 
differences in comparison to the tubing vials are its thicker walls, higher mass and the 
steeper bottom concavity (Hibler and Gieseler 2010, 2012). The molded vials are 
mechanically strong and therefore they have a reduced risk of vial breakage (Hibler and 
Gieseler 2012). Thus they are traditionally preferred for the products with high fill volumes 
(> 50 ml) or if there is a high hazard potential (Hibler and Gieseler 2010, 2012). Due to the 
greater concavity of the vial bottom, molded vials have traditionally exhibited poorer heat 
transfer characteristics than the tubing vials (Pikal et al. 1984; Tang and Pikal 2004; Kuu et 
al. 2009). However, modern molded vials can be produced for nominal volumes as small as 
5 ml and they possess comparable heat transfer coefficients as the tubing vials (Hibler and 
Gieseler 2010; Hibler et al. 2012).  
Plastic vials have also been introduced for freeze-drying. Their advantages over the 
traditional glass vials are better break-resistance, reduced mass, higher resistance to pH 
changes and lower likelihood of releasing alkali oxides and traces of metals (DeGrazio 
2010). There is a report of improved uniformity within a freeze-dried cake, which had been 
produced in plastic vials (DeGrazio 2010). The main drawback of the plastic vials is their 
high moisture permeability. Therefore it may be necessary to seal the products using a 
secondary packaging barrier such as pouch of aluminum foil (DeGrazio 2010). 
Furthermore, the heat transfer of the plastic vials is approximately 30% lower than that of 
glass vials (Hibler et al. 2012) leading to an inevitable increase in the process times. Lastly, 
their compatibility to be used with protein formulations are yet to be clarified (Kasper et al. 
2013b). 
 
In order to match the demands of the market, the use of other types of containers has 
been proposed. As a way of achieving enhanced user convenience, the glass-barreled 
syringes and cartridges have been introduced. These containers consist the freeze-dried 
product and the diluent in the same vessel (Teagarden et al. 2010b; Patel and Pikal 2011; 
Otto 2014). An example of a dual-chamber freeze-drying syringe is presented in Figure 
2.7b. These containers have two compartments separated by a stopper in the middle. The 
syringes also have a plunger at the other end. One example of the operation is that the 
liquid product is filled into the syringes/cartridges which are placed into an auxiliary 
plexiglass or aluminum holder platform and then freeze-dried (Patel and Pikal 2010; 
Teagarden et al. 2010b). After the process, the product compartment of the syringe is closed 
with a stopper, the diluent is dispensed into the other compartment and another stopper is 
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used to seal the system. When needed for use, simply pressing the syringe reconstitutes the 
freeze-dried product by allowing the diluent to bypass the middle stopper (Polin 2003). The 
use of a prefilled syringe and a cartridge type of containers can eliminate overfills and 
decrease sterility problems since the final product consists of one piece containing all of the 
accessories required for reconstitution (Sacha et al. 2010; Patel and Pikal 2011). Dual-
chamber syringes suit well for production of single dose products with filling volumes 
ranging from 0.1 to 5 ml (Otto 2014). Today prefilled syringes account for 25–30% of the 
market share of the small-volume freeze-drying containers (Sacha et al. 2010). 
 
High-purity biological standards and reference materials are usually freeze-dried in 
glass ampoules (Matejtschuk et al. 2010; Patel and Pikal 2011). In freeze-drying, the 
ampoules are packed onto the shelves in a hexagonal array similar to vials (Patel and Pikal 
2011) or alternatively special tins may be used (Matejtschuk et al. 2010). When freeze-dried 
in the tins, the liquid product is automatically dispensed prior to the process and the 
ampoules are packed into stainless steel tins that are loaded onto the shelves (Matejtschuk 
et al. 2010). The main advantage of the ampoules is that there is no need for stoppers, which 
are known to be a risk to product integrity (Oetjen and Haseley 2004; DeGrazio 2010). On 
the other hand, the ampoules need to be closed outside of the freeze-dryer in either a flame-
induced fusion or a capillary closure device (Phillips et al. 1991; Matejtschuk et al. 2010). 
This external closure can lead to increased moisture and oxygen levels. In addition, the 
flame sealing can cause blow-out of the product and these phenomena can compromise the 
integrity of the product (Matejtschuk et al. 2010; Patel and Pikal 2011). Due to problems 
inherent in closure, a special ampoule for freeze-drying has been designed in order to 
facilitate flame sealing and to minimize the ingress of oxygen (Matejtschuk et al. 2010). 
 
Trays are used to freeze-dry bulk products. Open-top stainless steel or steel-laminated 
aluminum trays with edges have traditionally been the choice for bulk freeze-drying (Patel 
and Pikal 2011). During operation, the trays are filled with a liquid product and loaded 
onto the shelves. The use of the open metal trays has several drawbacks. First, the product 
in the open-top container is prone to blow-out during the freeze-drying process, resulting 
in smaller yield and the need for extensive cleanup (Patel and Pikal 2011). Second, metallic 
trays may become warped during continued usage and then their heat transfer will be 
impaired (Pikal et al. 1984). 
The LYOGUARD® tray is a newcomer to the freeze-drying of bulk products (Gassler and 
Rey 2004). LYOGUARD® trays are made of polypropylene and they have a semipermeable 
GORE-TEX® membrane top. This membrane does allow the permeation of water vapor but 
inhibits the uptake of contaminant particles or atmospheric moisture (Hibler and Gieseler 
2012). The LYOGUARD® trays have several advantages over the steel trays. They result in 
better yields, prevent cross-contamination, eliminate cleaning issues, have smaller 
mass,and possess more uniform heat transfer properties (Gassler and Rey 2004; Hibler and 
Gieseler 2012). Furthermore, they can withstand sterilization and the mass transfer 
resistance of the membrane is insignificant. However, the functionality of the 
semipermeable membrane on long-term storage has yet to be confirmed (Patel and Pikal 
2011). Therefore, aluminum foil pouches are available to seal LYOGUARD® trays prior to 
storage and shipment (Gassler and Rey 2004). 
 
Different kinds of well systems, e.g. blisters and bags are also used as freeze-drying 
containers, although more rarely. SP Scientific (Warminster, USA) has developed a special 
Virtis 96-well system capable of high throughput freeze-drying. The system consists of 
glass or plastic vials embedded into an aluminum block. The closure of the wells can be 
performed inside the freeze-dryer using a patented LyoCapTM capmat stopper (Patel and 
Pikal 2011). There are also publications describing the use of brass 96-well plates for freeze-
drying (Trnka et al. 2013; Trnka et al. 2014). Blister packages are mainly utilized in the 
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production of freeze-dried, fast orally disintegrating tablets (Hibler and Gieseler 2012). 
Zydis® is an example of this kind of technology. Polyvinyl chloride (PVC) and 
polyvinylidene chloride (PVDC) have reported as being used as the blister material of 
Zydis® products on the European market (Corveleyn and Remon 1997, 1999). However, the 
more challenging environments encountered in North and South America require the use 
of aclar laminates, aluminum foil wraps or blister packs (Seager 1998). The plastic bags are 
the primary packaging type in use for freeze-dried blood products. Freeze-drying in plastic 
bags can require the adoption of supporting structures in order to ensure optimal 
positioning (Hibler and Gieseler 2012). 
 
Excipients 
Only a few freeze-dried formulations consist of the API on its own (Schwegman et al. 2005). 
The excipients are additional formulation substances that carry out different functions in 
order to achieve the required quality criteria of the product. Along with the API itself, 
excipients are of major importance as a part of the freeze-dried formulation and can even 
constitute a major fraction of the freeze-dried solid (Franks 1998; Pikal 2002). The most 
commonly used excipient types and descriptions of their function in the formulation are 
presented in Table 2.3. 
 
Table 2.3. Most commonly used excipients in the freeze-dried pharmaceutical formulations (Lai 
and Topp 1999; Parkins and Lashmar 2000; Wang 2000; Pikal 2002; Schwegman et al. 2005; 
Sadikoglu et al. 2006; Matejtschuk 2007; Carpenter et al. 2010). 
Type Main function Examples of substances 
Stabilizers Protect the API against stresses occurring 
during the freeze-drying process and storage 
Sucrose, trehalose, maltose 
Bulking agents Enhance rigidity and elegance of the dried 
cake via increase in bulk mass  
Mannitol, glycine, dextran, 
PVP, PEG, BSA, HES, inulin 
Surfactants Inhibit freezing-induced denaturation of the 
API 
Polysorbate 20 and 80, SDS, 
poloxamer 188 
Buffers Control and stabilize pH Tris, histidine, citrate, 
phospate 
Tonicity modifiers Reduce the osmotic pressure via isotonicity  Mannitol, glycine, NaCl, 
glycerol 
Collapse inhibitors Increase collapse temperature of the 
formulation 
Dextran, HES 
 
Stabilizers are one very important group of excipients since their function is to preserve 
the API from the adverse effects of freezing, drying and subsequent storage (Pikal 1990b; 
Arakawa et al. 1993; Prestrelski et al. 1993b; Carpenter et al. 1994; Pikal 1994; Roy and 
Gupta 2004). During the freeze-drying process and subsequent storage, many 
biopharmaceutical APIs such as proteins encounter multiple stresses that can trigger 
degradation (Wang 1999; Chang and Pikal 2009; Carpenter et al. 2010; Pikal 2010). 
Therefore, stabilizers are usually required to inhibit or slow down those degradation 
reactions. Several mechanisms have been proposed for protein stabilization by excipients, 
but which the two best accepted theories are ‘water substitute mechanism’ (Carpenter and 
Crowe 1989; Crowe et al. 1993a, 1993b; Prestrelski et al. 1993a; Pikal 2010) and ‘vitrification 
mechanism’ (Hatley et al. 1991; Slade et al. 1991; Pikal 2010). Briefly, according to the first 
hypothesis, during drying the stabilizer (e.g. sucrose) replaces the water’s hydrogen 
bonding with the protein. The latter theory suggests that stabilization is achieved by the 
formation of an amorphous glassy state which immobilizes the protein. However, neither 
of the theories describes all of the details behind the mechanism of stabilization 
(Schwegman et al. 2005; Chang and Pikal 2009; Pikal 2010). Nevertheless, there are some 
commonly accepted facts about the stabilization process. First, the level of stabilization is 
dependent upon the concentration of the stabilizer (Arakawa et al. 1993; Wang 2000; 
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Cleland et al. 2001; Schwegman et al. 2005). Second, the stabilizer needs to remain 
amorphous during processing in order to provide sufficient protection to the API against 
degradation (Pikal 1990b; Lai and Topp 1999; Nail et al. 2002; Pikal 2002; Schwegman et al. 
2005). Disaccharides such as sucrose and trehalose are the most common stabilizers in 
freeze-dried pharmaceutical products. These also act as lyoprotectants in the natural world 
(Wang 2000). Reducing sugars such as glucose and lactose should be generally avoided 
since they are prone to react with the amino groups of proteins and cause degradation via 
the Maillard reaction (Wang 1999; Pikal 2002; Schwegman et al. 2005). Recent studies have 
demonstrated that some rarely used disaccharides such as cellobiose and melibiose can 
provide equivalent or even better protein protection than sucrose or trehalose (Heljo 2013). 
 
In general, the recommended range of the total solid content of the formulation is 
roughly 1–10%-m/v (10–100 mg/ml) in order to avoid undesired effects such as blowout or 
high values of 
p
R  (Pikal 1990b, 2002; Matejtschuk 2007). With some products, the quantity 
of the API is very small and in these cases, bulking agents may be used to increase the total 
solid content of the formulation to above 1%-m/v. Below the aforementioned limit, the 
drying rate is high due to a small 
p
R  value but the product is prone to blowout during 
primary drying. Blowout is a phenomenon in which the water vapor flow detaches some of 
the product off the fragile cake and carries it out of the container (Pikal 2002). Thus, for the 
low dose drugs, it is necessary to increase the bulk mass in order to achieve enhanced 
mechanical strength in the freeze-dried cake. Another function of bulking agents is to 
enhance the appearance of the freeze-dried product to state where it is visually satisfactory 
(Carpenter et al. 1997; Pikal 2002). 
Bulking agents can either crystallize or remain amorphous during the process. The most 
commonly used crystalline bulking agents are mannitol and glycine. Polymorphism is an 
important, but not well understood aspect associated with crystalline bulking agents (Pikal 
2002). Crystalline bulking agents can form different polymorphs during freeze-drying. The 
hydrate forms are usually metastable and should be avoided in the end product, in order to 
ensure sufficient stability and safety (Yu et al. 1999; Pikal 2002). In addition, crystalline 
systems usually require an amorphous excipient (e.g. sucrose) as a stabilizer (Johnson et al. 
2002; Meyer et al. 2009). Bulking agents can also be amorphous. Generally, amorphous 
bulking agents have a relatively high molar mass. Amorphous bulking agents such as 
dextran, polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), bovine serum albumin 
(BSA), hydroxyethyl starch (HES) and inulin have also been reported to be able to exert 
stabilizing effects (Prestrelski et al. 1993a; Anchordoquy and Carpenter 1996; Allison et al. 
2000; Garzon-Rodriguez et al. 2004; Hinrichs et al. 2005; Carpenter et al. 2010). However, 
one has to bear in mind that an excessive amount (> 10%-m/v) of the dissolved solids will 
increase the value of 
p
R  and prolong the drying times (Pikal 2002).  
 
The nonionic surface active agents, surfactants, can exert multiple functions in a 
formulation. The main function of the surfactant is to inhibit surface-induced (i.e. at air-
water and ice-water interfaces) denaturation of protein via a reduction in the surface 
tension of the formulaton (Wang 2000; Carpenter et al. 2010). The addition of surfactants 
has also been shown to decrease the likelihood of aggregation of the proteins (Chang et al. 
1996; Webb et al. 2002; Carpenter et al. 2010). In addition, the use of surfactants may also 
aid the maintenance of protein stability during reconstitution of the freeze-dried product 
(Webb et al. 2002). Surfactants are usually added into the formulation at very low levels, 
often below 0.1%-m/v (Pikal 2002). 
 
Generally, biopharmaceuticals such as proteins are very sensitive to hydrogen ion 
activity and remain stable only within a narrow pH range (Wang 2000). Therefore, buffers 
need to be incorporated to adjust and stabilize the pH of the formulation in liquid state 
(Carpenter et al. 1997; Lai and Topp 1999). However, some buffer compounds (i.e. phospate 
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buffers) should be avoided since they cause a drastic freezing-induced pH shift (Carpenter 
et al. 1997; Croyle et al. 2001; Nail et al. 2002; Matejtschuk 2007; Pikal 2010). The 
concentration of the buffer compounds should be kept low in comparison to other solutes 
in order to avoid the crystallization of the buffer (Pikal 1990b; Pikal et al. 1991; Roy et al. 
1992). Furthermore, high buffer concentrations can alter the storage stability of the product 
(Wang 2000). 
 
Tonicity modifiers are added to the products intended to be administered via 
subcutaneous or intramuscular injection. Their task is to make the reconstituted product 
isotonic and to minimize the pain induced by its administration (Pikal 2002). In many 
products, the tonicity modifiers are most likely included in the diluent rather than in the 
formulation to be freeze-dried (Pikal 2002). However, mannitol and glycine, the most 
common crystalline bulking agents, can also be used to adjust tonicity (Carpenter et al. 
1997; Sadikoglu et al. 2006). Sodium chloride (NaCl) and glycerol are other compounds 
which can be used as tonicity modifiers (Pikal 2002; Sadikoglu et al. 2006). However, the 
amount of NaCl or glycerol should be kept at minimum since both of them lower the 
c
T  
value of the formulation significantly, thus prolonging the freeze-drying cycle (Carpenter et 
al. 1997; Pikal 2002). Further, high salt concentration may cause aggregation of the proteins 
(Pikal 1990b, 2002). 
 
Collapse inhibitors are substances that are added to the formulation in order to make the 
freeze-drying process more efficient by allowing higher drying temperatures (Pikal 1990b; 
Liapis et al. 1996; Pikal 2002). If the formulation has a very low 
c
T  value (i.e. < -35°C), very 
low primary drying temperatures will be required to keep the 
p
T  below 
c
T . Subsequently, 
this will lead to long process times. In addition, if the product possesses a fill depth greater 
than 2 cm along with the low 
c
T  value, the resulting process becomes rather impractical 
(Pikal 2002). In such cases, the 
c
T  of the formulation could be increased by the addition of 
collapse inhibitors, excipients that have relatively high 
c
T  value. For example, the addition 
of dextran (
c
T  -10°C) or HES (
c
T  -5°C) increases the 
c
T  value of the formulation (Pikal 
1990b; Wang 2000; Pikal 2002) and this can achieve a more efficient freeze-drying process. 
The resulting 
c
T  of the formulation can be estimated using the Gordon-Taylor equation 
(Hancock and Zografi 1994). Collapse inhibitors can also have bulking and/or stabilizing 
function in the formulation. 
2.2 QUALITY OF THE FREEZE-DRIED PHARMACEUTICALS 
The pharmaceutical quality can be defined as ‘the suitability of either a drug substance or a 
drug product for its intended use’ (ICH 2009). Quality is a paramount prerequisite of a 
commercial drug product with respect to its safety and efficacy. In the worst case scenario, 
an insufficient level of quality is a medicinal risk causing a threat to the customer, either 
directly or indirectly (e.g. via drug shortage caused by batch rejections and recalls). The 
lack of quality also poses an financial risks in the form of batch rejections and recalls, image 
damage and legal costs (Blackburn et al. 2011). The paradigm of pharmaceutical quality 
assurance is currently shifting from end product testing to ensuring the quality already 
during development and manufacturing. As the guideline of International Conference of 
Harmonization states ‘the quality cannot be tested into products; i.e. quality should be built 
in by design’ (ICH 2009). The following chapters discuss the quality attributes of freeze-
dried products and pharmaceutical quality assurance as understood in the traditional sense 
and according to the prevailing paradigm shift. 
2.2.1 Critical Quality Attributes of the Freeze-Dried Product 
The quality of the freeze-dried end product develops during its whole processing from the 
liquid formulation to a dry solid cake sealed in specified container (Costantino and Pikal 
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2004; Andrieu and Vessot 2011). Quality is the cumulative sum of all formulation and 
processing related attributes such as composition of the liquid formulation, container and 
closure system, sterility level of the processing facility and freeze-drying process conditions 
(Patel et al. 2013). The critical quality attribute (CQA) is defined as ‘a physical, chemical, 
biological or microbiological property or characteristic that should be within an appropriate 
limit, range, or distribution to ensure the desired product quality’ (ICH 2009). The exact 
CQAs are product-specific, but some general quality attributes for freeze-dried products 
are defined in Table 2.4. 
 
Table 2.4. General critical quality attributes of a freeze-dried product (FDA 1993; Carpenter et 
al. 1997; Andrieu and Vessot 2011; Patel et al. 2013; Trappler 2013; Mehta and Dhapte 2014). 
CQA Definition 
Stability The stability of the product is in sufficient level at least until the 
defined date of expiration  
Sterility Level of contaminants should be below a predefined limit 
Moisture content Residual moisture should be within predifined levels 
Visual appearance Elegant, uniform cake structure without observable meltback, 
collapse, shrinkage or cracking 
Reconstitution time For injectables, dry cake is completely dissolved in a reasonable 
time for its intended use (seconds – minutes)  
 
The ultimate reason for freeze-drying is to preserve the stability of the product. Thus, the 
stability of the product is the most important quality attribute and it exerts huge 
significance on the product performance (Carpenter et al. 1997). For example, therapeutic 
efficacy and safety of the product will be dependent upon product stability. Along with the 
moisture, other physical properties of the product such as crystallinity/polymorphism and 
glass transition temperature can have effects on the stability and become a CQA (Patel et al. 
2013; Trappler 2013). Batch-wise, the quality denotes consistent intra- and inter-batch 
product quality. The process has to produce uniform product quality not only within a 
single batch but also between different batches (Trappler 2013). Dose uniformity is 
evaluated on the basis of content uniformity and weight variation (FDA 1993). 
2.2.2 Traditional Approach with End Product Testing 
One could make the provocative claim that the tradition of pharmaceutical quality has been 
biased towards delivering high quality validation reports instead of high quality products. 
In fact, there is a sound evidence to back up this claim. At the end of the 20th century, the 
FDA addressed quality aspect of pharmaceuticals by issuing its Guideline on General 
Principles of Process Validation (FDA 1987). It stated that validation is ‘establishing 
documented evidence which provides a high degree of assurance that a specific process 
will consistently produce a product meeting its predetermined specifications and quality 
aspects’. Retrospectively, the statement itself is valid still today. But, as a consequence, the 
validation process became a discrete, even an isolated, part of quality assurance and 
activities were focused more on the documentation rather than on ensuring quality (Galan 
2010). 
The traditional approach encounters some pitfalls in the concept of ensuring quality of 
the products. First, as a result of series of trial and error experiments, sufficient level of 
quality will be been achieved and some adequate process parameters are obtained. The 
process is then validated using these settings. In practice, this means that the process is 
fixed and these same settings will be utilized in the future with the assumption that the 
process will produce always the same outcome, i.e. constant quality. Second, the quality of 
the whole batch is evaluated based on a few end products. For example, in industrial scale 
freeze-drying, where the batch size may be as many as tens of thousands, the dose 
uniformity is tested from 30 samples and RM is commonly evaluated on the basis of three 
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samples (Trappler 2013). The above assumptions are justified only if the process would 
always deliver an identical and uniform product quality. However, the quality is subject to 
variation due to many reasons such as stochastic and heterogeneous nucleation, ageing or 
moving of the equipment, change in material supplier etc. (Galan 2010). Furthermore, if the 
quality assurance is based on small subsample, this does not most likely represent all of the 
variation present in the quality attributes of the whole batch. However, if this subsample 
meets acceptance criteria, the whole batch is defined acceptable for release into the market. 
Despite the obvious handicaps and the substantial risks involved, most pharmaceutical 
development and manufacturing systems rely on quality assurance often by end product 
testing (Blackburn et al. 2011). 
2.2.3 Quality by Design and Process Analytical Technology 
Regulatory authorities have also addressed the issues related to traditional quality 
assurance. In order to upgrade the state of pharmaceutical manufacturing, product quality 
efficiency and regulatory specifications, FDA reached out towards industry and introduced 
the QbD concept first in 2002 as a result of the pharmaceutical current good manufacturing 
practices (cGMP) (FDA 2004a, 2006). The main goal of the new guidelines is that the 
product should be designed and built to ensure quality instead of being tested for quality 
(FDA 2004a, 2004b). The paradigm shift can be viewed as a step from the concept of 
‘process validation’ towards ‘continuous improvement’. The new guidelines emphasize the 
need for a thorough process understanding and control of CQAs by continuous monitoring 
of the process (Guenard and Thurau 2005). ICH has defined QbD as ‘a systematic approach 
to development that begins with predefined objectives and emphasizes product and 
process understanding and process control, based on sound science and quality risk 
management’ (ICH 2009). The implementation of the QbD approach into pharmaceutical 
development and manufacturing is incorporated in the ICH guidelines Q8, Q9 and Q10 
(ICH 2005a, 2008, 2009). In short, the objective is to assist companies to enhance product 
quality and process efficiency and to make more flexible decision making by the regulators. 
These documents address several aspects encompassing fulfillment of the requirements of 
QbD. The manufacturing and use of a drug product always include some degrees of risk 
and quality related risk makes its own contribution to the total risk. Therefore the quality 
risk management process is initiated with the objective to identify and control any potential 
quality issues encountered during development and manufacturing (ICH 2005a). This step 
requires identification of the relationships between material interactions, applied 
processing conditions and product quality attributes on the basis of sound scientific 
knowledge. As a result of risk management, one can recognize those attributes which have 
significant importance to product safety and efficacy. Based on these attributes, the quality 
target product profile (QTPP) is defined, CPPs and potential CQAs of final drug product 
and raw materials are identified, a control strategy including process and product design 
spaces is established and finally, robust process performance throughout the product 
lifecycle is ensured by ongoing in-process monitoring combined with continual verification 
of the system performance (ICH 2008, 2009; Rathore 2009; Shah et al. 2012).  
Since in-process monitoring is a necessity of QbD implementation, the application of 
new analytical technologies was encouraged in the PAT initiative (FDA 2004b). Here, the 
PAT is considered as ‘a system for designing, analyzing, and controlling manufacturing 
through timely measurements (i.e. during processing) of critical quality and performance 
attributes of raw and in-process materials and processes, with the goal of ensuring final 
product quality’ (FDA 2004b). The PAT initiative emphasized the importance of in-depth 
process understanding to achieve the ability to predict product quality attributes over all 
possible sources of variability such as materials used, process parameters, manufacturing, 
environmetal and other conditions. Implementation of PAT includes three steps: design, 
analysis and control (Rathore et al. 2010). The PAT tools needed to execute these steps can 
be categorized into multivariate tools for design, data acquisition and analysis, process 
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analyzers, process control tools and tools for continuous improvement and knowledge 
management (FDA 2004b). 
2.2.4 Classification of the Process Analyzers for Freeze-Drying 
The QbD approach promotes the application of in-process measurement technologies that 
are able to provide information about the CPPs and CQAs in real-time during the 
processing with the objective of ensuring the quality of the final product. These process 
analyzers can be applied to measure of physical, chemical, and biological attributes present 
during a freeze-drying process. The analysis can be based on the attributes of materials 
being processed or the process parameters. The measurement interface can be established 
in various modes that are defined in FDA’s PAT initiative (FDA 2004b): 
 
At-line The sample is removed from the process and analyzed in close proximity to the 
process stream. 
 
On-line The sample is diverted from the manufacturing process, analyzed, and may be 
returned to the process stream. 
 
In-line The sample is analyzed invasively or noninvasively in its typical state within 
the process stream. 
 
The selection of the most appropriate technique for process monitoring is always case 
dependent. Moreover, the scale of the process and demanded sterility level affect on the 
choice of the monitoring technique. However, some general features of an ideal technique 
have been proposed (Patel and Pikal 2009; De Beer et al. 2011b): 
 
1. Applicable for scale-up and retrofitting to the existing freeze-dryer 
2. Representative measurement principle capturing the desired CQAs and CPPs 
3. Good reproducibility and sensitivity 
4. Convenient verification of the performance during routine operation  
5. Ability to withstand steam sterilization 
 
In addition, the techniques can be roughly categorized into two groups based on 
whether their operational principle relies on monitoring the whole batch or on individual 
sample vials present in the process. These methods are referred to as batch and vial 
techniques, respectively (Barresi et al. 2009b; Johnson et al. 2009; Barresi and Fissore 2011; 
Jameel and Kessler 2012).  
2.3 BATCH MONITORING TECHNIQUES 
Process analyzers for batch monitoring are used to analyze a given parameter assumed to 
be common throughout the whole freeze-drying process. The typical measured parameters 
include pressure, flow or the composition of gas present in the process. In the following 
chapters, the batch techniques are presented according to their principle used in the 
measurement. 
2.3.1 Applications of Pressure Measurement 
Capacitance Manometer 
A capacitance manometer (CM) is used to measure absolute champer pressure (
c
p ) during 
freeze-drying process (Armstrong 1980). This has become the main device for controlling 
the pressure in the freeze-dryers of all scales, mainly due to its robustness, accuracy, wide 
operational pressure range, independence of gas composition and ability to withstand 
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steam sterilization (Nail and Johnson 1992; Patel and Pikal 2009). The functional principle 
of CM is based on the measurement of the capacitance of a flexible metal diaphragm that is 
placed between two fixed electrodes. The reference side of the diaphragm is evacuated and 
sealed to represent zero pressure, less than 410  mTorr. The sample side of the diaphragm 
is exposed to the pressure of the drying chamber. As the pressure of the chamber varies, the 
diaphragm stretches changing its distance to the electrodes. The change in output voltage 
caused by change in capacitance of the diaphragm is directly proportional to the value of 
c
p  (Cameron 1997; Patel and Pikal 2009). When used alone, CM has no capability for 
drying end point monitoring but when combined with Pirani gauge, this becomes possible. 
 
Pirani Gauge 
A Pirani gauge is used to determine the partial pressure of certain gas (e.g. nitrogen) in the 
drying chamber. The operation of Pirani gauge is based on changes in the thermal 
conductivity of the gas present during the freeze-drying process (Nail and Gatlin 1985; Nail 
and Johnson 1992; Bardat et al. 1993). The Pirani gauge contains a metal filament with a low 
emissivity, commonly platinum, that is kept at a constant temperature by controlling 
applied electric current that can be calibrated against the pressure.  
There are several disadvantages associated with using Pirani for pressure measurement. 
Its measurement range is limited to low pressures where the conductive heat transfer from 
the filament to the gas is directly proportional to pressure (Patel and Pikal 2009). The Pirani 
gauge can only achieve a reliable pressure measurement for the gas against which it has 
been calibrated, most usually nitrogen, as the thermal conductivity of gas changes with 
varying compositions (e.g. from water vapor to nitrogen at the end of primary drying). In 
addition, the inaccuracy of the Pirani measurement increases with prolonged usage. This is 
caused by the increased emissivity of the filament due to oxidation (Patel and Pikal 2009). 
Despite its flaws, the joint use with the CM enables primary drying end point detection. It 
can also withstand steam sterilization which is necessary in many industrial applications 
(Costantino and Pikal 2004; Patel et al. 2010a). 
 
Comparative Pressure Measurement 
A comparative pressure measurement is based on the combined use of CM and Pirani 
gauge that is calibrated to nitrogen (Nail and Johnson 1992; Patel and Pikal 2009). During 
primary drying, practically all of the gas in the drying chamber is water vapor. In 
operation, absolute pressure of the system is kept constant, controlled by the CM. Instead, 
the Pirani gauge registers 60% higher pressure than CM as thermal conductivity of water 
vapor is 60% higher than that of nitrogen (Patel et al. 2010a). At the end of primary drying, 
ice sublimation is completed and the majority of chamber gas is changed from water vapor 
to nitrogen. The end point of the primary drying is observed as a slope in the Pirani 
pressure reading that declines to the absolute pressure read by CM (see Figure 2.5) (Nail 
and Johnson 1992; Patel and Pikal 2009). 
 
Pressure Rise Tests 
The pressure rise test (PRT) is a general name for the methods based on the pressure rise 
occurring in the drying chamber during the isolation period (Fissore et al. 2009; Barresi and 
Fissore 2011). The PRT methodology was developed already in the early 1960’s (Kan 1962; 
Neumann 1968). In the PRT method, the flow of sublimated water vapor is momentarily 
(~3-30 s) interrupted by closing the duct connecting the drying chamber and the condenser, 
and the pressure rise is recorded over time at certain frequency using the pressure sensor 
(e.g. CM). A protocol to select the optimal time intervals between the PRTs and sampling 
frequency during PRT has been proposed (Fissore et al. 2010b). Subsequently, the pressure 
rise data are analyzed graphically or mathematically by fitting of a model of the process to 
the data.  
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Several algorithms have been proposed for the model, namely the barometric 
temperature measurement (BTM) (Willemer 1992; Oetjen and Haseley 2004), the 
manometric temperature measurement (MTM) (Nail and Johnson 1992; Milton et al. 1997; 
Tang et al. 2005), the dynamic pressure rise (DPR) (Sadikoglu and Liapis 1997; Liapis and 
Sadikoglu 1998), the pressure rise analysis (PRA) (Chouvenc et al. 2004, 2005; Hottot et al. 
2005) and the dynamic parameters estimation (DPE) (Velardi et al. 2008; Barresi et al. 
2009b). As a solution for the fit, several product and process related parameters can be 
estimated. In general, the method can be used to primary drying end point detection, based 
on the estimated values of the sublimation flow and the residual ice content (Barresi and 
Fissore 2011). The monitoring of secondary drying and observation of the RM content via 
PRT is also possible by combining the measured flux of desorption and mathematical 
modelling of the process (Fissore et al. 2010a). There are several advantages associated with 
the PRT methods i.e. feasible scale-up and compatibility with the automatic vial loading 
systems (Pisano et al. 2013). However, all of the PRT methods can only be applied to the 
freeze-dryers which have an external condenser chamber. The disadvantage of most PRT 
methods for commercial application is the requirement that there should be a fast closing 
valve between drying chamber and condenser (Johnson et al. 2009). Another disadvantage 
of PTR methods is the assumption that there is a constant leak rate of the freeze-dryer once 
they are calibrated. Thus, the obtained results are prone to change after the maintenance of 
the system. Furthermore, depending on the length of the isolation period, there is a risk for 
partial ice melting or collapse due to the increase in value of pT  (Wiggenhorn et al. 2005). 
Although there are many PRT methods, the MTM and DPE methods have been studied 
most extensively. In conjunction with BTM, these have also led to commercial applications. 
Therefore, MTM and DPE are discussed in more detail in the following paragraphs. The 
other PRT methods (i.e. BTM, DPR and PRA) will be briefly discussed at the end of this 
chapter. 
 
In the MTM procedure, the isolation valve is closed for 25 seconds in every 60 minutes 
during which the pressure rise is recorded. Subsequently, the MTM equation, based on 
steady state heat and mass transfer theory, is fitted to the pressure rise data (Milton et al. 
1997; Tang et al. 2005). In the MTM method, the pressure rise is assumed to arise from four 
mechanisms; ice sublimation at a constant temperature, an increase in the ice temperature 
during the isolation period, an increase in the temperature of the ice sublimation interface 
and the leak rate of the chamber. As a direct solution to the MTM equation the values of 
vapor pressure of ice at the sublimation interface (
ice
p ) and 
p
R  are obtained. Based on the 
values of 
ice
p  and 
p
R , several other product and process related parameters are 
determined; 
v
K , dm/dt, dQ/dt, 
p
T , 
b
T  and the ice layer thickness (
ice
l ) (Tang et al. 2006a, 
2006b, 2006c; Gieseler et al. 2007b). The MTM method can be used to detect the end point of 
primary drying and to evaluate moisture content in real-time (Tang et al. 2005). The 
p
R  
data estimated by the MTM has been used to examine the effect of annealing (Lu and Pikal 
2004), the degree of supercooling (Rambhatla et al. 2004), the cake shrinkage (Rambhatla et 
al. 2005) and the sublimation rates during primary drying (Johnson et al. 2010; Parker et al. 
2010). The method has also been used to study the effect of product load on freeze-drying 
behavior (Patel et al. 2010b). The MTM method is a key feature of a commercial freeze-
drying process control and optimization system known as SMART
TM
 (Tang et al. 2005; 
Gieseler et al. 2007b). SMART
TM
 is a feedback system using MTM data to control the 
process by automatically adjusting both the values of the 
s
T  and the 
c
p  in order to 
maintain the 
p
T  value as close to the optimal product temperature as possible (Tang et al. 
2005). SP Scientific has incorporated the SMART
TM
 system into their laboratory scale 
LyoStar freeze-dryer series. 
However, the MTM method is not ideal as it assumes low heterogeneity and radiation 
effects within the batch. In a real life process, the value of 
p
T  varies from vial to vial. This 
heterogeneity causes MTM produced data with a bias towards the colder centre vials (Tang 
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et al. 2006a). Thus, the method cannot be used for monitoring spatially dependent 
phenomena such as the edge vial effects. In addition, the MTM produces valid parameter 
estimates only until the first 2/3 of primary drying. During the latter stage of primary 
drying, MTM tends to underestimate the values of 
p
T  (Tang et al. 2005). This defect is 
attributable to the faster drying of the edge vials that leads to a distorted value in the input 
parameter of sublimation interface area (
sub
A ) as the process proceeds (Tang et al. 2005, 
2006a; Schneid 2009). In order to minimize temperature heterogeneity of the batch, it is 
recommended to use radiation thermal shields (Tang et al. 2006a, 2006b, 2006c). There are 
also some limitations relating to the process and formulation parameters. The MTM 
procedure requires a minimum ice sublimation area in order to obtain valid 
ice
p  and 
p
R  
data. Thus, the method cannot be applied for the drugs with limited availability (e.g. 
expensive API, production scale of few milligrams) (Gieseler et al. 2007b). It is also notable 
that the MTM method has to be performed only for similar type of samples (e.g. same 
formulation and fill depth) since the mixture of products distorts the MTM calculus and 
obtained results (Tang et al. 2006b). The MTM produces unreliable parameter estimates 
when applied to formulations with a high amorphous content (> 150 mg/ml) (Tang et al. 
2005; Gieseler et al. 2007b). A similar observation has been made with a combination of 
high protein content (> 20 mg/ml) and a high primary drying temperature (> +25°C) 
(Johnson et al. 2010). This error is likely due to the ‘re-adsorption’ of water by the dried 
amorphous layer and it becomes more pronounced at the high fill depths of the product 
(Gieseler et al. 2007b). Biased 
p
T  estimates are also observed when the MTM is conducted 
at very low (< -45°C) or high (> +25°C) primary drying temperatures (Tang et al. 2006a; 
Johnson et al. 2010). In addition, due to the heterogeneity present in the batch temperature, 
the 
p
R  values will be underestimated when the MTM is applied to a process with low 
values of 
s
T  (< -20°C) and 
c
p  (< 80 mTorr) (Tang et al. 2006b) or formulations with a low 
total solid content (~10 mg/ml) (Tang et al. 2006c). Subsequently, this systematic error in 
determination of 
p
R  lead to the overestimation of 
v
K  values especially during the early 
stage of primary drying (Tang et al. 2006c). Similar to other PRT methods, the temperature 
of the sample will increase slightly (1–2°C) during the isolation period due to the reduced 
sublimation of ice (Schneid 2009). 
 
In the DPE method, the isolation valve is closed for 20–30 seconds in every 30 to 60 
minutes during which the pressure rise is recorded (Velardi et al. 2008; Fissore et al. 2009). 
In the curve-fitting of the pressure rise data, the DPE algorithm exploits the unsteady state 
mathematical model for the mass transfer in the drying chamber and for the energy balance 
at the frozen layer of the product (Velardi and Barresi 2008). The DPE fitting procedure is a 
non-linear regression analysis performing an internal loop, the algorithm provides an 
approximation of the initial values for two to three parameters (i.e. the sublimation 
interface temperature, the effective diffusivity coefficient and the sublimation area 
correction coefficient) and determines the rest of the parameters iteratively by minimizing 
the difference between the simulated and actual chamber pressure (Velardi et al. 2008). The 
DPE method takes into account the different temperature dynamics existing at the ice 
sublimation interface and at the vial bottom. Moreover, the increase in the pT  during the 
isolation period is also taken into account (Fissore et al. 2010b; Barresi and Fissore 2011). 
The solution of the DPE equation results in the whole product temperature profile from the 
bottom of the vial to the ice sublimation interface 
b-p
T(l) , as well as the estimates of 
p
R , 
ice
l  
and 
v
K  (Velardi et al. 2008). It has been reported that the DPE method can be used to 
primary drying end point detection (Pisano 2009; Pisano et al. 2010). The DPE method has 
been included into a pilot scale Lyotris GMP freeze-dryer by Telstar (Terrassa, Spain). The 
main advantage of the DPE method over the MTM is that it allows parameter estimation 
also during the latter stages of primary drying (Velardi et al. 2008). This is accomplished 
with the introduction of a correction coefficient γ that compensates the reduction of the ice 
sublimation area (Velardi et al. 2008; Barresi et al. 2010). Another advantage over the MTM 
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is that the DPE requires a smaller sublimation interface area (Pisano 2009). The DPE 
method is an integral part of the LyoMonitor and LyoDriver software systems for freeze-
drying process monitoring and control purposes, respectively (Barresi et al. 2009b; Barresi 
et al. 2009c). 
LyoMonitor is a special software combining responses of various devices to monitor 
primary drying (Barresi et al. 2009b; Barresi and Fissore 2011). The configuration of 
LyoMonitor system consists of several thermometers as soft-sensors, the microbalance 
system, the residual gas analyzer (RGA), the dew point monitor and the DPE method 
utilizing the CM as a pressure sensor. The LyoMonitor makes it possible to monitor the 
results from all included PAT tools and evaluation of the status of the process (Barresi et al. 
2009b). The LyoMonitor compiles all the benefits (and drawbacks) of the aforementioned 
tools, providing information of both individual products as well as the whole batch. 
Therefore, the end point of primary can be confirmed from multiple sources (Barresi and 
Fissore 2011). Similar to LyoMonitor, the LyoDriver is also a modular system but its 
software undertakes automatized controlling and optimization of the freeze-drying process 
(Fissore et al. 2008; Barresi et al. 2009b; Barresi et al. 2009c; Barresi et al. 2010; Pisano et al. 
2010). LyoDriver is a model-based control tool to minimize the drying time. The controller 
algorithm of LyoDriver manipulates the temperature of the shelf based on the parameter 
estimates of the DPE (i.e. 
p
T  , 
v
K  and the diffusivity coefficient) and process variables (i.e. 
temperature of the shelf cooling fluid, cooling rate and 
c
p ) (Fissore et al. 2009; Pisano et al. 
2010). The screening of optimal freeze-drying recipe for a given product is possible within a 
few runs (Barresi et al. 2009b). LyoDriver system also detects the end point of primary 
drying and automatically switches the user-determined process conditions for secondary 
drying (Barresi et al. 2009c). It has an advantage over the SMART
TM
 system; the LyoDriver 
takes account of the thermal inertia of the freeze-dryer and the increase in the value of 
p
T  
during the isolation period (Barresi et al. 2009b).  
An improvement was made to the LyoDriver system by the introduction of model 
predictive control (MPC) software for freeze-drying process control (Daraoui et al. 2010). 
The MPC method is also based on the DPE algorithms. One major difference with the 
LyoDriver is that the MPC enables simultaneous manipulation of the 
s
T  and the 
c
p  values 
in order to control and optimize the vapor flow rate and the drying time (Barresi and 
Fissore 2011). Therefore, the MPC is much alike as SMART
TM
 system. The feature of 
controlling both the values of 
s
T  and 
c
p  is an advantage, especially if the mass transfer 
resistance is a major bottleneck for the drying rate or when the optimal value for 
c
p  is not 
known (Pisano et al. 2011). It has been shown that primary drying controlled with the MPC 
is 15% faster than that of LyoDriver (Pisano et al. 2013), although the difference becomes 
negligible if the optimal value of 
c
p  is known by the user applying these methods (Pisano 
et al. 2011). Another clear advantage of MPC over LyoDriver and as well as the SMART
TM
 
system, is that the MPC can recognize presence of the choked flow conditions of the freeze-
dryer. Therefore the MPC can control the optimal vapor flow rate in the constraints set by 
the product and the process (Pisano et al. 2013). 
There are also negative sides to the DPE method; there are no reports where the 
technique would have been used to monitor secondary drying stage or to evaluate RM in 
real-time during the process, unlike the MTM. Like any other PRT method, the DPE 
assumes low inter-vial temperature heterogeneity and low heat radiation transfer effects. 
Despite the γ-factor, the DPE method also results in an underestimation of the 
p
T  values at 
the end of primary drying (Velardi et al. 2008; Fissore et al. 2010b). The isolation period of 
the DPE also interferes with the ice sublimation causing an increase in the 
p
T  value. 
Furthermore, the method is valid only for similar type of products at the time. 
 
Instead of applying mathematical curve fitting, the BTM algorithm uses the pressure 
value in the steepest point of the pressure rise slope with which to estimate the value of 
p
T  
(Oetjen and Haseley 2004; Schneid 2009). Its advantages are noninvasivity due to the short 
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length of the isolation period (3 s) and simple data analysis to predict end point of primary 
drying. The BTM method is the basis of the thermodynamic lyophilization control (TLC®) 
protocol for process monitoring and the determination of primary and secondary drying 
end points (Oetjen and Haseley 2004; Barresi and Fissore 2011). TLC® has been incorporated 
into the freeze-dryers manufactured by GEA (Düsseldorf, Germany). The disadvantages of 
the BTM include lower accuracy of the 
p
T  estimate as compared to other algorithms (Pisano 
et al. 2013) and underestimation of the 
p
T  values towards end of the primary drying 
(Oetjen and Haseley 2004).  
The DPR method is based on unsteady state mathematical model and it is used to predict 
the thickness and temperature profile of the residual ice layer (Liapis and Sadikoglu 1998; 
Fissore et al. 2010b). However, the application of DPR for in-line monitoring is very 
complicated since it requires determination of several initial parameters such as the 
temperature and partial vapor pressure at the vial headspace and the diffusivity and 
permeability of the dried layer (Fissore et al. 2010b; Barresi and Fissore 2011).  
The principle of the PRA is similar to that used in MTM, but it takes account of both the 
heat capacity of the vial glass that is in contact with the product and desorption of bound 
water. The PRA utilizes the simple macroscopic heat and mass balances of the frozen 
product to estimate the values of 
p
T , 
p
R  and 
v
K  (Liapis et al. 1996; Chouvenc et al. 2004). 
The main benefit of the PRA model is the possibility to operate with slow closing valves 
(Chouvenc et al. 2005). PRA also possesses a wider operating temperature range than the 
MTM. However, the parameter estimates of the PRA algorithm are biased especially at the 
early stage of primary drying. This is mainly due to simplified assumptions about the 
product temperature behavior during the isolation period. The value of 
b
T  is assumed to 
remain constant and the temperature increase in the sublimation interface and in the rest of 
the product is regarded as being identical (Chouvenc et al. 2004). 
 
Condenser Pressure 
Condenser pressure (
cond
p ) is usually measured with an additional CM located in the 
condenser. The condenser pressure reflects mostly to the partial pressure of nitrogen. The 
end of primary drying is detected as an increase in 
cond
p  since the frequency of the nitrogen 
bleeds controlling the system pressure increases (Patel et al. 2010a). The drawback of this 
method is the poor sensitivity due to the low magnitude of the pressure increase (Johnson 
et al. 2009). This can be problematic especially in processes with slow sublimation rates of 
ice (Patel and Pikal 2009). 
2.3.2 Applications based on Measurement of Composition or Flow of the Gas 
Tunable Diode Laser Absorption Spectroscopy 
Tunable diode laser absorption spectroscopy (TDLAS) is a method that can be used to 
measure flow and composition of the gas in the duct connecting drying chamber and 
condenser (Gieseler et al. 2007a). Two laser beams are transmitted through the flowing gas 
in the duct, one directed with and the other directed against the vapor flow at an angle of 
45°. The content of the gas is calculated from the absorption lines of the target gas 
molecules using Beer’s Law. The velocity of the flow can be determined using Doppler 
shifted absorption peaks of the two different beams (Lackner 2007). 
The TDLAS is a versatile method and it has been applied to determine the primary and 
secondary drying end points (Gieseler et al. 2007a; Patel et al. 2010a; Awotwe-Otoo et al. 
2014), measure the 
p
T  (Schneid et al. 2009), estimate the value of 
v
K  (Kuu et al. 2009), 
perform an optimization of the process (Kuu and Nail 2009), detect choked flow conditions 
(Patel et al. 2010c) and study the effects of the dryer load on drying behavior (Patel et al. 
2010b). Moreover, TDLAS can be used for RM analysis during secondary drying (Schneid 
et al. 2011) and estimation of the dry layer resistance of the product (Kuu et al. 2011). 
LyoFlux® is a commercial application utilizing TDLAS technology developed by Physical 
Sciences Inc. (Andover, USA). For example, LyoFlux® is compatible so that it can be 
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incorporated into LyoStar laboratory scale freeze-dryer series (Schneid et al. 2009; Schneid 
et al. 2011). The disadvantages of the method include its difficult calibration and the 
requirement that the duct has a sufficient length to allow absorption measurements 
(Gieseler et al. 2007a; Patel and Pikal 2009; Barresi and Fissore 2011). Therefore, it has been 
stated that retrofitting of the TDLAS into existing units could be difficult or even impossible 
(Galan 2010; Barresi and Fissore 2011). Further, it has been reported that TDLAS makes 
inaccurate 
p
T  estimates when used at high 
c
p  values (> 200 mTorr) (Schneid et al. 2009) 
and inaccurate moisture content estimation for products containing low amounts of 
residual water (< 1%-m/m) (Schneid et al. 2011). 
 
Gas Plasma Spectroscopy 
Gas plasma spectroscopy (also known as Lyotrack) measures the ratio of water vapor to 
nitrogen (humidity) in the drying chamber (Mayeresse et al. 2007; De Beer et al. 2009b; De 
Beer et al. 2011a). The main parts of the device are an optical spectrometer and a quartz 
tube combined with a radio frequency transmitter which acts as a plasma generator 
connected to the drying chamber. During operation, gas inside the quartz tube is first 
ionized and photons emitted by the plasma are collected with an optic fiber and diffracted 
with the spectrometer. Since the emission spectrum is a characteristic of the gas 
composition, the humidity of the measured gas can be determined.  
The advantages of the device include its ability to withstand steam sterilization, 
compability for use with organic solvents, feasible retro-fitting, good sensitivity and 
reproducibility to detect both primary and secondary drying end points (Mayeresse et al. 
2007; Hottot et al. 2009; Barresi and Fissore 2011). Adixen (Annecy, France) have exploited 
this technique when developing the Lyotrack system for on-line determination of the 
average moisture content of a batch. Lyotrack has been included into the pilot scale freeze-
dryers by Martin Christ. There are some negative sides to the method; its use during a 
freeze-drying process has been reported to increase the amount of decomposition of API 
due to free radical oxidation (Patel et al. 2010a). 
 
Residual Gas Analyzer 
The RGA can be used to identify the gas composition of the drying chamber by a 
quadrupole mass spectrometer (Kan 1962; Jennings 1980). When it is being used, the gas 
from the process is diverted to the mass spectrometer, where the molecules are ionized and 
accelerated by an electric field. Then the ions are recorded in the detector, depending of 
their mass to charge ratio.  
Due to the high sensitivity and chemical specificity from a gaseous sample, the RGA can 
be applied for multiple purposes during freeze-drying i.e. primary/secondary drying end 
point detection, moisture content determination and monitoring processes with organic 
solvents (Jennings 1980; Willemer 1992; Connelly and Welch 1993; Jennings 1999; 
Wiggenhorn et al. 2005). It can also be applied for in-line freeze-drying process diagnostics 
such as detection of vacuum leakage, sublimation of low molecular weight formulation 
excipients and the detection of contaminant components (e.g. out-gassing of elastomeric 
components, back-streaming of vacuum pump oil) (Leebron and Jennings 1981; Nail and 
Johnson 1992). The method also has been proposed as a way to determince the oxygen level 
for oxidation sensitive products (Patel and Pikal 2009). For example, GEA has introduced 
the RGA based LYOPLUSTM device into their pharmaceutical freeze-dryers to allow the 
direct detection of the contamination and leakage and to provide an indirect estimate of the 
average moisture content of the products via the correlation with the measured chamber 
moisture level. One major disadvantage of the system is the laborious and case-dependent 
calibration for quantitative analysis (Barresi and Fissore 2011). Furthermore, RGA is not 
able to withstand steam sterilization but it can be isolated from damaging steam by using 
an additional valve (Patel and Pikal 2009). 
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Dew Point Monitor 
Dew point monitor is used to determine the frost point that is the temperature at which the 
equilibrium vapor pressure of ice equals the partial pressure of water vapor (Roy and Pikal 
1989). The operation of the method is based on changes in the capacitance of a thin film of 
aluminum oxide due to the adsorption of water. The capacitance is expressed as output 
voltage and calibrated to dew point or partial pressure of 
2
H O . The change of gas 
composition from water vapor to nitrogen causes a decrease in the dew point temperature. 
The advantages of the dew point monitor are its good sensitivity and its ability to detect 
both primary (Genin et al. 1996; Rambhatla et al. 2004; Trelea et al. 2007) and secondary 
drying end points (Roy and Pikal 1989; Bardat et al. 1993). In addition, it has also been 
applied in the on-line determination of residual water, but only during the primary drying 
phase (Genin et al. 1996). The dew point monitor has been incorporated as a PAT tool into 
the laboratory scale freeze-dryers by SP Scientific and Telstar. However, it is not able to 
withstand the steam sterilization (Roy and Pikal 1989) but it can be installed so that the 
sensor is isolated from the steam via a sterilizing filter and valve (Patel and Pikal 2009). 
 
Windmill Sensor 
The windmill sensor is used to measure the water vapor flow between the drying chamber 
and condenser (Barresi and Fissore 2011). The end point of primary drying can be detected 
as a decrease in the flow (Johnson et al. 2009). The main disadvantage of the method is that 
it is poorly sensitive, providing only approximate information about the process (Johnson 
et al. 2009). In addition, the sensor restricts the vapor flow to some extent, causing the risk 
of a temperature increase of the product (Barresi and Fissore 2011). 
2.4 VIAL MONITORING TECHNIQUES 
A common factor for the vial process analyzers is that they are used to analyze a single 
product or group of products during a freeze-drying process. Since the emphasis of this 
chapter is placed on in-line Raman and NIR spectroscopic methods, their off-line 
applications will be also briefly discussed. Other analytical techniques will be described in a 
more concise fashion. 
2.4.1 Applications of Spectroscopic Methods 
Raman Spectroscopy 
Raman spectroscopy is a vibrational spectroscopy technique used in pharmaceutical R&D 
which has emerged in the wake of PAT initiative. Raman spectroscopy provides a wide 
range of physical and chemical information about the sample. The operational principle of 
the Raman method is based on the inelastic scattering of the radiation from the sample 
molecules. When the sample is illuminated with monochromatic radiation, a minor portion 
(~ 810 ) of the incident photons exchanges energy with the sample molecules. This inelastic 
scattering is called the Raman Effect. In order that Raman scattering can occur by the 
molecule, its vibration mode must result in a change in the polarizability of the molecule. 
Raman spectroscopy studies fundamental vibrations and the Raman Effect occurs strongly 
in certain functional groups such as CC, CN and CS (Gardiner and Graves 1989; Long 2002; 
Jestel 2005; Bugay and Brittain 2006b; O'Neil and Edwards 2011). The theory of Raman 
spectroscopy will be more comprehensively discussed in chapter 2.6.2. During the process, 
the sample is irradiated with a laser (e.g. Nd:YAG 532 nm, stabilized diode 785 nm, 
Nd:YVO4 1064 nm) and a fiber optic probe. The scattered radiation is collected with the 
probe, guided to the detector (e.g. CCD, InGaAs) and finally analyzed in order to obtain the 
Raman spectrum (Bugay and Brittain 2006b). Since the water molecule is a very weak 
Raman scatterer, the method is ideally suited for the analysis of aqueous sample matrices 
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which are typically encountered during the freezing and primary drying phases of a freeze-
drying process.  
Raman spectroscopy has been extensively applied in the off-line analysis of the freeze-
dried products. For example, off-line Raman spectroscopy has been used in the solid-state 
analysis of crystalline freeze-dried formulations (Chen et al. 1991; Xie et al. 2008; Grohganz 
et al. 2011), diagnostic investigation of the freeze-dried cells (Shibata et al. 1986; Krafft et al. 
2003), the characterization/classification of the drying-induced changes in the protein 
secondary structure (Byler et al. 1988; Belton and Gil 1994; Al-Azzam et al. 2002; Sane et al. 
2004; Tattini Jr. et al. 2005; Pieters et al. 2012a; Pieters et al. 2013; Pieters et al. 2014), the 
investigation of hydrogen bonding in freeze-dried sugar-polymer formulation (Taylor and 
Zografi 1998) and the evaluation of phase separation in amorphous freeze-dried 
formulations (Padilla et al. 2011a; Padilla et al. 2011b; Padilla and Pikal 2011). 
Raman systems have also been instrumented so that they can perform in-line 
measurements during freeze-drying process, all of these studies found in the literature are 
presented in Table 2.5. In summary, these applications have noninvasively and 
nondestructively assessed the evolution of solid-state form of excipients, monitored drying-
induced changes in protein secondary structure, studied amorphous phase separation 
during the freezing step and utilized Raman spectroscopy in freeze-drying process and 
formulation optimization and as a tool for batch quality control. As can be seen from Table 
2.5, the first in-line applications of Raman spectroscopy were mostly performed using 
laboratory scale shelf freeze-dryers followed by a qualitative analysis of the spectral data. 
However, recently the focus of the research has been on microscale applications with data 
analysis aiming towards more quantitative information. 
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Table 2.5. In-line Raman spectroscopy applications in pharmaceutical freeze-drying. 
Application Scale 
Data 
analysis 
Type of 
analysis 
Reference 
Investigation of solid-state form of mannitol 
during freezing and annealing steps 
Micro1 PCA 
LCE 
Mapping 
Qualitative Beattie et al. 
2007 
 
Monitoring of crystallization and solid-state 
transformations of mannitol  
Lab PCA Qualitative Romero-Torres 
et al. 2007 
Evaluation of the ice behaviour and solid-state 
form of mannitol with different process and 
formulation parameters 
Lab PCA 
MCR 
Qualitative De Beer et al. 
2007 
Study on complementary properties of Raman 
and NIR: Raman for detection of crystallization 
of ice and mannitol, monitoring evolution of 
solid-state form of mannitol 
Lab PCA 
MCR 
Qualitative De Beer et al. 
2009a 
 
Study on complementary properties of multiple 
PAT tools: Raman for monitoring of ice 
behaviour, crystallization and solid-state 
transformations of mannitol  
Lab PCA 
MCR 
Qualitative De Beer et al. 
2009b 
Investigation of crystallization mechanisms of 
fenofibrate and mannitol in controlled 
nucleation 
Lab Univariate/ 
visual 
Qualitative de Waard et al. 
2010 
Batch modelling as quality control tool for 
freeze-drying 
Lab PLS 
PARAFAC 
Semiquant. Sarraguca et al. 
2010 
Freeze-drying process and formulation 
optimization using DOE approach and 
combination of multiple PAT tools: Raman for 
the optimal solid-state composition 
Lab PCA Qualitative De Beer et al. 
2011a 
Characterization of drying-induced structural 
changes of proteins  
Micro Univariate/ 
visual 
Corr. Coeff. 
Semiquant. Hedoux et al. 
2012 
Investigation of protein stabilization 
mechanism by trehalose  
Micro Univariate/ 
visual 
Corr. Coeff. 
Mapping 
Semiquant. Hedoux et al. 
2013 
Study on formation of metastable mannitol 
solid-state forms in different process and 
formulation parameters 
Micro MCR Semiquant. Cao et al. 2013 
1 The used stage was not vacuum-controlled, so only the freezing step was monitored 
 
Raman spectroscopy offers several advantages for freeze-drying process monitoring. 
Since water produces only weak signals in the Raman spectrum, Raman spectroscopy is 
very suitable for the analysis of the aqueous samples (Rantanen 2007; Strachan et al. 2007). 
Therefore, the Raman method can provide critical information about the product during 
the entire freeze-drying process (De Beer et al. 2009a; De Beer et al. 2011b). The method 
does not require sample preparation and its nondestructive nature allows subsequent 
analysis of the same sample (Bugay and Brittain 2006b; Strachan et al. 2007). From the PAT 
point of view, Raman spectroscopy is a powerful tool as it is fast and noninvasive, allowing 
real-time analysis in remote locations from fiber optic probes (McCreery 2000; Bugay and 
Brittain 2006b; Rantanen 2007; Strachan et al. 2007). In addition, Raman measurements can 
be usually conducted through either glass or plastic, making it ideal for direct analysis of 
the products in their packaging (Vankeirsbilck et al. 2002). Raman spectroscopy can also be 
used to detect any collapse of the product occurring during the process (De Beer et al. 
2009b). For comparison to NIR spectroscopy, the linewidths of the Raman spectrum are 
narrower and the chemical specificity of the spectral information is greater (McCreery 
2000). Therefore, Raman spectroscopy is especially well suited to the solid-state analysis of 
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pharmaceuticals (Bugay and Brittain 2006b; Strachan et al. 2007) and for monitoring various 
critical process and product related attributes during a freeze-drying process (De Beer et al. 
2007). 
 
The fluorescence phenomenon has traditionally been the main disadvantage associated 
with Raman spectroscopy. The laser irradiation can result in the transition of the sample 
molecules into the excited electronic state. This excited state is then spontaneously 
fluoresced back to the ground electronic state emitting radiation that masks the Raman 
spectrum. However, fluorescence can be avoided by employing a laser with a longer 
excitation wavelength i.e. NIR lasers instead of those operating in the visible region 
(McCreery 2000; Vankeirsbilck et al. 2002; Strachan et al. 2007; De Beer et al. 2011b). The 
weakness of the Raman Effect is another major limiting factor of this method and because 
of this, analytical concentrations greater than 0.01 M are usually required if one is not to be 
below the limit of detection (McCreery 2000; Kudelski 2008). This is related to another 
problem, in order to achieve the highest possible intensity of the Raman signal, the 
excitation laser power should be kept as high as possible. Unfortunately, this can lead to 
warming or even decomposition of the sample (Vankeirsbilck et al. 2002; Rantanen 2007; De 
Beer et al. 2011b). One proposed way to minimize heating is to rotate the sample (Johansson 
et al. 2002). However, since the sample is stationary during the common freeze-drying 
process in shelf design, this procedure is not possible. Therefore, it is critical to determine 
the optimal measurement conditions (De Beer et al. 2011b). Another issue is the interference 
of the ambient light that can cause artifacts in the Raman spectrum (Rantanen 2007). This is 
especially problematic with larger scale in-line applications where the elimination of light 
from the environment might be difficult (McCreery 2000). If the elimination of the ambient 
light is not possible, its interfering effect can be reduced by using tailor-made fiber optic 
probes or dark spectrum correction (McCreery 2000). In many applications, spectral 
preprocessing (e.g. standard normal variate (SNV) transformation or derivatives) or an 
internal standard is required to reduce the variance caused by interfering effects such as 
fluctuations in excitation intensity and changes in positioning or temperature of the sample 
(Vankeirsbilck et al. 2002; Rantanen 2007; Strachan et al. 2007; Rinnan et al. 2009; De Beer et 
al. 2011b). Although some Raman applications can be conducted with the univariate 
approach, the MVDA of the Raman spectra is often necessary in order to extract the 
relevant information (Vankeirsbilck et al. 2002; Rantanen 2007; Strachan et al. 2007). In 
addition, calibration of the Raman method can be achieved with reference Raman spectra of 
pure analytes or known mixtures (Bugay and Brittain 2006b; Strachan et al. 2007). In some 
applications, it is required to use of other analytical method (e.g. HPLC or XRPD) as a 
reference (Strachan et al. 2007). Another problem with the Raman measurement is the 
effective sample volume that should be as large as possible if one wishes to achieve 
acceptable representativeness (Rantanen 2007). The effective sample volume can be 
optimized by increasing the area that is being measured (Bell et al. 2004); for example by 
employing probes with a larger spot size of the laser beam (Rantanen 2007). The use of a 
larger spot size (diameter of 3–5 mm) has also been reported to enhance the spectral quality 
and decrease the prediction error by minimizing the subsampling effects (Johansson et al. 
2005; Wikström et al. 2005). Since the Raman measurement requires a line of sight from the 
probe to the sample, the Raman probe needs to be placed in close proximity to the vial to be 
monitored and this vial may be then subjected to an increased heat transfer radiation due to 
altered array of the vials. This might lead to an elevated temperature and higher drying rate 
in the monitored vial, reducing the representativeness of the analysis. In addition, the 
placement of the probes into the process requires manual operation, making it difficult or 
even impossible to implement Raman spectroscopy in sterile GMP production scale freeze-
drying processes (Patel and Pikal 2009). 
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Fourier Transform Infrared Spectroscopy 
Fourier Transform Infrared (FT-IR) spectroscopy is a powerful technique to characterize 
molecular interactions occurring in the sample. FT-IR spectroscopy is based on absorption 
of EM radiation, most typically within the middle IR region (4000–400 1cm or 2.5–25 µm) 
(Steele 2002; Brittain 2006a; Griffiths and de Haseth 2007). FT-IR spectroscopy studies 
absorption caused by excitation of fundamental molecular vibrations. In operation, sample 
is irradiated using middle IR light source, most commonly resistively heated silicon carbide 
rod, Globar (Griffiths and de Haseth 2007). Michelson interferometer is an essential piece of 
FT-IR spectrometer. Interferometer produces an interferogram that is transformed into an 
IR spectrum by Fourier transformation (Bugay and Brittain 2006a). FT-IR instruments 
possess several good features required of process analyzer. First, fast acquisition is possible 
since FT-IR equipment enables simultaneous collection of data over the whole spectral 
range without the need of gratings or slits. Second, it has high sensitivity and resolution 
resulting in narrow linewidths and high structural selectivity. Last, the FT-IR spectrometer 
is capable for internal calibration of wavelengths, enhancing precision and reproducibility 
of the acquisition (Bugay and Brittain 2006a; Griffiths and de Haseth 2007). 
FT-IR spectroscopy is highly sensitive to conformational changes of proteins, most 
commonly based on changes in CO stretching band attributable to amide I band (1700–1600 
1cm ) (Carpenter et al. 1998; Pelton and McLean 2000; van de Weert et al. 2001; Kong and 
Yu 2007; Carpenter et al. 2010). Consequently, FT-IR spectroscopy has been frequently 
applied as an off-line technique to characterize conformation of protein and interactions 
between protein and excipients in the freeze-dried formulations (Carpenter and Crowe 
1989; Prestrelski et al. 1993a; Prestrelski et al. 1993b; Costantino et al. 1995; Dong et al. 1995; 
Griebenow and Klibanov 1995). Furthermore, FT-IR spectroscopy was applied to in-line 
freeze-drying process monitoring before NIR spectroscopy applications. FT-IR 
spectrometer with custom-built attenuated total reflection (ATR) sampling accessory was 
used to investigate cryoprotecting mechanism of disaccharide in protein formulation 
during freeze-drying process (Remmele Jr. et al. 1997). Later, real-time IR microscopy was 
applied to study protein secondary structure during freeze-drying process (Schwegman et 
al. 2007). 
There are also some major shortcomings of FT-IR technique to be applied for freeze-
drying process monitoring purposes. First, the presentation of sample for FT-IR 
measurement is problematic since there is usually need of sample preparation. This issue 
can be overcome to a some extent by application of ATR technique that requires little or no 
sample preparation (Bugay and Brittain 2006a; Griffiths and de Haseth 2007). However, the 
sample needs to be in physical contact with the ATR crystal during the measurement. The 
invasive measurement hampers applicability of the FT-IR technique for freeze-drying 
process monitoring. Second, FT-IR spectra of the aqueous samples can be interfered with 
strong water absorbtion in the middle IR region (McCreery 2000; Griffiths and de Haseth 
2007). 
 
Near-Infrared Spectroscopy 
NIR spectroscopy is another vibrational spectroscopic technique that can be applied for 
monitoring of various physical and chemical attributes of the freeze-dried product. Similar 
to other spectroscopic methods, the operation of the NIR spectroscopy method is based on 
the interaction between matter and EM radiation. The NIR region refers to 800-2500 nm of 
the EM spectrum. When the sample is irradiated with NIR light, some of the molecular 
vibrations absorb the energy and are excited to a higher vibrational state. However, all 
molecular bonds are not NIR active. In order to absorb NIR radiation, molecular vibration 
must result in a change in the dipole moment of the molecule. This kinds of molecular 
bonds which can vibrate include OH, CH and NH (Ciurczak 2001; Bokobza 2002; Simpson 
2005; Cogdill and Drennen 2006; O'Neil and Edwards 2011). The theory of NIR 
spectroscopy will be more comprehensively discussed in chapter 2.6.1. In practice, the 
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sample is illuminated using a light source (e.g. halogen light bulb, light-emitting diode) and 
a fiber optic probe. The transmitted/reflected radiation is collected with the probe and 
measured with the detector (e.g. CCD). In diffuse reflectance measurements, the absorbance 
spectrum of the sample is obtained by comparing a diffuse reflected radiation to radiation 
from the reflectance reference (Cogdill and Drennen 2006). NIR spectroscopy is especially 
sensitive for measuring moisture but it can be also applied in many other analyses. 
NIR spectroscopy has been frequently used for off-line analysis of freeze-dried products 
in different pharmaceutical applications such as the determination of the RM content 
(Kamat et al. 1989; Jones et al. 1993; Last and Prebble 1993; MacDonald and Prebble 1993; 
Derksen et al. 1998; Savage et al. 1998; Zhou et al. 1998; Lin and Hsu 2002; Stokvold et al. 
2002; Sukowski and Ulmscheiner 2005; Zheng et al. 2008; Grohganz et al. 2009; Grohganz et 
al. 2010b; Muzzio et al. 2011; Yip et al. 2012), determination of the solid-state form of the 
formulation (Bai et al. 2004; Grohganz et al. 2010a; Grohganz et al. 2011; Grohganz et al. 
2013), differentiation of surface and hydrate water (Derbyshire et al. 2002; Zhou et al. 2003; 
Cao et al. 2006), quantitation of the phenol content in insulin formulations (Maltesen et al. 
2011), determination of protein conformational stability via amide A/II combination band 
(Bai et al. 2005; Izutsu et al. 2005; Izutsu et al. 2006; Katayama et al. 2009; Pieters et al. 2012a) 
and evaluation of a viral vaccine formulations (Hansen et al. 2013). In addition, NIR 
imaging has been applied to detect phase separation in freeze-dried protein-sugar 
formulations (Jovanovic et al. 2006), multi-compound assessment of a freeze-dried 
liposomal formulation (Zidan et al. 2010) and for high-throughput screening of moisture-
induced changes in the freeze-dried protein formulations during storage (Trnka et al. 2014). 
Subsequently, NIR spectroscopy has also proved feasible for in-line monitoring of 
pharmaceutical freeze-drying. All of the in-line NIR freeze-drying applications found in the 
literature are summarized in Table 2.6. These studies have applied NIR spectroscopy for 
characterization of water and ice behavior of the product, determination of the solid-state 
form of the formulation, monitoring of the protein unfolding, freeze-drying process and 
formulation optimization and the detection of primary and secondary drying end points. 
All of the in-line NIR applications were carried out using laboratory scale freeze-drying 
equipment, mainly with qualitative analysis of the data. In addition, the majority of the 
studies employed shelf freeze-dryers and noninvasive measurement principle; with the 
exceptions marked in the footnote of Table 2.6. 
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Table 2.6. In-line near-infrared spectroscopy applications in pharmaceutical freeze-drying. 
Application Scale 
Data 
analysis 
Type of 
analysis 
Reference 
Investigation of ice crystallization, ice sublimation 
and water desorption 
Lab1 PCA Qualitative Brülls et 
al. 2003 
Quantification of water content and determination 
of drying end point 
Lab2 PLS 
PCA 
Quantitative 
Qualitative 
Zhou et al. 
2003 
Moisture content determination during different 
drying stages 
Lab PLS Quantitative Presser 
2003 
Study on complementary properties of Raman and 
NIR: NIR for monitoring drying steps and solid-
state characterization of mannitol 
Lab PCA 
 
Qualitative De Beer et 
al. 2009a 
Study on complementary properties of multiple PAT 
tools: NIR for detection removal of hydrate water, 
determination of drying end point and solid-state 
characterization of mannitol 
Lab PCA 
 
Qualitative De Beer et 
al. 2009b 
Freeze-drying process and formulation optimization 
using DOE approach and combination of multiple 
PAT tools: NIR for investigation of drying phase and 
selection of optimal process step temperatures 
Lab PCA Qualitative De Beer et 
al. 2011a 
Detection of protein unfolding and monitoring 
protein-lyoprotectant interactions  
Lab AWA Qualitative Pieters et 
al. 2012b 
Monitoring of drying-induced changes of 
multicomponent formulation, identification of solid-
state form of mannitol and sublimation of solvents  
Lab Mws 
Corr. Coeff. 
PCA 
Qualitative Rosas et 
al. 2014 
1 Measurement was invasive, NIR probe was in contact with the sample, 2 The dryer used was not a shelf 
type freeze-dryer, instead authors used in-house designed 1-liter filter-dryer 
 
The above applications demonstrate the versatility of NIR spectroscopy as a PAT tool 
that can be applied in the qualitative and quantitative analysis of different important 
product and process related parameters occurring during freeze-drying. Since the water 
molecule is a strong NIR absorber, NIR spectroscopy is a sensitive way to conduct a 
moisture content analysis (De Beer et al. 2011b; Bedi et al. 2012). Other advantages of the 
method include the capability to measure through the glass, and the fact that the technique 
does not require sample preparation or even direct contact with the sample (Büning-Pfaue 
2003; Reich 2005; Cogdill and Drennen 2006; Räsänen and Sandler 2007). These features 
allow a noninvasive and nondestructive measurement principle, meaning that the same 
sample to be used in some other subsequent analysis (Patel and Pikal 2009). Furthermore, 
the method is rapid, robust and the possibility to use remote fiber optic probes enables real-
time in-process measurements (Reich 2005; Luypaert et al. 2007; Räsänen and Sandler 2007; 
De Beer et al. 2011b). Similar to Raman spectroscopy, NIR spectroscopy can also be used to 
detect the collapse of the product during the process (De Beer et al. 2009b). The low molar 
absorptivity of NIR absorbance bands provide a greater information depth of the 
reflectance measurement than can be obtained with ultraviolet-visible (UV/VIS) and IR 
spectroscopies (Cogdill and Drennen 2006; Räsänen and Sandler 2007; De Beer et al. 2011b). 
 
However, the use of NIR as a PAT tool is not only plusses, there are also some 
disadvantages. The strong OH absorbance overwhelms the NIR spectrum during the 
freezing step of the freeze-drying process (De Beer et al. 2009a). This feature hampers the 
analytical ability of NIR to detect critical information during the freezing step. Similar to 
Raman spectroscopy, NIR spectroscopy cannot usually be used as a direct analytical 
technique, the relevant information needs to be extracted from the spectra by calibration 
using some reference method (e.g. HPLC, KF titration) and a MVDA tool such as partial 
least squares (PLS) regression, multiple linear regression (MLR) or principal component 
regression (PCR) (Fearn 2005; Reich 2005; Cogdill and Drennen 2006; Luypaert et al. 2007). 
39 
 
 
 
The calibration is often a laborious, time-consuming task demanding a specialist, requiring 
both NIR and reference measurements and subsequent data analysis of large sample set 
representing the whole concentration region of the analyte under interest (Workman Jr. 
2001; Büning-Pfaue 2003). Moreover, the established calibration model is usually valid only 
for the specific formulation and within the specified variation of the processing parameters 
(Jones et al. 1993; Last and Prebble 1993; Lin and Hsu 2002). Since the NIR spectrum is 
greatly affected by any variations in the sample temperature due to changes in hydrogen 
bonding (Luck and Ditter 1970; Praprotnik et al. 2004; Cogdill and Drennen 2006), the 
temperature perturbations in the spectra need to be taken into account by increasing the 
number of model factors or by estimating nonlinear model terms (Workman Jr. 2001; 
Hageman et al. 2005; Cogdill and Drennen 2006). Especially in an in-line NIR application, 
another problem is to decide how the arrangement and timing of the reference 
measurements for photometric correction (i.e. dark current substraction, normalization) can 
be organized if the equipment does not contain integrated self-referencing technology 
(Cogdill and Drennen 2006). In contrast to IR spectra, the absorption bands of NIR spectra 
are broad and overlapping, resulting in lower specificity of the spectrum and higher 
detection limits of compounds (McCreery 2000; Büning-Pfaue 2003; Luypaert et al. 2007). 
Therefore, spectral preprocessing such as derivatives might be required in order to enhance 
subtle features in the NIR spectra (Cogdill and Drennen 2006; Räsänen and Sandler 2007; 
Rinnan et al. 2009). Since the NIR method is commonly applied to measure individual 
freeze-dried dosage forms (e.g. vials), the information depth (and effective sampled mass) 
need to capture as much of the product mass as possible in order to achieve a 
representative measurement (Cogdill and Drennen 2006). Although the information depth 
of the NIR diffuse reflectance measurement is greater than that of UV/VIS or IR 
spectroscopy, it is a convolution of parameters such as composition, density and particle 
size, but it is also dependent upon the wavelength (Berntsson et al. 1998; Clarke et al. 2002). 
In the literature, the reported values of the information depth have ranged from 0.1 mm 
(Andersson et al. 1999) up to 5 mm (MacDonald and Prebble 1993). In powder blends, it has 
been estimated to be ~1 mm (Cho et al. 1997; Berntsson et al. 1998; Berntsson et al. 1999; 
Olinger et al. 2001). In conjunction with the information depth, the question arises of how to 
determine the optimal location of the illumination spot since it is commonly smaller than 
the dimensions of the sample. For example, if the drying end point and the moisture 
content are to be determined with NIR, the optimal setting would capture information from 
the bottom centre of the vial as it is has been shown to be the final location where the ice is 
sublimated and water desorbs (Pikal and Shah 1997; Sheehan and Liapis 1998). However, 
the current state of technology enables only in-line measurement through the bottom side 
of the vial (De Beer et al. 2009a; De Beer et al. 2009b; De Beer et al. 2011a). In a solid-state 
analysis during freeze-drying, the location of the NIR spot might not be as crucial (De Beer 
et al. 2009a; De Beer et al. 2009b; Grohganz et al. 2011; Grohganz et al. 2013). As for Raman, 
the NIR probe requires a line of sight to the sample. Therefore, placement of the probe 
might lead to elevated sample temperatures. In addition, the current technology does not 
allow for automatic placement of the probes, precluding production scale application, 
especially in the sterile GMP or with automatic loading systems (Patel and Pikal 2009). 
 
Dielectric Spectroscopy 
Dielectric spectroscopy can be applied to study dielectric properties of materials with a 
limited electrical conductivity. Dielectric properties refer to capability of a material to 
polarize in an external EM field. Dielectric spectroscopy operates in the range of 6 1210 10   
Hz of the EM spectrum (Pearson and Smith 1998; Kremer 2002; Barker and Antonijevic 
2011). At the different frequencies, polarization of the material arises from different sources 
(e.g. deformation of electronic orbitals, stretching of atomic bonds, dipolar reorientation of 
molecules, interfacial polarization or surface conductance) (Pearson and Smith 1998; Barker 
and Antonijevic 2011). Dielectric spectroscopy covers different types of methodologies such 
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as frequency-domain impedance analysis (IA), dielectric thermal analysis (DETA) and time-
domain reflectometry (TDR). One common factor in the different techniques is that the 
sample is perturbed electrically (e.g. an electric field, a voltage) and the response of the 
material (e.g. a resulting current) is measured. The ratio between the observed current and 
the applied voltage is dependent of the physico-chemical properties of the sample (Pearson 
and Smith 1998). A dielectric spectrum is obtained from the scan over a range of 
frequencies (Barker and Antonijevic 2011). 
Several off-line studies conducted with DETA methodology have demonstrated the 
potential of dielectric spectroscopy for freeze-drying process monitoring. The method has 
been applied to evaluate the molecular mobility of water and excipients in freeze-dried 
products (Her et al. 1994; Yoshioka et al. 1999; Yoshioka and Aso 2005; Bhardwaj and 
Suryanarayanan 2011, 2012a). This information has been used to predict the stability of the 
freeze-dried protein formulations (Duddu and Dal Monte 1997; Duddu et al. 1997; Pearson 
and Smith 1998; Bhardwaj and Suryanarayanan 2012b). The other off-line studies have 
demonstrated the capability of the method for moisture content determination of freeze-
dried products (Suherman et al. 2002; Ermolina et al. 2007a, 2007b; Ermolina and Smith 
2011).  
Dielectric spectroscopy has also been used for in-line monitoring of the freeze-drying 
process by applying the frequency-domain IA LyoDEATM technology developed by GEA. In 
this system, the electrodes are attached noninvasively to the outer surface of the glass vials 
(e.g. at the neck of the vial) (Smith et al. 2013a). These in-line applications have 
demonstrated the capability of the method to elucidate freezing step (Smith et al. 2014a), to 
correlate the dielectric response to value of 
p
T  (Smith et al. 2013b), to determine the 
sublimation rate and the end point of primary drying (Smith et al. 2013a; Smith et al. 2014b) 
and to estimate the glass transition temperature and the fragility index of the product 
(Smith et al. 2013b). Another commercial application of the dielectric spectroscopy for in-
line freeze-drying process monitoring is exemplified by the LyoRx system introduced by 
Martin Christ. LyoRx monitors the electrical resistance and the temperature of the product 
to permit the determination of the freezing/eutectic point and process optimization. The 
main drawback of the LyoRx is its invasive measurement principle involving immersion of 
the electrodes into the sample solution. 
Dielectric spectroscopy has several advantages for in-line process monitoring. The 
noncontact electrodes allow noninvasive measurement (Suherman et al. 2002), also without 
alteration of the typical hexagonal array of vials (Smith et al. 2013a; Smith et al. 2013b, 
2014a, 2014b). Furthermore, the system can be operated in a multi-channel mode allowing 
simultaneous measurement of multiple vials (Smith et al. 2013a). The method is applicable 
for both liquid and solid samples and it is very sensitive at detecting water (Barker and 
Antonijevic 2011), and thus it should be well suited for freeze-drying process monitoring. 
Even though dielectric spectroscopy is relatively simple in concept, it has not really made a 
breakthrough in pharmaceutical analysis. This is mainly due to the complex interpretation 
of the data (Barker and Antonijevic 2011). The dielectric spectrum cannot be used as a 
fingerprint of the material. Instead, the spectrum needs to be interpreted against a priori 
knowledge of the samples (Barker and Antonijevic 2011). Therefore, a change in some 
process or formulation variable can introduce a bias into the obtained results. Similar to 
TCs and Raman or NIR spectroscopic methods, the dielectric method require manual 
assembly of the cables to connect electrodes. Thus, the method is incompatible with 
automatic vial loading systems nor can it be used in a sterile GMP facility. 
 
Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is a very powerful analytical tool for 
structural analysis of materials in gaseous, liquid and solid state. NMR spectroscopy can be 
applied to study atoms that have non-zero spin quantum number ( I 0 ), for example 1H  
and 13C  (Rule and Hitchens 2006). Briefly, the principle of the NMR method is based upon 
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interaction of an external magnetic field and the nuclear magnetic dipole moments of the 
sample atoms. When the sample is placed in the intense external magnetic field 
0
B , the 
magnetic dipoles start to precess around the field vector 
0
B  with a certain angle  . 
Subsequently, the spins of the nuclei are excited to a higher energy level with a resonant 
radiofrequency pulse 
1
B  orthogonal to 
0
B  (
1 0
B B ), defined by Larmor frequency. During 
the excitation, the nuclei absorb energy causing phase coherence of the dipole moments and 
a change in the precession angle  . After the 
1
B  pulse, coherent magnetization of the 
dipole moments create a resonating magnetic moment that relaxes back to ground state and 
the free induction decay (FID) is measured as a current in the receiver coil over the time. 
The relaxation process is characterized by longitudinal (
1
T ) and transverse (
2
T ) relaxation 
times. Fourier transform of the FID signal and a dimensionless conversion result in a 
chemical shift (  ) spectrum that expresses the local shielding of the nuclear spins from the 
field 
0
B . The value of the parameter   is dependent upon the chemical environment of the 
nucleus (i.e. electron density). The  -scale and spin-spin coupling with the neighboring 
atoms are the tools used to elucidate the structure of the sample molecule (Rule and 
Hitchens 2006).  
The NMR relaxation times determined using temperature-varied NMR spectroscopy 
have been applied to study instability-related molecular mobility in the freeze-dried protein 
formulations (Yoshioka et al. 1999; Yoshioka and Aso 2005; Yoshioka et al. 2011). The in-line 
applications of NMR spectroscopy have used the relaxation times (
1
T  and 
2
T ) in the 
estimation of primary drying end point (Monteiro Marques et al. 1991) and magnetic 
resonance imaging (MRI) in direct observation of the shape and position of the sublimation 
front during freeze-drying process (Li and Nail 2006).  
Despite the major analytical potential of the method, freeze-drying NMR applications 
have been scarce for several reasons. The main obstacle to wide use of the method is very 
complex instrumentation; the requirement of the external magnetic field restricts 
applicability to process monitoring both in laboratory and production scales. Further, 
measurement can be conducted only for an individual product in a specific NMR sample 
tube. Thus, the heat and mass transfer characteristics vary significantly to those in vials or 
other containers during traditional freeze-drying in shelf design. Therefore, the use of NMR 
spectroscopy is limited mainly to off-line freeze-drying R&D (Patel and Pikal 2009). 
2.4.2 Applications of Temperature Measurement 
Thermocouples 
Thermocouples (TCs) are used to measure the 
b
T  of few individual products in the freeze-
drying process (Cameron 1997). TC is a circuit, made of two different metal wires that are 
connected at the ends. When the junction spot is exposed to varying temperatures, the 
Seebeck effect produces a voltage that can be expressed in terms of the temperature 
(Pollock 1991; Park and Hoersch 1993). TCs have a wide temperature range and a fast 
response time. In operation, the tip of the TC is placed where the ice is expected to remain 
longest (i.e. the bottom centre of the vial) (Kan 1962; Roy and Pikal 1989).  
TCs can be applied for primary drying end point detection since a loss of contact with ice 
is observed as a sharp increase in 
b
T  (see Figure 2.5). However, there are several 
disadvantages to the use of TCs. First, the technique is invasive and the vials with TC dry 
faster than the vials without TC. The tip of the TC acts as an additional nucleation site so 
that the vials with the TC freeze sooner with a lower degree of supercooling than the vials 
without TC (Roy and Pikal 1989). The lower degree of supercooling results in a larger pore 
structure and a faster sublimation rate of ice (Searles et al. 2001a; Rambhatla et al. 2004). 
Second, due to point sensing, the thermal response of TC is subject to erroneous end point 
detection of primary drying (Roy and Pikal 1989; Pikal and Shah 1997). Third, the accuracy 
of TCs is mediocre (~1°C). Fourth, not only the tip of the TC needs to be manually placed to 
the vial, but also the TC jack needs to be connected to the jack panel of the freeze-dryer. 
Therefore, the use of TCs cause a substantial sterility risk and they are not compatible with 
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the current automatic vial loading systems (Patel and Pikal 2009). Despite the 
disadvantages, TCs are frequently applied for the freeze-drying process monitoring. 
 
Resistance Temperature Detector 
Similar to TCs, resistance temperature detectors (RTDs) are used for temperature sensing 
(
b
T ) of the selected samples. The principle of operation of the RTD is based on the 
temperature dependence of the electrical resistance of metals. RTDs consist of Wheatstone 
bridge circuit, constructed from coil of metal wire (Pt, Cu, Ni) that is wrapped around a 
ceramic coated platinum tube (Cameron 1997).  
The main differences to the TCs are better accuracy, better repeatability, sterilizability 
and larger thermo-sensitive area. RTDs can also be applied for primary drying end point 
detection. Martin Christ offers PT-100 type of RTDs for the product temperature 
monitoring in their freeze-dryers. Since the use of RTDs is an invasive technique, the 
disadvantages of RTDs are much similar to those of the TCs (Patel and Pikal 2009). In 
addition, the operation of RTD requires an electric current that will generate heat, causing 
an increase in the sample temperature compared to the vials without RTDs. 
 
Temperature Remote Interrogation System 
The temperature remote interrogation system (TEMPRIS) is a wireless temperature 
measurement (
b
T ) technique for individual products developed by IQ Mobil Solutions. The 
operation principle rests upon the temperature dependence of resonance of a quartz crystal 
(Schneid and Gieseler 2008). The sensor tip of the device is connected to the crystal with a 
thermally conducting material. The crystal is wirelessly resonated using an amplitude-
modulated EM signal in the internationally available 2.4 GHz industrial, scientific and 
medical (ISM) radio band. The temperature of the sample is then determined from the 
back-scattered response frequency of free oscillation of the crystal (Schneid and Gieseler 
2008).  
TEMPRIS can be applied for primary drying end point detection. The major advantage 
of TEMPRIS over TCs and RTDs is the wireless and passive battery-free measurement 
principle, enabling compatibility with the automatic vial loading system (Schneid and 
Gieseler 2008; Patel and Pikal 2009). Wireless temperature sensing system called as 
WTMplus has been incorporated by Martin Christ into their pilot and production scale 
freeze-dryers. TEMPRIS is an invasive method so its disadvantages are essentially the same 
as those of TCs and RTDs. An additional negative feature of the current TEMPRIS 
technology is the relatively large probe size in comparison with TCs and RTDs (Patel and 
Pikal 2009). 
 
Optical Fiber Sensor 
Optical fiber sensor (OFS) can be used for invasive or noninvasive monitoring of the 
b
T  
during a freeze-drying process (Kasper et al. 2013a). The main component of the OFS is an 
optical glass fibre containing fiber Bragg gratings (FBGs) with periodical variation of 
refractive index. When the fiber is irradiated, the light is reflected and refracted in the FBGs 
as predicted by Fresnel equations. Since the refractive indices of FBGs are temperature 
dependent, the observed reflection can be expressed in terms of temperature (Kasper et al. 
2013a).  
Similar to other temperature sensors, OFS can be used to detect the end point of primary 
drying. When compared to the TCs and RTDs, OFSs are more sensitive, have faster 
response time and achieve better resolution, enabling detection of events such as 
crystallization of the excipients and the glass transition of the formulation (Kasper et al. 
2013a). Moreover, OFSs can also be applied for noninvasive monitoring of products so that 
the glass fiber is fused outside to the bottom centre of the vial. OFSs are also sterilizable. On 
the negative side, the use of OFSs requires wires that demand manual assembly by the 
operator. 
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Soft-Sensor 
A soft-sensor is a tool that can estimate any product or process variable (e.g. 
p
T ) combining 
a non-contact measurement technique and a priori knowledge of the process (Fortuna et al. 
2007). In freeze-drying, the soft-sensor consists of an externally attached temperature sensor 
(e.g. TC, wireless thermometer) at the bottom of the vial and a mathematical model of the 
freeze-drying process (e.g. Kalman filter algorithm) applying the temperature response.  
The soft-sensor method has been used to establish the temperature profile of the product 
and to estimate of the position of the sublimation front as well the mass and heat transfer 
coefficients (Barresi et al. 2009a; Barresi et al. 2009b; Barresi et al. 2009c; Velardi et al. 2010). 
The method has also been applied for primary drying optimization (Velardi et al. 2009; 
Bosca et al. 2013). The current state of soft-sensor technology makes possible monitoring of 
a group of vials (Barresi et al. 2009b). A wireless system has also been adapted to 
production scale freeze-drying (Corbellini et al. 2010) and at least in theory, it should be 
applicable with the automatic vial loading systems. The soft-sensor has also been used for 
controlling a freeze-drying process in the LyoDriver system in which its response is 
combined with the other analytical tools and the DPE method (Barresi et al. 2009b; Barresi 
et al. 2009c). The disadvantages of the method include interfered conductive heat transfer 
through the bottom of the vial and the inability to monitor secondary drying phase. 
2.4.3 Miscellaneous Applications 
X-ray Powder Diffractometry 
X-ray powder diffractometry (XRPD) is a powerful tool for elucidating the structural 
morphology of a sample. XRPD is widely recognized as a standard technique in the solid-
state characterization of pharmaceutical materials (Gilmore 2011). The main parts of the 
XRPD device are the X-ray source, sample holder, beam collimator, detector and 
goniometer. Shortly, the operation of the method is based on the scattering of X-rays from 
the electrons, atoms and crystal lattices of the sample material. When the X-ray interacts 
with a single electron, the electron starts to oscillate with the same frequency as the electric-
field component of the incident X-ray. This oscillation emits EM radiation in all directions. 
The net scattered amplitude is a result of interference among the multiple spherical waves 
scattered from all electrons. When considering a whole atom that consists multiple 
electrons, the scattering occurs from the electron orbitals causing phase difference of 
scattered waves. The diffraction from the three-dimensional crystal lattices can be generally 
expressed using the Laue equations although in XRPD it is more useful to apply Bragg’s 
Law since that defines relationships between the angle of diffraction, wavelength and 
spacing of the crystallographic planes of the lattice (Pecharsky and Zavalij 2009; Gilmore 
2011). 
Before being used in-line applications, off-line X-ray photography was used to study 
sublimation kinetics of the freeze-dried samples that were extracted from the process using 
a sample thief (Schelenz et al. 1995). Since then, XRPD has been extensively applied to 
study crystallization behaviour of mannitol containing formulations during the freezing 
step and annealing (Cavatur et al. 2002; Hawe and Friess 2006a, 2006b; Dixon et al. 2009; 
Mehta et al. 2013) but also during the entire freeze-drying process (Cavatur and 
Suryanarayanan 1998; Liao et al. 2007; Sundaramurthi and Suryanarayanan 2010). XRPD 
has been also used to reveal the crystal structure of the metastable mannitol hemihydrate 
(Nunes et al. 2004).  
The main advantage of the XRPD is that it allows the investigation of the effect of 
process and formulation parameters on crystalline form of the excipients. This feature 
allows optimization the process and formulation so that the desired polymorphic form of 
the end product can be obtained. Further, the XRPD analysis can be applied to both 
qualitative and quantitative analysis and it is very sensitive at detecting even small 
chemical changes in the sample (Gilmore 2011). One major disadvantage of the XRPD for 
the freeze-drying process monitoring is that its use is limited to the micro- or milliliter scale, 
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studying only an individual sample. A substantial size of the instrument combined with its 
incapability for remote sampling rule out the instrumentation of the method to the larger 
scale. Furthermore, since the analysis is limited to the solid-state characterization of the 
sample, a vast number of other CQAs or CPPs cannot be monitored with XRPD. For these 
reasons, XRPD is tends to be used only in pharmaceutical freeze-drying R&D.  
 
Microbalance 
Microbalance systems are used to determine the mass loss of the water/ice during a freeze-
drying process (Pikal et al. 1983; Wiggenhorn et al. 2005; Patel and Pikal 2009). The device 
typically consists of a small balance with a holding arm for a vial. During the process, the 
vial is periodically lifted and weighed during ~10 s period.  
The microbalance system can be applied to measure the sublimation rates of samples 
(Pikal et al. 1983; Roth et al. 2001; Rovero et al. 2001; Gieseler and Lee 2008a, 2009; Hottot et 
al. 2009), thus enabling determination of primary drying end point. The technique has also 
been applied for the determination of the 
p
R  values of different materials (Pikal et al. 1983; 
Gieseler and Lee 2008b) and the investigation of the desorption rate during secondary 
drying (Pikal et al. 1990). The method is not limited to weighing of only a single vial since it 
has been described a modified system capable of simultaneous measurement of 15 vials 
(Vallan 2007; Barresi et al. 2009b). Martin Christ has included the LyoBalance microbalance 
system into some of their pilot scale freeze-dryers.  
The disadvantages of the method include interruption of the conductive heat transfer 
from the shelf to the vial during the weighing period (Roth et al. 2001). In addition, since 
the monitored vial is outside the tight hexagonal array of other process vials, it receives 
more heat via radiation transfer meaning that it is subjected to a higher sublimation rate 
(Hottot et al. 2009; Patel and Pikal 2009). Since the instrumentation of the microbalance 
demands manual operation, it is not compatible for use in the sterile GMP or with an 
automatic loading system. In addition, the microbalance is not able to withstand steam 
sterilization and the shelf where it is located cannot be used for hydraulic stoppering. 
 
Heat Transfer Monitor 
The calorimetric measurement of the heat transfer from the shelf to the bottom of the vial 
can be used to monitor the primary drying stage. The method utilizes an array of paired 
TCs, one attached to the bottoms of an empty vial and the others to a product vial (Jennings 
and Duan 1995) or to the top of the shelf and bottom of the vial (Chen et al. 2008). These 
methods are called drying process monitoring (DPM) and heat flow transducer, 
respectively. In the process, the observed voltage represents the heat flow. 
The method can be applied for the detection of the primary drying end point (Jennings 
1999; Chen et al. 2008). The drawbacks of the method are the manual assembly of 
transducers and the interference with heat transfer (Patel and Pikal 2009), causing a sterility 
risk and incompatibility with automatic loading systems. 
 
Photographic Observation 
A visual monitoring of the sublimation interface can be accomplished by photographic 
observation. In the operation, the pictures of the sublimation front are captured at the 
suitable intervals. Photographic observation has been used to study sublimation and to 
compare the real situation with theoretical models of drying characteristics at either the 
microscale (Zhai et al. 2003) or in laboratory scale freeze-drying (Zhai et al. 2005; Chen et al. 
2008).  
There are several weaknesses with the method. The visual observation is limited only to 
primary drying and the end point detection is not reliable since the ice sublimation 
interface is not geometrically planar within the sample vial (Patel and Pikal 2009). 
Moreover, capturing of the photographs requires a line of sight to the sample. Thus it is 
compatible only with freeze-dryers containing a transparent door or window. For these 
45 
 
 
 
reasons, the application of photographic observation has no real use as a PAT tool for 
freeze-drying. 
2.5 SUMMARY OF THE PROCESS MONITORING TECHNIQUES 
All of the freeze-drying process monitoring PAT tools described and their main features are 
listed in Table 2.7. In general, the batch techniques are more readily amenable to be applied 
for larger scale sterile GMP freeze-drying than the vial techniques, mainly due to their 
feasible scale-up without the need for manual operation, sterilizability and compatibility 
with the automated vial loading systems. Some of the batch techniques (i.e. PRT, TDLAS, 
Lyotrack and RGA) are able to deliver product related information such as temperature and 
moisture content. However, the obtained value is an average of the entire batch and can be 
unreliable in extreme or heterogeneous freeze-drying process conditions (e.g. PRT, 
TDLAS). Moreover, the accuracy of PRT and TDLAS methods is reduced in situations 
where the water vapor flow is reduced (i.e. small initial sublimation area or during the 
latter stages of the process). Furthermore, none of the batch techniques allows monitoring 
of the solid-state of the product.  
Instead, the vial techniques are the only available methods to elucidate product-specific 
characteristics (not all listed in Table 2.7). Spectroscopic methods such as Raman, NIR and 
dielectric spectroscopy can be used to extract individual product information as well as the 
process information. Only the aforementioned methods provide any insight about the 
individual critical product parameters such as the solid-state form, water and ice behavior, 
collapse and the moisture content. These are major advantages over the batch techniques 
especially in the process and formulation R&D phase. However, the lack of representativity 
of the analysis is the main disadvantage encountered with all vial techniques. Further, most 
of the vial techniques require manual operation and thus are not compatible with the 
automatic vial loading systems. Moreover, many of the vial techniques are not able to 
withstand sterilization. 
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2.5.1 Special Aspects of Raman and Near-Infrared Spectroscopic Methods 
Instrumentation 
From the process monitoring point of view, the stationary nature of the traditional batch 
freeze-drying makes it relatively easy to approach. During the freeze-drying process, the 
samples are kept in the same positions. In contrast, during other typical pharmaceutical 
unit operations such as blending, granulation or tabletting, the sample mass is in 
continuous movement complicating the implementation of process analyzers. However, 
several other aspects need to be taken account when implementing process analyzer for 
freeze-drying process monitoring. For example, the extreme processing conditions, the 
design of the freeze-dryer, minimizing sample interference and the applied loading, 
stoppering and cleaning systems pose special demands of any monitoring technique. The 
instrumentation of the spectroscopic method such as Raman and NIR requires the use of 
remote probe heads and fiber optic cables. These have to be capable of providing reliable 
data under the extreme temperature and pressure changes typically encountered during 
the freeze-drying process. Ideally, fibers and probes also have to be able to withstand 
cleaning and/or sterilization procedures. Further, one needs to organize the 
instrumentation of the probes and fibers (i.e. interfacing into the drying chamber and the 
placement). Usually, manual operation is required in order to introduce the spectroscopic 
accessories into the freeze-drying process. However, when working either in sterile GMP 
production or with automatic loading and CIP/SIP systems, the manual placement of the 
probes and fibers is not possible. In such cases, spectroscopic monitoring cannot be done 
unless an alternative way can be found for interfacing. 
 
Container Type and Material 
The type and material of the container are crucial aspects when considering freeze-drying 
process monitoring with Raman and NIR spectroscopic methods. The material should be as 
transparent as possible in the NIR region since the noninvasive measurements of the 
products through their final packaging are preferred. In particular, in in-line process 
monitoring applications, interfacing without subsampling is a common prerequisite 
(Ciurczak and Drennen 2001; Cogdill and Drennen 2006; Rantanen 2007; De Beer et al. 
2011b). Both Raman and NIR spectroscopy can be used to acquire sample spectra through 
most of the common pharmaceutical packaging materials (i.e. glass and plastics) but there 
are some restrictions. In conventional backscattering Raman spectroscopy, quartz is the 
most preferable container material since it is virtually transparent in the NIR region 
(Griffiths and de Haseth 2007). Glass is also a relatively weak Raman scatterer and 
measurements are usually possible without removal of the sample from its container 
(McCreery 2000; Vankeirsbilck et al. 2002; Bugay and Brittain 2006b; LaPlant 2010). 
Although any increase in the wall thickness of the container will increase the signal 
attenuation, the measurements through up to 3 mm thick glass are possible with only 60% 
signal attenuation (McCreery 2000). Further, if one utilizes 180° backscattering geometry, 
then the shape of the container area under measurement is not critical since the 
illumination and collected radiation pass through the same surfaces (McCreery 2000). 
Raman spectroscopy can also be applied for the analysis of intact dosage forms in many 
plastic containers when operating in the NIR wavelength range (McCreery 2000; Johansson 
et al. 2010). However, plastics generally have much stronger Raman bands than quartz or 
glass (Berger 2010). Thus, the applicability of Raman spectroscopy on the plastic container 
systems needs to be carefully evaluated. If substantial interfering spectral effects from the 
container material are observed, these can be either substracted by response calibration 
with luminescence standards (McCreery 2000) or corrected by applying the spatially offset 
Raman spectroscopy (SORS) mode instead of backscattering measurements (Macleod and 
Matousek 2008; Macleod et al. 2010). 
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Diffuse reflectance NIR spectroscopy can be applied to measure samples inside glass (or 
quartz) containers (McCreery 2000; Williams 2001). However, the absorption of secondary 
overtones of the OH at 1400 nm is a characteristic encountered with some glass types 
(Kawata 2002). The NIR measurements can also be conducted through plastics but the 
absorption by the container material needs to be determined and possibly eliminated by 
subtracting the material reference spectrum from the sample spectrum or reducing the 
spectral region for analysis (Williams 2001). In general, increasing the thickness of the 
packaging material can decrease the spectral sensitivity of the measurement (Ciurczak and 
Drennen 2001). 
In summary, the most common freeze-drying container types (i.e. vials and syringes) are 
generally applicable to be monitored with Raman and NIR spectroscopic techniques if one 
takes account the packing material. However, in certain cases where some auxiliary sample 
platform (e.g. an aluminum sample holder for syringes or steel tins for ampoules) is used 
during freeze-drying, the line of sight from the probe head to the sample might be lost and 
the implementation of spectroscopic monitoring becomes close to impossible.  
 
Excipients 
The excipients are also of special significance since the solid content of the vial (or other 
container) is the subject of the measurement. Especially with low dose drugs, excipients 
such as stabilizers and bulking agents can make up the majority of the total solid content of 
the product (Pikal 2002). The type and concentration of the used excipients affect the 
measured spectrum. For example, different solid-state forms of the excipients can be 
distinguished from Raman and NIR spectrum (De Beer et al. 2009b). Furthermore, since the 
information depth of the spectroscopic measurement is dependent upon the density of the 
measured sample (Berntsson et al. 1998; Clarke et al. 2002), it is also most likely to be 
dependent upon the total solid content of the freeze-dried formulation. 
 
Scale-Up 
It does seem that the technical prerequisites of Raman or NIR spectroscopic monitoring in 
production scale can be fulfilled. However, the production scale application of either of 
these methods is still some way from being a reality (De Beer et al. 2011b). In the short term, 
the most probable applications of these methods might be found in smaller scale freeze-
drying processes related to R&D. Since the R&D is usually conducted on the smaller scale, 
the scalability issue of the Raman and NIR techniques becomes less significant. Further, the 
possibility to operate at a smaller scale saves resources, which is a very beneficial attribute 
in the case where the API is subject to limited availability. In addition, operation on a 
smaller scale saves the time needed for analysis and this can streamline process 
development since the total process time is decreased drastically. 
2.6 SPECTROSCOPIC METHODS 
The term spectroscopy refers to the investigation of the interaction between EM radiation 
and material. This interaction can be expressed in terms of energy transfer from an external 
radiation to a given property of the material (e.g. the bonds in a molecule). These types of 
interactions include absorption, scattering, emission etc. There are a vast number of 
different types of spectroscopic methods; they are commonly categorized according to the 
wavelength region of the EM spectrum where the certain types of interactions occur. 
Vibrational spectroscopies study transitions between vibrational energy levels of the 
molecule. These transitions can be observed directly through absorbance in the IR region of 
the EM spectrum or through inelastic scattering of incident energy via the Raman Effect 
(Brittain 2006b). The content of this chapter is focused only on theory of Raman and NIR 
spectroscopies since they were the methods used in the experimental part of the work. 
Table 2.8 compares the characteristic features of Raman and NIR spectroscopies. 
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Table 2.8. Comparison between characteristics of Raman and NIR spectroscopies (Siesler 2002). 
Parameter Raman spectroscopy NIR spectroscopy 
Interaction Inelastic scattering Absorption 
Excitation radiation Monochromatic VIS-NIR Polychromatic VIS-IR 
Selection rule for 
vibration  
Change in polarizability 
 
Change in dipole moment 
 
Vibrations Fundamental Overtones and combinations 
Structural selectivity High Low 
Region of radiation 
4000–50 cm-1 
2.5–200 µm 
12500–4000 cm-1 
800–2500 nm 
 
Raman spectroscopy measures the fundamental vibrations occurring in the middle IR 
region of the EM spectrum (4000–400 1cm  or 2.5–25 µm). In general, Raman spectroscopy 
is useful in characterizing molecules which possess symmetric vibrations or nonpolar 
groups characterized by a high degree of polarizability. Such groups (e.g. C–S, S–S, C–C, 
N=N, and C=C) exert significant changes in the induced dipole moment upon excitation. In 
contrast, NIR spectroscopy measures the spectral transitions associated with overtones and 
combinations of fundamental vibrations occurring in the NIR region of the EM spectrum 
(12500–4000 1cm  or 800–2500 nm). Usually, the molecules possessing antisymmetric 
vibrations and polar groups yield the most intense NIR absorption bands. The most 
commonly utilized bands in NIR region include hydrogen atom; C–H, N–H, O–H and S–H 
(Ciurczak 2001; Brittain 2006b; Bugay and Brittain 2006b; Cogdill and Drennen 2006). Table 
2.9 compares the factors determining Raman and IR activity of a simple diatomic molecule. 
Raman and NIR spectroscopies can be considered as complimentary methods due to their 
differences in the type of interaction and the selection rule of the vibration. Raman 
spectroscopy is associated with the measurement of scattered photons of the incident 
radition while NIR spectroscopy studies the photons absorbed by the sample molecules. In 
order to be Raman active, a particular bond must evoke a change in the polarizability ( ) 
during its vibrational mode. The corresponding selection rule for IR (and NIR) active 
vibration is the change in the dipole moment ( ).  
 
Table 2.9. Raman and IR active vibrations of homonuclear and heteronuclear diatomic 
molecules (Keresztury 2002). 
Parameter 
Type of molecule 
X
2
 X-Y 
Normal mode of vibration 
X-X stretching 
 
X-Y strecthing 
Dipole moment 0  
Derivative of dipole moment 
0
0
Q
 
 
 
 
0
0
Q
 
 
 
 
IR activity No Yes 
Shape of polarizability ellipsoid 
 
 
 
Derivative of polarizability 
0
0
Q
 
 
 
 
0
0
Q
 
 
 
 
Raman activity Yes Yes 
 
The spectroscopic applications can be used to obtain quantitative information of the 
sample in such occasions where a relationship exists between the measured variables and 
quantity of interest (i.e. concentration) (Beebe et al. 1998). This relationship is defined by 
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Beer’s Law stating that the spectral absorbance y at certain wavelength   is proportional to 
the concentration x of the analyte (Heise and Winzen 2002): 
 
      y dx ,  (2.4) 
 
where the   is the molar absorptivity of the analyte at the particular wavelength and d is 
the optical pathlength. The following chapters 2.6.1 and 2.6.2 discuss the theoretical 
background of the transitions observed in NIR and Raman spectroscopy, respectively. 
2.6.1 Near-Infrared Spectroscopy 
Basics of Near-Infrared Spectroscopy 
The first report on NIR radiation was published by William Herschel already in 1800 
(Herschel 1800). He used a glass prism to refract beam of sunlight into a spectrum and 
measured temperature changes within each color. He observed that the temperature 
increases beyond the visible red and postulated a new invisible form of light, infra red. NIR 
spectroscopy operates in the wavelength region 800–2500 nm of the EM spectrum. The NIR 
spectra arise from the absorption bands resulting from the overtones and combinations of 
the fundamental middle IR stretching and bending vibrations (Ciurczak and Drennen 2001; 
Simpson 2005; Cogdill and Drennen 2006). The vibrations appearing in NIR region result in 
broad overlapping peaks with lower absorption intensities than in the middle IR region. 
The lower absorption is due to low transition probability of overtones and combinations 
that causes the intensity of a particular vibration to decrease by a factor of 10–100 from its 
fundamental counterpart (Ciurczak and Drennen 2001; Siesler 2002; Simpson 2005; Cogdill 
and Drennen 2006). Along with its issues, the low molar absorptivity present in NIR region 
has also some analytical benefits over middle IR. These include its ability to analyze 
condensed samples, the greater depth of analyzed sample matrices and the quantification 
of analytes in the presence of water (Griffiths 2002; Simpson 2005). 
 
Nuclei Motion in Molecules 
Since both NIR and Raman spectra result from the transitions between vibrational energy 
states of the molecule, it is convenient to first consider the molecular vibrations. The 
vibrational energy of a molecule is associated with different types of motion of nuclei such 
as rotation, stretching and bending. As the nuclei number of the molecule increases, one 
obtains a larger number of possible motions. Therefore it is useful to define the degree of 
freedom (v) which determines the number of possible motions. When considering a 
nonlinear molecule with N atoms, the atoms will have 3N-6 vibrational degrees of freedom. 
In the case of a linear molecule, degrees of freedom equal 3N-5 (Brittain 2006b). For 
example, water (
2
H O ), which was the analyte of interest in two publications in the thesis, is 
a nonlinear, triatomic molecule which has three (3  3-6 = 3) vibrational modes that are 
presented in Figure 2.8. These are symmetric OH stretching (
1
 ), OH bending (
2
 ) and 
asymmetric OH stretching (
3
 ). 
 
 
Figure 2.8. Vibrational motions in a water molecule: symmetric OH stretching (
1
 ), OH bending 
(
2
 ) and asymmetric OH stretching (
3
 ). 
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Vibrational Energy Levels  
The above-mentioned motions are associated with energy. Each of the molecule’s atom to 
atom bonds vibrates with a characteristic frequency which is the lowest energetic state 
allowed by quantum mechanics (Ciurczak 2001). These vibrations may be excited to higher 
energy levels if they absorb energy of a radiation with the particular frequency. According 
to the basic quantum mechanics, the exchanged energy E  is directly proportional to the 
frequency of the radiation and can only have quantized values (Keresztury 2002): 
  
 E   h , (2.5) 
  
where h is the Planck’s constant and   is the frequency of the radiation expressed in hertz 
(Hz = 1 1s ). In the simplified classical approach, the bonds of the molecule can be 
considered as ideal harmonic oscillators. When a molecule absorbs IR radiation, its 
individual bonds start to vibrate with the frequencies determined by Hooke’s Law 
(Ciurczak 2001; Steele 2002; Brittain 2006b): 
 
 A B
A B
m m1
k
2 m m



  , (2.6) 
 
where k is the classical force constant representing bond strength, 
A
m  and 
B
m  are the 
masses of the two bonding atoms A and B, respectively. The potential energy V of such 
harmonic systems can be described by Equation (2.7) (Bokobza 2002): 
 
    
22
e
1 1
V x kx k r r
2 2
   ,  (2.7) 
 
where x is the displacement coordinate defined as the difference between internuclear 
distance r and equilibrium internuclear distance 
e
r  of the two atoms. 
The classical theory is good at predicting the fundamental vibrational frequencies of a 
simple diatomic molecule and to some extent the stretch frequency of a two-atom bond 
within a polyatomic molecule. However, the classical model erroneously predicts a 
continuum of energy levels of the molecular vibrations. In reality, the possible energy levels 
are quantized and quantum mechanical treatment of the phenomena is required in order to 
describe these discrete energy levels. These vibrational energy levels are obtained as a 
solution of time-independent Schrödinger equation (Ciurczak 2001; Brittain 2006a): 
 
  
 
   
2
2
x
E x V x x
2m x
 
    

h
,  (2.8) 
 
where   is the wave function of nuclear motion, V is the potential energy function, m is 
the mass of the particle. For polyatomic molecules, the possible energy levels are numerous. 
If every bond of the nonlinear and triatomic molecule such as 
2
H O  is assumed as 
independent, diatomic, harmonic oscillator, the possible vibrational energy levels are as 
follows (Bokobza 2002; Brittain 2006b): 
 
  1 2 3 1 1 2 2 3 3
1 1 1
E , ,
2 2 2
        
     
          
     
h h h , (2.9) 
 
where 
i
 is the vibrational quantum number representing the possible vibrational mode. 
The value of 
i
 is always a positive integer. At room temperature, most molecules are at 
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their lowest possible energy level, usually denoted as ground state (Ciurczak 2001). In the 
ground state, each of the vibrational quantum numbers equals zero ( 0 
i
) and the system 
energy becomes: 
 
   1 2 3
1 1 1
E 0,0,0
2 2 2
    h h h .  (2.10) 
 
The associated transitions between the ground state (0,0,0) and any excited energy state 
(
1 2 3
, ,   ) are then defined as follows (Bokobza 2002): 
 
  
 
1 1 2 2 3 3
E         h h h .  (2.11) 
 
The transition is called fundamental if one of the vibrational states 
i
 is excited from the 
ground energy state ( 0 
i
) to the first excited state ( 1 
i
). Overtone is a transition where 
one of the vibrational modes is excited from the ground state straight to the upper state 
( 1 
i
 i.e. 0 
i
 → 2, 3, ...) while the other modes remain at the ground level. The 
simultaneous transitions of two or more modes from the ground state to excited states are 
known as combination bands (Ciurczak 2001; Bokobza 2002). These transitions can also be 
expressed in terms of wave functions of each vibrational mode as depicted in Table 2.10 
(Brittain 2006b). 
 
Table 2.10. Example of wave function changes during fundamental, overtone and combination 
vibrational transitions. 
Type of transition Examples of change of wave function 
Fundamental 
000 100
  , 
000 010
  , 
000 001
   
Overtone 000 200  , 000 300  , 000 020   etc. 
Combination 000 110  , 000 011  , 000 120   etc. 
 
However, harmonic simplification of a vibrating bond has its flaws. First, the harmonic 
model predicts equally spaced vibrational energy levels. Second, it only allows 
fundamental transitions within vibrational states by 1  
i
 (Bokobza 2002; Brittain 2006b; 
Griffiths and de Haseth 2007). Either of these assumptions does not apply in reality. In real 
molecules, the vibration of a given bond is greatly affected by the surrounding chemical 
environment i.e. the electron withdrawing and donating properties of the neighboring 
atoms and functional groups (Ciurczak 2001). Thus, an anharmonic oscillator model has to 
be employed in order to overcome these restrictions. Anharmonicity can be expressed by 
two effects, mechanical anharmonicity and electrical anharmonicity. The mechanical 
anharmonicity is attributable to the effects of cubic and higher terms in the anharmonic 
potential energy function (Bokobza 2002): 
 
   2 3
1
V x kx k'x higher terms
2
   ,  (2.12) 
 
where k' k . An empirical Morse’s function is often used to express mechanical 
anharmonicity potential energy V and it takes into account the energy barriers of the bond 
at both ends of the extreme stretching distances as defined in Equation (2.13) (Bokobza 
2002; Simpson 2005; Brittain 2006b) 
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    
2
x
e
V x = D 1 e   , (2.13) 
 
where   is a constant related to the width of the potential and 
e
D  is the dissociation energy 
that is needed to break the bond from its equilibrium position. Figure 2.9 demonstrates the 
anharmonic effect. The energy barrier of the vibrational motion slowly approaches the zero 
at the far end of the stretch while the nuclei charges create a rapidly increasing barrier in as 
the distance between two atoms becomes reduced (Ciurczak 2001). 
 
 
Figure 2.9. Potential energy of a two-atom bond as a function of of the internuclear distance. 
Dashed and solid lines represent the potential approximated using a harmonic oscillator model 
(Hooke’s Law) and an anharmonic oscillator model (Morse function), respectively. The 
horizontal solid lines depict the discrete and nonequally spaced energy levels arising from the 
anharmonicity. Adapted with permission from Griffiths and de Haseth 2007. 
 
The second anharmonic effect, electrical anharmonicity, allows for the overtone 
transitions. For small displacements from the equilibrium configuration, the effect of the 
vibration to the dipole moment   of the bond can be expressed as a linear function of a 
vibrational displacement (
i
Q ) which defines the ith normal coordinate of the particular 
vibration. The electrical anharmonicity arises from the quadratic and higher order terms of 
this dipole moment expression (Bokobza 2002; Steele 2002): 
 
 
2
2
0 2
0 0
1
higher terms
2
 
 
   
           
i i
i i
Q Q
Q Q
,  (2.14) 
 
where 
0
  is the dipole moment at the equilibrium internuclear distance. In order that a 
molecule would be able to absorb IR radiation (and thus to be IR and NIR active), at least 
one of its bonds must have a dipole moment and the vibration must result in change in it. 
Thus, at least one value of the electric dipole moment derivative must differ from zero 
(Steele 2002): 
 
54 
 
 
 
0
0
 
 
 iQ
.  (2.15) 
 
When the anharmonic effects are included, the vibrational energy levels of the triatomic 
molecule are no longer equally spaced and Equation (2.9) expands to the following form 
(Bokobza 2002; Simpson 2005): 
 
 
 
2
1 2 3 1 1 2 2 3 3 11 1
2 2
22 2 33 3 12 1 1
13 1 3 23 2 3
1 1 1 1
E , ,
2 2 2 2
1 1 1 1
2 2 2 2
1 1 1 1
2 2 2 2
         
   
   
       
              
       
      
           
      
     
         
     
h h h X
+ X X X
+ X X
,  (2.16) 
 
where 
ik
X  are the anharmonicity constants whose values depend on the mode of vibration 

i
. Figure 2.10 illustrates the transitions between the vibrational energy levels observed in 
IR and NIR region. In the IR region the transitions occur from the ground state ( 0 
i
) to 
the first excited state ( 1 
i
), as the fundamental transitions. Overtones ( 1 
i
) and 
combinations (several 1 
i
) of these fundamental transitions appear within the NIR 
region. Raman bands are attributable to the fundamental transitions but their origins differ 
from those observed in IR spectroscopy, as will be demonstrated in the next chapter, 2.6.2. 
 
 
Figure 2.10. Diagram of transitions between the vibrational energy levels corresponding to the 
IR/NIR absorption, and Rayleigh and Raman scattering. 
 
Since water was the analyte of interest in two publications of the experimental part of the 
thesis, Table 2.11 shows the assignment of fundamental, overtone and combination bands 
of pure water in vapor phase. In the NIR spectra of water, within the region 800–2500 nm, 
many weak overlapping bands are observed. In general, the peak intensity decreases with a 
decrease in the wavelength. From the listed bands in Table 2.11, the most distinct ones in 
the NIR region typically are the combination bands 
1 2
   and 
1 3
   observed at 1910 and 
1379 nm, respectively (Ozaki 2002; Weyer and Lo 2002; Brittain 2006b). 
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Table 2.11. Assignment of fundamental, overtone and combination vibrations of water in the 
vapor phase. 
Vibrational quantum 
number of upper state 
(
1 2 3
, ,   ) 
Assignment 
Wavelength 
(nm) 
Wavenumber 
(cm-1) 
Ref(s) 
(0,1,0) Bending 6270 1595 a 
(0,2,0) 1st overtone of bending 3174 3151 a 
(1,0,0) Symmetric stretching 2735 3657 a 
(0,0,1) Asymmetric stretching 2662 3756 a, c  
(0,3,0) 2nd overtone of bending 2143 4667 a 
(1,1,0) Combination band 1910 5235 a 
(0,1,1) Combination band 1875 5332 a, b, c 
(1,2,0) Combination band 1476 6775 a 
(0,2,1) Combination band 1455 6874 a, c  
(2,0,0) 1st overtone of symm. stretching 1389 7201 a 
(1,0,1) Combination band 1379 7250 a, b, c 
(0,0,2) 1st overtone of asymm. stretching 1343 7445 a  
(2,1,0) Combination band 1141 8762 a 
(1,1,1) Combination band 1135 8807 a, b, c 
(0,1,2) Combination band 1111 9000 a 
(3,0,0) 2nd overtone of symm. stretching 943 10600 a 
(2,0,1) Combination band 942 10613 a, b, c 
(1,0,2) Combination band 920 10869 a 
(0,0,3) 2nd overtone of asymm. stretching  906 11032 a, c  
(2,1,1) Combination band 823 12151 b, c 
a Ozaki 2002, b Weyer and Lo 2002, c Brittain 2006b 
2.6.2 Raman Spectroscopy 
Basics of Raman Spectroscopy 
The theoretical foundation for the possibility that there would be a frequency shift during 
light scattering was first predicted by Adolf Smekal in 1923 (Smekal 1923). The existence of 
this inelastic scattering was experimentally verified in 1928 by Sir Chandrasekhara Raman, 
who visually observed frequency changes in sunlight in the transparent materials using a 
telescope as a collector (Raman 1928; Raman and Krishnan 1928). The phenomenon was 
named after its experimental discoverer. Raman spectroscopy is based on an inelastic 
scattering of the light from the material during which energy exchange can occur between 
the incident photons and sample molecules. When a monochromatic beam of radiation 
0
  
(i.e. laser operating at visible or NIR range) encounters the sample material, some of the 
incident radiation is scattered by the molecules of the material. The scattering of light 
involves excitation of the sample molecules into the virtual energy states as illustrated in 
Figure 2.10. The virtual state can be considered as a very short-lived distortion of the 
electron cloud induced by the oscillating electric field of the radiation rather than the actual 
true quantum state of the molecule (McCreery 2000; Keresztury 2002). 
The major fraction of the excited virtual states is discharged at the same frequency 
0
  
without exchange of energy. This is called Rayleigh scattering and it occurs in the case when 
the molecules are much smaller than the wavelength of the incident radiation (McCreery 
2000; Bugay and Brittain 2006b). The intensity of the Rayleigh scattering is only about 
4 310 10   of the intensity of the incident excitation radiation (Keresztury 2002). However, 
as depicted in Figure 2.10, a minor fraction of the photons of incident radiation scatters 
inelastically exchanging energy with the sample molecules. The scattered radiation is 
observed at the discrete frequencies 
0
   
i
, where the 
i
 refers to transitions between 
vibrational or rotational energy levels of the molecule. The existence of the frequency 
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difference is called the Raman Effect or Raman scattering. The frequency difference is usually 
denoted as the Raman shift. The Raman shifts are referred to as Stokes scattering if the 
wavenumber of the scattered radiation is lower than that of the incident radiation (
0
 
i
). 
The shifts appearing at the higher wavenumbers (
0
 
i
) are referred to as anti-Stokes 
scattering (Keresztury 2002; Bugay and Brittain 2006b). The Stokes scattering occurs in 
molecules that are in the ground vibrational state ( 0 
i
) while the anti-Stokes requires 
molecules to be present in the first excited state ( 1 
i
). The Stokes and anti-Stokes Raman 
peaks are symmetrically located at opposite sides of the Rayleigh peak, but the anti-Stokes 
peaks have much lower intensities than those on the Stokes side (McCreery 2000). The 
reason for the lower intensities on the anti-Stokes side of the Raman spectrum is the lower 
number of molecules existing in the first excited state (
1
N ) than in the ground state (
0
N ). 
The ratio of a Boltzmann distribution can be used to approximate the relationship between 
populations in the different energy states of each vibrational mode (Griffiths and de Haseth 
2007):  
  
 
0
B
c
T1
0
N
e
N



h
k  , (2.17) 
 
where the c is the speed of light, 
B
k  is the Boltzmann’s constant and T is the temperature. 
However, the above-mentioned types of scattering are not the only light scattering 
phenomena that can be encountered, more than 25 types of Raman spectroscopies are 
known to exist (Long 2002). 
The Raman scattering is a very feeble effect. It is approximately 3–5 orders of magnitude 
weaker than the Rayleigh scattering. Thus, only about 10 810 10   of the incident photons 
scatter inelastically causing the Raman Effect (McCreery 2000; Keresztury 2002). Along with 
fluorescence phenomena, the weakness of the Raman Effect is the main limiting factor of 
Raman spectroscopy. The low probability of the incident photon to experience the Raman 
Effect is concisely expressed with the following equation (Siesler 2002): 
 
 4 8
Raman Rayleigh Source
I 10 I 10 I   .  (2.18) 
  
A Raman spectrum displays the intensity of the Raman bands as a function of the 
frequency difference of the incident and scattered radiation (
0
 
i
), commonly expressed 
in wavenumbers ( 1cm ). The measured Raman spectrum typically ranges from 50 to 4000 
1cm  covering the more readily observable Stokes side (Siesler 2002). The intensity of any 
given band in the Raman spectrum can be expressed as follows (Griffiths 2002): 
 
  
2
4
Raman 0 0
d
I KI
d

 
 
   
 
i Q
,  (2.19) 
 
where K is the constant of proportionality, 
0
I  is the power of the laser, 
0
 
i
 is the 
wavenumber of the measured band and d d Q  is the change in polarizability with normal 
coordinate of the vibration. The value of K is dependent upon various instrumental factors 
such as the optical geometry, collection efficiency of the scattered radiation, sensitivity of 
the detector and amplification. As can be seen from Equation (2.19), the intensity of a 
Raman band increases linearly with the power of the laser, on fourth power of the 
excitation wavenumber and on second power of the change in polarizability occurring 
during the vibration. 
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Classical Theory of Rayleigh and Raman Scattering 
A convenient way to understand the Raman Effect is to consider the classical theory of 
scattering using the harmonic approximation where the effects of mechanical and electrical 
anharmonicity are neglected. The classical description assumes that the oscillating electric 
field of the incoming radiation induces a dipole moment in the molecule (McCreery 2000; 
Brittain 2006b). The induced dipole will discharge by scattering the radiation, with or 
without exchanging energy with vibrations in the molecule. The magnitude of the induced 
polarization (P) is dependent upon the intensity of the electric field of the incident radiation 
(E) and the polarizability of the molecule ( ) (McCreery 2000; Keresztury 2002; Brittain 
2006b): 
 
  0 0cos 2 c t    P E E ,  (2.20) 
  
where 
0
E  is the amplitude of the electric vector of the incident radiation and 
0
  is the 
frequency of radiation interacting with the molecule. Equation (2.20) forms the basis for 
both the classical and quantum mechanical treatments of Raman scattering (McCreery 
2000). For isotropic molecules, the polarizability  , is a scalar quantity. Instead, anisotropic 
molecules require a tensor description. For small amplitudes of such molecular vibrations, 
the polarizability of the molecule can be expressed in terms of vibrational coordinates 
(Keresztury 2002; Brittain 2006b): 
 
 
0
0

 
 
   
 
i
i
Q
Q
,  (2.21) 
  
where 
0
  is the molecular polarizability and  
0i
Q   is the rate of change of the 
polarization at the equilibrium configuration. On the other hand, the molecular vibrations 
can also be considered as harmonic, time-dependent functions vibrating with a 
characteristic harmonic wavenumber 
i
 of the ith normal mode (Keresztury 2002; Brittain 
2006b): 
 
  0 cos 2 c t i i iQ Q ,  (2.22) 
  
where 0
i
Q  is the vibrational amplitude of vibration. By inserting Equations (2.21) and (2.22) 
into Equation (2.20) and performing the trigonometric transformation, the polarization will 
have the following expression (McCreery 2000; Keresztury 2002; Brittain 2006b): 
 
        0 0 0 0 0
0
1
cos 2 c t cos 2 c t cos 2 c t
2

        
           
i i i
i
P E Q E
Q
.  (2.23) 
   
Even though Equation (2.23) is derived using classical theory and thus is an incomplete 
simplified expression of the phenomena, it provides useful insights into the Raman Effect. 
First, Equation (2.23) predicts that three frequencies will be observed during scattering. The 
first term corresponds to Rayleigh scattering, in which the wavenumber of the scattered 
radiation is the same as that of the incident radiation, 
0
 . The second and third terms 
account for the Stokes scattering (
0
 
i
) and anti-Stokes scattering (
0
 
i
), respectively. 
Second, both the Rayleigh and Raman scattering intensities are directly proportional with 
the intensity of the incident radiation 
0
E  (i.e. intensity of the laser) (McCreery 2000). Third, 
a given normal vibration will appear in the Raman spectrum only if the polarizability is 
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changed during the vibration. The same expressed mathematically, at least one of the 
derivative components of the polarizability tensor must differ from zero (Keresztury 2002): 
 
 
0
0
 
 
 iQ
.  (2.24) 
  
Finally, Equation (2.23) shows that the Raman shift is independent of the wavenumber 
(or wavelength) of the incident radiation. Thus, the bands of the Raman spectra obtained 
using different excitation sources (i.e. lasers with different wavelengths) appear at the same 
wavenumbers, but with highly varying intensities as stated in Equation (2.19) (Keresztury 
2002; Griffiths and de Haseth 2007). 
2.7 DATA ANALYSIS 
The PAT process analyzers produce vast amount of data such as spectra. The process data 
produced by just one PAT probe can form a multidimensional data matrix, possibly 
consisting of thousands of variables that are measured repeatedly at certain time intervals 
(e.g. once per minute). However, the measured data are not synonyms for information. The 
collected data need to be analyzed in order to extract relevant information, to provide 
sufficient selectivity for an analytical method and thus to increase process understanding 
(Miller 2005; Rajalahti and Kvalheim 2011). In the applications of spectroscopic methods, 
the produced data are always multidimensional and the essential information is hidden 
within the vast range of variables that are correlated. Therefore, the use of MVDA tools is 
necessary if one has to handle spectroscopic data. Challenging interpretation of the 
spectroscopic data is illustrated in Figure 2.11 presenting preprocessed NIR spectra of oils. 
Visually, the spectra are quite the same and only subtle differences can be observed. 
 
 
Figure 2.11. Example of preprocessed NIR spectra of four different types of oil. Adapted with 
permission from Brereton 2009. 
 
MVDA tools can be applied for several purposes such as qualitative exploratory analysis 
and quantitative multivariate calibration. An exploratory analysis can be applied to extract 
information of sample chemistry or process dynamics. For example, this type of analysis 
can be used to recognize patterns of the data, detect the underlying chemical or physical 
differences of these patterns and also explain sources of observed variation (Miller 2005; 
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Cogdill and Drennen 2006). In general terms, the goal of the calibration is to relate the 
predictor variable(s) to an independent response variable(s) in a quantitative fashion. In a 
spectroscopic data analysis, the predictor variables are the spectra, containing intensity 
values measured in multiple wavelengths or wavenumbers. The response variables often 
relate to the property or quantity of the interest (e.g. concentration of certain analyte). 
Multivariate calibration is used to calibrate data with a large amount of predictor variables 
and it can be applied to estimate the concentrations of more than one analyte. In addition, 
multivariate calibration is necessary if the spectral selectivity is low so that the analyte of 
interest cannot be explicitly identified using single wavelength and univariate calibration 
approach. This is especially typical with NIR spectra (Boysworth and Booksh 2001). 
Furthermore, if the developed method is intended to be applied for quantitative prediction 
of the properties of the future samples, the validation of the method is required in order to 
be assured of its suitability for intended purpose. The following chapters will describe and 
discuss the MVDA tools and the validation concept used in the experimental part of the 
thesis. 
2.7.1 Principal Component Analysis 
Principal component analysis (PCA) is probably the most common multivariate statistical 
technique for reducing the huge amount of data and extracting information from these very 
complex data sets (Gemperline 2006; Brereton 2007; Miller and Miller 2010). PCA is usually 
performed as a first step of the MVDA, used to explore and interpret the different sources 
of variation of the data (Hubert 2006). The goal of the PCA is to express the variation 
present in many correlated variables (e.g. absorption of different wavelengths) by 
generating new variables called as principal components (PCs) (Beebe et al. 1998). These PCs 
are orthogonal (uncorrelated) to each other and their linear combinations account for the 
maximum variance of the data (Mark 2001). 
One can assume that there is a 2-dimensional data matrix X (e.g. spectra of sample) with 
size of n m  (n rows of spectra recorded at m columns of wavelengths). Prior to PCA, 
spectroscopic data is often mean-centred so that the mean spectrum is subtracted from 
every spectra of the data set i.e. the mean of the column is subtracted from each value of 
that particular column, ij jx x . By this procedure, the mean of the each column is zero and 
an established regression model does not require an intercept. Furthermore, mean-centring 
often makes a model more simple and interpretable (Beebe et al. 1998; Boysworth and 
Booksh 2001; Brereton 2009). In PCA, the matrix X is decomposed into a bilinear, least 
squares model as a product of matrices T and PT (Wold et al. 1987; Næs et al. 2002): 
 
 T X TP E ,  (2.25) 
 
where T is n k  sized score matrix and TP  is the transpose of the loading matrix P sized 
k m , with k being the number of calculated PCs. E is the residual matrix, sized same as the 
X ( n m ), containing the variance not explained by the first k PCs. Equation (2.25) can be 
rewritten so that the projection of matrix X into k-dimensional subspace is expressed as a 
sum of products of score vectors 
a
t  and loading vectors 
a
p , a = 1, 2, ..., k: 
 
 T T T
1 1 2 2
...    
k k
X t p t p t p E .  (2.26) 
  
The vectors 
a
t  and 
a
p  are orthogonal (uncorrelated) so that the product between each of 
them is 0 ( T T0 & 0,  
i j i j
i jt t p p ). The length of the loading vectors is normalized to 1 
( T 1
i j
p p ) (Wold et al. 1987). The first score vector 
1
t  and the first loading vector 
1
p  
correspond to the first principal component (PC1) and so on. The establishment of the PCs 
is illustrated in Figure 2.12. 
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Figure 2.12. Graphical representation of a PCA transformation of two first principal components. 
a) The loading vector of the first principal component is oriented to the direction of largest 
variance. The corresponding score vector consists of the projections of the original data points 
onto the first loading vector. b) Subsequent principal components account for the remaining 
variance of the data so that the loading vectors are orthogonal to each other. 
 
Statistically, PCA finds lines, planes and hyperplanes in the k-dimensional space that 
approximate the X matrix as well as possible in the least squares sense. The first loading 
vector 
1
p  probes in the direction of largest variance in X (Eriksson et al. 2006). The score 
vector 
1
t  is found by projection of the original data points onto the first loading. The 
direction of the second loading vector 
2
p  is towards the largest remaining variance that is 
orthogonal to the 
1
p . The first score vectors 
a
t  can be viewed as latent variables that 
capture most of the information of the data. The dimension and complexity of the PCA 
model are dependent upon the number of established PCs. A PCA model with one PC is a 
straight, one dimensional projection of the original data points, the model with two PCs is a 
two dimensional plane and the model with k components is a k-dimensional hyperplane 
(Wold et al. 1987). In addition, the noise of the data set (e.g. instrument based variations) is 
spread among all PCs of the model but the first PCs have the highest signal-to-noise ratio. 
Subsequent PCs usually describe noise more than actual information, so the exclusion of 
these nonsignificant PCs will filter noise out from the data (Beebe et al. 1998).  
 
The results of PCA are usually expressed as figures. An example of presentation of PCA 
results is depicted in Figure 2.13 where the scores and loadings of NIR spectra (see Figure 
2.11) are illustrated. Since the visualization of a multidimensional system is impossible, the 
information of the score matrix T is presented in 2D (or 3D) scatter plots with axes being 
two different PCs (e.g. PC1 vs. PC2) (Wold et al. 1987; Brereton 2009). These score plots (e.g. 
Figure 2.13a) are a powerful tool to observe possible patterns and to extract relevant 
information out of the data. Briefly, similar observations form clusters and dissimilar 
observations locate at opposite sites along the specific PC. The loading matrix TP  is used to 
explain the origin of PCs. Especially in spectroscopic applications, the loading vectors 
a
p  
are plotted as a function of wavelengths that are the original variables as illustrated in 
Figure 2.13b. With this procedure, the contribution of the different spectral regions to each 
PC can be conveniently interpreted. Thus, the loadings can be used to track the physical or 
chemical source of the observed variation (Næs et al. 2002; Brereton 2009). The combined 
use of scores and loadings can help to understand the main sources of variation and 
patterns of the data. 
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Figure 2.13. An example of presentation of PCA results. a) PC score plot of two first principal 
components reveals clustering of the data according to a type of oil. b) The corresponding 
loadings can be used to identify the chemical/physical source attributable to the observed 
spectral variation. Adapted with permission from Brereton 2009. 
 
Even though the PCA is a relatively simple and powerful tool to extract relevant 
information from complex data, the analyst has to bear in mind a few basic restrictions 
associated with the method. First, PCA is very sensitive to anomalous observations. Since 
the PCs are generated in the direction in which the variance is maximized, the first 
components are attracted towards outlying points. If these outliers are present in the data 
matrix, the generated PCs are distorted and the interpretation of PCA results becomes 
unreliable (Wold et al. 1987; Hubert 2006). Another issue is related to interpretation of PCs. 
Although the different PCs express the uncorrelated variations of the data, each PC still 
contains a representation of data variations that are correlated with each other. Thus the 
loadings usually contain spectral features originating from multiple sources. Therefore, one 
single physical/chemical explanation for each PC might not comprehensively describe all 
the variation that the specific PC has captured. Conversely, the PCs cannot be used to 
explicitly isolate information of the individual analytes (Mark 2001; Næs et al. 2002; Cogdill 
and Drennen 2006). Moreover, if the relevant information underlies in spectral changes that 
are subtle compared to the irrelevant information, an exploration of lower order PCs might 
be necessary. Furthermore, PCA is not suitable for handling data where the variables are 
uncorrelated (Miller and Miller 2010). 
2.7.2 Classical Least Squares Regression 
Classical least squares (CLS) regression is a tool for multivariate calibration. The CLS 
utilizes full-spectrum analysis improving precision and accuracy (Franke 2002). The direct 
CLS method is a suitable choice for the multivariate calibration if all the analytes present in 
the system are known and these can be measured in a pure form (Beebe et al. 1998). The 
CLS regression creates a linear mixture model of the spectra as a function of analyte 
concentration (Kramer 1998; Boysworth and Booksh 2001; Franke 2002; Heise and Winzen 
2002):  
 
 T X CS E ,  (2.27) 
 
where X is a n m  matrix containing spectra of a sample (n rows of spectra recorded at m 
columns of wavelengths), C is a n q  concentration matrix of the analytes (n concentrations 
of q analytes), TS  is a q mmatrix of pure analyte spectra and E is the n m  error matrix of 
spectral residuals. In the case when the spectrum of each pure analyte is available, the 
analyte concentrations of unknown samples can be directly estimated by solving Equation 
(2.27) (Kramer 1998; Heise and Winzen 2002; Miller 2005; Griffiths and de Haseth 2007): 
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  
1
T T
unk unk cal unk
ˆ C = X K X S S S ,  (2.28) 
 
where 
unk
X  is the spectra of the unknown sample mixture and 
cal
K  is the pseudo-inverse of 
matrix S, also called as the calibration matrix (Beebe et al. 1998; Kramer 1998).  
 
The major limitation of the direct CLS method is that all components of a studied 
mixture have to be known and measured in a pure form. This might be rather inconvenient 
with formulations containing multiple excipients and prolong the time needed for the 
calibration (Boysworth and Booksh 2001; Franke 2002; Heise and Winzen 2002; Strachan et 
al. 2007). Another drawback is the assumption that the obtained spectra of the mixture of 
analytes are affected only by variations in the pure analytes. In other words, CLS assumes 
X to be free of error so that all of the errors are attributable to S. This is a somewhat risky 
assumption since the spectrum of pure analyte might not be the same in the mixture due to 
many reasons such as interactions between components through hydrogen bonds, 
temperature variations and changes in optical path length or scattering effects during 
diffuse reflectance measurements (Franke 2002; Heise and Winzen 2002; Mark 2002; 
Hageman et al. 2005; Cogdill and Drennen 2006). 
2.7.3 Partial Least Squares Regression 
PLS regression, also known as ‘projection to latent structures’, is a widely used method for 
multivariate calibration. PLS regression is used to construct a model between response 
variables Y (e.g. reference quantity values of an analyte) and intercorrelated predictor 
variables X (e.g. spectra of an analyte) (Wold et al. 1984; Bjørsvik and Martens 2001; Wold 
et al. 2001; Eriksson et al. 2006). PLS utilizes inverse calibration where the analyte of interest 
is calibrated while implicitly accounting for the other sources of variation. The inversion 
problem is solved by establishing linear combinations of the original predictor x-variables 
called factors or latent variables (LV) that are assumed to be responsible for the observed 
variation (Beebe et al. 1998; Wold et al. 2001). PLS utilizes noise robust full-spectrum 
analysis and thus it is well suited for calibration of the spectral data consisting of hundreds 
or even thousands of variables. PLS is applicable to the kind of data where the x-variables 
(i.e. wavelengths) are correlated (Beebe et al. 1998; Wold et al. 2001; Rajalahti and Kvalheim 
2011). In the case of data with a random error (e.g. instrument noise) PLS performs better 
than PCR (Hasegawa 2002). Furthermore, unlike PCR or MLR, PLS establishes LVs so that 
they describe not only variation in x-variables but also in response y-variables. From the 
physical point of view, this is reasonable since both the reference values and the measured 
spectra are subject to error (Miller 2005; Brereton 2007). Moreover, a single PLS model can 
be built for simultaneous prediction of all columns of Y (i.e. multiple analytes) (Eriksson et 
al. 2006). This method is usually referred to as PLS2 (Beebe et al. 1998; Næs et al. 2002; 
Kalivas and Gemperline 2006). Analogously, the PLS1 refers to method in which each 
column of Y is modelled separately. The following text discusses only application of the 
PLS1 method. 
If one assumes that there is a 2-dimensional data matrix X of spectra sized n m  (n rows 
of spectra recorded at m columns of wavelengths) and matrix Y of reference values sized 
n l  (n rows of reference values at l columns of analytes). In the case when only one analyte 
has to be predicted, the response matrix Y reduces into 1n  sized response vector, 
sometimes denoted as y (Næs et al. 2002; Lopes et al. 2004). Prior to PLS, both X and Y are 
recommended to be mean-centred (Wold et al. 1984; Geladi and Kowalski 1986; Wold et al. 
2001; Næs et al. 2002). In PLS, similar to PCA, the matrix X is decomposed into a score 
matrix T ( n k ) and a loading matrix TP  ( k m) with k being the number of generated LVs. 
The same type of decomposition is also performed to Y, producing the score matrix U ( n k ) 
and the loading matrix or the Y-weight matrix TQ  ( k l ). The residuals of the model are 
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located in matrix E ( n m ) and matrix F ( n l ), representing irrelevant variability in X and 
Y, respectively (Geladi and Kowalski 1986; Hasegawa 2002; Næs et al. 2002). The 
decomposition of matrices X and Y is expressed in Equations (2.29) and (2.30): 
 
 T T T T
1 1 2 2
...      
k k
X TP E t p t p t p E   (2.29) 
 T T T T
1 1 2 2
...      
k k
Y UQ F u q u q u q F .  (2.30) 
 
The aim of the PLS regression is to model X and Y so that both residuals E and F are 
approximately equal to zero (Kalivas and Gemperline 2006). In addition, PLS determines 
the LVs of the model simultaneously by maximizing the covariance between Y and all 
possible linear functions of X (Næs et al. 2002; Eriksson et al. 2006). In this process the 
loading weight vectors 
a
q  and 
a
w  are defined so that the covariance is maximized for each a 
= 1, 2, ..., k of LVs (Næs et al. 2002; Eriksson et al. 2006; Hubert 2006):  
 
   Ta a a yx acov , Yq Xw q S w ,  (2.31) 
 
where the 
yx
S  is the cross-covariance matrix between the x- and y-variables. Both weight 
vectors 
a
p  and 
a
w  are orthogonal unit vectors. The loading weight matrix W is obtained by 
covariance maximization criterion and each of its vectors 
a
w  determines the direction of 
the particular LV. This covariance maximization procedure guarantees that the generated 
LVs are directly related to the variation in Y. The inner relationship between the scores of 
the X and the scores of the Y is expressed as follows (Eriksson et al. 2006): 
 
  U T H ,  (2.32) 
 
where H is the residual matrix. The inner relation presented in Equation (2.32) is improved 
by performing an iterative calculation of the score matrices T and U (Eriksson et al. 2006; 
Kalivas and Gemperline 2006). The exchange of the scores allows information of X data to 
be used in the adjustment of the orientation LVs in the Y data, and vice versa (Geladi and 
Kowalski 1986; Eriksson et al. 2006; Kalivas and Gemperline 2006). The scores 
a
t  and 
loadings 
a
p  along these 
a
w  axes are obtained as follows (Næs et al. 2002; Hubert 2006): 
 
 
a a
t Xw   (2.33) 
 x a
a T
a x a

S w
p
w S w
,  (2.34) 
 
where 
x
S  is the covariance matrix of x-variables. The score vectors 
a
t  are orthogonal and 
they are used as regressors for both X and Y. The PLS regression produces double set of 
loading vectors, 
a
w  and 
a
p , that are not identical. Since the vectors 
a
w  are obtained in an 
iterative fashion from X and its residuals, their comparison and interpretation can become 
complicated. Instead, the loading vectors 
a
p  are calculated by regressing X directly onto 
the final score matrix T. Therefore it is recommended to use loading vectors 
a
p  in the 
interpretation of LVs (Næs et al. 2002). Unlike loading weight vectors 
a
w , the obtained 
loading vectors 
a
p  are not orthogonal (Bjørsvik and Martens 2001).  
The regression coefficient matrix B is used for prediction of new observations and it is 
defined as the product of matrices W, TP  and TQ . It determines the direction in the 
variable space with the strongest relation to the response (Bjørsvik and Martens 2001; Næs 
et al. 2002): 
  
1
T T

B W P W Q .  (2.35) 
64 
 
 
Finally, the established multiple regression model can be applied to new measured 
unk
X  
in order to predict response values Yˆ  (Bjørsvik and Martens 2001; Wold et al. 2001; Miller 
2005; Kalivas and Gemperline 2006): 
 
 
unk
ˆ +Y X B F .  (2.36) 
  
Along with the ability to predict response values of new unknown samples, PLS score 
and loading plots are available to interpret the characteristics of the model visually, similar 
to PCA. These plots can also be used as integrated diagnostics to detect inhomogeneities or 
outliers (Wold et al. 2001; Eriksson et al. 2006). Furthermore, plots consisting of observed 
versus predicted values are useful in the visual evaluation of goodness of fit. The predictive 
capability of the established PLS model has been traditionally evaluated by calculating 
descriptive chemometric validation parameters such as root mean square error of 
calibration (RMSEC), root mean square error of cross-validation (RMSECV) and root mean 
square error of prediction (RMSEP) (Boysworth and Booksh 2001; Wold et al. 2001; Næs et 
al. 2002; Eriksson et al. 2006). These parameters are calculated using following equations 
(Beebe et al. 1998; Mark 2001; Næs et al. 2002): 
  
  
2
1
1
ˆRMSEC
1 
 
 

n
i i
i
y y
n k
  (2.37) 
  
2
1
RMSECV 1
ˆ
RMSEP 
 
n
i i
i
y y
n
,  (2.38) 
 
where k is the number of included LVs. The RMSEC is calculated using the predicted 
values of the calibration set. The value of RMSECV is obtained during cross-validation and 
it indicates how much predicted values of cross-validation samples deviate from their 
corresponding reference values on average. Instead, RMSEP is calculated using external 
validation samples and it reflects the predictive capability of the model with unknown 
samples. These parameters allow one to obtain an error value in absolute terms so that the 
lower the value, the lower will be the error of the model. RMSEP provides the best estimate 
for future performance since it is calculated based on samples that were not used in the 
establishment of the model (Boysworth and Booksh 2001). 
 
Despite its good applicability for quantitative spectral data analysis, there are some basic 
principles that need to be remembered when employing the PLS method. First, one has to 
examine the predictive power of each LV in order to avoid under- or overfitting (Wold et al. 
2001; Miller 2005). Underfitting refers to the situation where the number of selected LVs is 
significantly lower than the actual number of sources responsible for the actual spectral 
variation. As an outcome of underfitting, the selected LVs do not sufficiently model the 
observed variation and the contribution of the model error to total prediction error is high. 
In contrast, an overfitted model has too many LVs and the lower order factors are 
modelling noise more than the actual physical/chemical variation. In this case, the model 
error is low but the total prediction error is increased due to the increase in the estimation 
error (Næs et al. 2002). A common method to decide on the appropriate number of LVs is to 
perform a cross-validation where the model is built by leaving out an individual spectrum 
or blocks of spectra at a time. The predictive significance of each LV is then evaluated by 
the RMSECV value calculated using the omitted spectra (Bjørsvik and Martens 2001; Wold 
et al. 2001; Lopes et al. 2004). Second, the accuracy of the model is likely to vary with a 
varying quantity of an analyte. Since the traditional chemometric validation parameters 
only describe the performance of the model deductively at a general level, these parameters 
do not account for quantity related alterations in predictive capability. Along with other 
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criticism on the subject, the above-mentioned shortcoming has led to the statement that the 
validation of a quantitative analytical method based only on the chemometric parameters is 
inadequate for pharmaceutical regulatory requirements (De Bleye et al. 2012). Third, as 
with any data analysis, PLS contains an assumption of homogeneity of the data meaning 
that the results should be acquired in a similar state throughout the investigation and the 
effect of an external source of variation should be the same for X and Y. In the calibration 
phase, the influence of this kind of external source as temperature can be accounted for 
applying more LVs (Workman Jr. 2001; Hageman et al. 2005). However, the future samples 
should also be also measured in the same range of conditions as the calibration set in order 
to obtain reliable predictions. Fourth, the constructed model cannot be used to predict 
future samples in an extrapolative manner. In order to obtain reliable prediction values, the 
unknown samples should be within the same response quantity range as the calibration 
samples. Fifth, even though the established model should be kept as parsimonious as 
possible, preprocessing of spectra is usually required in order to avoid modelling the 
spectral baseline (Cogdill and Drennen 2006). Further, preprocessing of spectra can 
improve the predictive performance of the model. Last, the performance of the model can 
be impaired by including noisy variables. Therefore, variable selection might improve the 
prediction capability of the model (Næs et al. 2002; Miller 2005). 
2.7.4 Accuracy Profile Concept for Validation of an Analytical Method 
The validation of an analytical method is a procedure to demonstrate its suitability for its 
intended purpose (ICH 2005b; USP36 2008). At the end of the validation process, a decision 
has to be made about the validity of the method. Traditionally, this decision has been made 
on basis of several separate statistical parameters without assessing the uncertainty. With 
this approach, there is a risk that an unsuitable assay will be accepted or a valid assay will 
be rejected (Feinberg et al. 2004; Feinberg 2007; Hubert et al. 2007a; De Bleye et al. 2012). 
The accuracy profile concept has been introduced in an attempt to harmonize and simplify 
the validation protocols of the quantitative analytical methods. Furthermore, the accuracy 
profile is stated to improve the decision efficiency of the validation (Hubert et al. 2004; 
Hubert et al. 2007a; Hubert et al. 2007b, 2008). The accuracy profile summarizes the 
validation data into a single informative graph. This graphical representation provides a 
tool with which to assess the performance of the method and to come to a decision about 
whether the method is valid or not. One major advantage of this concept is that it also 
serves as a tool for risk management. It not only provides an assessment of the accuracy of 
the results of the validation samples but it also provides an estimate about how the method 
will perform in the future. Before going into the details of the concept, some essential 
validation terms are defined in Table 2.12. 
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Table 2.12. Terminology of validation of an analytical method (ISO 1994; ICH 2005b). 
Term Definition Remarks 
Accuracy The closeness of agreement between a test result or 
measurement result and the true value. Accuracy refers to 
a combination of trueness and precision. 
Measure of total 
error (systematic 
+ random error) 
Trueness Closeness of agreement between the average value 
obtained from a large series of test results and an accepted 
reference value. The measure of trueness if usually 
expressed in terms of bias.  
Measure of 
systematic error 
Precision Closeness of agreement between independent 
test/measurement results obtained under stipulated 
conditions. Precision may be considered at three levels: 
repeatability, intermediate precision and reproducibility. 
Measure of 
random error 
Repeatability Expresses the precision under the same operating 
conditions over a short interval of time.  
Intra-assay 
precision  
Intermediate 
precision  
Expresses within-laboratories variations: different days, 
different analysts, different equipment etc. 
Inter-assay 
precision 
Reproducibility Expresses the precision between laboratories (collaborative 
studies, usually applied to standardization of 
methodology). 
Inter-laboratory 
precision 
 
Response Function  
An analytical method will rarely produce a result in the very same units as the quantity of 
the analyte of the sample. More likely, the method produces a signal or a response y (e.g. 
area under the curve, peak height, absorption, spectrum) that is required to be expressed in 
terms of the actual quantity x (e.g. concentration) of the analyte in the sample. Therefore, 
the use of a response function f is required in order to establish the relationship between y 
and x: 
  
   y f x e ,  (2.39) 
  
where e is the error associated with the response function f. The response function, or 
calibration model, does not have to be linear; weighted regression algorithms are also 
applicable. However, the relationship characterized by the function f must be strictly 
monotonic (i.e. strictly decreasing or increasing) over the considered determination interval 
(Feinberg 2007; Hubert et al. 2007b). For example, in univariate analysis, the simplest 
response function is the linear regression (i.e. calibration curve) while in multivariate 
analysis, the response function is the multivariate calibration model (e.g. PLS or PCR 
regression model). By using the response function, the quantity values can be back-
calculated. 
 
Objective of an Analytical Method and the Validation 
The objective of an analytical method is that after each measurement it should produce a 
result (x) that is as close as possible or at least within the acceptance limit ( ) to the true 
value (
T
 ) of the quantity of sample to be determined as expressed in Equation (2.40) 
(Hubert et al. 2004): 
  
 
T T
          x x .  (2.40) 
 
The true value of quantity is a theoretical concept and cannot be experimentally 
determined. Therefore, the true value will always be unknown and an accepted reference 
value is used as an estimate of the 
T
 . The acceptance limit   is predefined according to 
the intended use of the method and it varies depending on the requirements of the 
application (e.g. 1–2% for the analysis of bulk pharmaceutical compounds, 5% for the 
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determination of APIs in dosage forms and 15% or 20% for bioanalysis) (Shah et al. 1992; 
FDA 2001; Feinberg et al. 2004).  
The validation phase should represent a guarantee that every single future measurement 
with the method will produce a result that will be close enough or within an acceptable 
distance to the true value. In other words, the tolerable risk level of error and the 
acceptance limit should be defined beforehand and the validation should elucidate the 
capability of the method to operate within these requirements. This is called as fit-for-
purpose approach. In the fit-for-purpose approach, an analytical method can be considered 
valid if each of its results will have a sufficient probability (  ) to fall within the acceptance 
limits (Hubert et al. 2004; Rozet et al. 2007c): 
  
  T    P x .  (2.41) 
 
The value of   is dependent upon the purpose of the method and should assessed a 
priori. The higher the value of  , the lower is the tolerable risk level (1  ) of obtaining a 
faulty result. The minimum values of   are usually 80, 90 or 95% representing the risk 
levels of 20, 10 and 5%, respectively (Rozet et al. 2007c). For example, with   chosen to be 
95% and acceptance limits of 15%, the method can be considered valid if at least 95 out of 
100 future measurements will produce a result which does not deviate by more than 15% 
from the true value. In this respect, the traditional validation approach evaluating only 
numerical indicators of validity (e.g. trueness, linearity etc.) is not sufficient to guarantee 
the future performance of the method (Feinberg et al. 2004; Feinberg 2007). 
 
Estimation of Trueness and Precision 
As well as the true value of quantity, the true bias and true precision of the analytical 
method are unknown. Thus it is necessary to estimate the values of these parameters 
during the validation phase. The reliability of these estimates is dependent upon the extent 
and quality of the validation experiments. Therefore, the experimental conditions of the 
validation experiments should represent as well as possible the conditions of the future 
routine operation of the analytical method (e.g. involved operators, change in equipment or 
materials, duration of the measurement campaign during different days etc.) (Rozet et al. 
2007c). 
In order to evaluate precision, variances associated to repeatability, intermediate 
precision and reproducibility are estimated. In the assessment of repeatability, the 
homogeneous validation sample should be measured in n repetitions within a short 
interval in time. Similarly, in the evaluation of intermediate precision, the validation 
experiments should be conducted in several series (p) such as on different days or by 
different operators. The evaluation of reproducibility would require several experiments 
between different laboratories and has not been considered in this thesis. The estimation of 
trueness and precision is carried out with the predicted values using the following 
statistical models (Hubert et al. 2007b): 
  
    
ijk j ij ijk
x e ,  (2.42) 
 
where 
ijk
x  is the kth predicted concentration of the ith series at the concentration level j  
(i = 1, 2, ..., p; j = 1, 2, ..., m; k = 1, 2, ..., n), 
j
 is the mean of the predicted concentrations of 
the concentration level j, 
ij
 is the difference between ith series average and the  j  (random 
variable with an average of 0 and variance of 2
B,

j
) and 
ijk
e  is the experimental error 
(random variable with an average of 0 and variance of 2
W,

j
). The experimental error is 
assumed to be independent of the series. The values of 2
W,

j
 and 2
B,

j
 represent the within 
and between series precision variances, respectively. The estimate values of these 
68 
 
 
parameters ( 2
W,
ˆ
j
, 2
B,
ˆ
j
 and ˆ
j
) are obtained at each concentration level j using the restricted 
maximum likelihood method (Hubert et al. 2007b; Rozet et al. 2007b; Miller and Miller 
2010): 
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where MSM j  and MSE j  stand for mean of squares for model and mean of squares for error, 
respectively. Depending on the values of MSM j  and MSE j , the estimates of within and 
between series precision variances are defined as follows (Hubert et al. 2007b): 
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These algorithms apply only in a balanced design in which the total number of 
repetitions n is identical in every series i at each concentration level j. p is the total number 
of number of series. The within series variance estimate is equal to the repeatability 
variance estimate ( 2
Re,
ˆ
j
). The sum of the within and between series variance estimates 
equals to the intermediate precision variance estimate ( 2
IP,
ˆ
j
). 
  
 2 2
Re, W,
ˆ ˆrepeatability:  
j j
  (2.48) 
 2 2 2
IP, W, B,
ˆ ˆ ˆintermediate precision:    
j j j
.  (2.49) 
  
Trueness (or bias) is obtained at each introduced concentration level j by calculating the 
difference between the estimated mean predicted concentration ( ˆ
j
) and the average of the 
accepted reference results (
T,

j
). The bias ( ˆ
j
) is defined as follows: 
 
 
T,
ˆ ˆ   
j j j
.  (2.50) 
 
Establishment of Accuracy Profile 
In the establishment of the accuracy profile, the  -expectation tolerance interval ( -ETI) is 
calculated (Mee 1984). Based on the estimated values of bias ( ˆ ) and precision variance 
(ˆ ), this interval defines an expected proportion   of future results (Mee 1984; Hubert et 
al. 2007b; Rozet et al. 2007c): 
  
   ˆ Tˆ, ˆ ˆ ˆˆ ˆ ˆ,             E P k x - k .  (2.51) 
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In Equation (2.51), the value of k is determined so that the expected proportion of future 
results falling into the interval is equal to  . The range of  -ETI at each concentration level 
j can be defined as stated in Equation (2.52) (Hubert et al. 2007b; Rozet et al. 2007b): 
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 
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j j
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pnB
,  (2.52) 
 
where the tQ  is the   quantile of the Student’s t-distribution with v degrees of freedom 
(Satterthwaite 1941). The other symbols denoted in Equation (2.52) are defined as follows: 
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 2 2
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ˆ ˆ ˆ
j j j
    .  (2.56) 
  
Equation (2.55) defines the value of jR  that expresses the importance of between series 
variance compared to within series variance at each concentration level. High jR  values 
either indicate that there is some problem with the variability of the analytical method or 
that an insufficient number of series (p) has been used during the validation experiments 
(Rozet et al. 2007b). Since the accuracy profile expresses the error values in relative scale, 
the range of  -ETI can be expressed in relative terms by rewriting Equation (2.52): 
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Equation (2.57) contains two terms that are the trueness and the coefficient of 
intermediate precision variance. Therefore, the  -ETI expresses the accuracy of the results, 
i.e. the total error that equals the sum of trueness and precision. The  -ETI is calculated 
separately for each concentration level j using Equation (2.57). 
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Interpretation of Accuracy Profile 
In the accuracy profile, the relative error is expressed as a function of concentration. An 
example of an accuracy profile is illustrated in Figure 2.14. 
 
 
Figure 2.14. An example of an accuracy profile. The profile is established in four concentration 
levels C1 – C4 that are marked with vertical black dashed lines. The plain red line represents the 
relative bias, blue dashed lines represent the β-expectation tolerance intervals and horizontal 
black dotted lines represent the acceptance limits (±λ). The LLOQ and ULOQ are defined as 
concentrations where the acceptance limits and β-expectation tolerance intervals intersect 
(tagged with vertical solid lines). The quantification range is the concentration range between 
LLOQ and ULOQ. 
 
In the accuracy profile (Figure 2.14), the acceptance limits (  ) are drawn as dotted 
horizontal lines. The lower and upper limits of  -ETIs (obtained using Equation (2.57)) are 
connected by straight lines across the studied concentrations 
1 4
C C . These lines 
interpolate the behaviour of  -ETI limits between the studied concentration levels 
(Feinberg et al. 2004). Similarly, the relative bias is interpolated across the studied 
concentration line with a pline. The interpretation of the accuracy profile is straightforward. 
According to the definition stated in Equation (2.41), the method can be considered valid if 
the  -ETI is totally included within the acceptance limits [ ,   ]. Once this condition is 
met,  % of the future measurements will fall within the acceptance limits. Therefore, the 
intersections between the acceptance limits and the interpolating  -ETI lines define the 
limits of the quantification. In Figure 2.14, the  -ETI at the first concentration level 
1
C  is 
not included within the acceptance limits. Between the concentrations 
1
C  and 
2
C , the 
interpolating lines intersect with the acceptance limits at both lower and upper levels. Here, 
the lower limit of quantification (LLOQ) is defined as the intersection where both 
interpolating lines are included within the acceptance limits. Analogously, the upper limit of 
quantification (ULOQ) can be determined between concentrations 
3
C  and 
4
C . The LLOQ 
and ULOQ values define the quantification range of the method which is depicted as the 
grey area in Figure 2.14. In this concentration range, the analytical method can operate 
within the predefined acceptance limits with a chosen tolerable level of risk i.e. the method 
is suitable for its intended purpose. Since the accuracy profile captures all of the relevant 
validation statistics and risk control information into a single graph, it provides a 
convenient and efficient tool to make a decision about the validity of the method. This 
improved decision-making can be extended to the comparison of different calibration 
models. By comparing the accuracy profiles constructed using the different response 
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functions and spectral preprocessing methods, the selection of the most accurate model 
becomes feasible (Feinberg et al. 2004; Feinberg 2007; Rozet et al. 2007a; Rozet et al. 2007b; 
Rozet et al. 2007c; Mantanus et al. 2009).  
 
As a conclusion, validation of an analytical method using the accuracy profile concept 
provides a platform with a risk management approach and visualization of the validation 
criteria with an analytical meaning. However, the accuracy profile concept does not resolve 
all of the issues present in validations such as the comparison of ‘alternative’ method to an 
‘official’ method. Despite its obvious benefits over the traditional validation approach, the 
accuracy profile concept has not yet received wide acceptance and standardization of the 
procedure is still needed (Feinberg 2007; Hubert et al. 2008). 
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3 Aims of the Study 
The overall aim of the study was to deepen the understanding of the freeze-drying process 
by elucidating the critical quality attributes of the freeze-dried product. This aim was to be 
accomplished by developing noninvasive Raman and NIR spectroscopy based methods for 
in-line monitoring of the freeze-drying process as guided by the PAT initiative. The 
following aims and deliverables were specifically established in each part of the study: 
 
I Determination of the solid-state form of the sample during microscale freeze-
drying process by implementing Raman spectroscopy into the process and 
applying suitable multivariate data analysis tool to extract solid-state related 
information out of the Raman process data. 
 
II Representative determination of the residual moisture of the samples across the 
batch and detection of end point of drying in the laboratory scale freeze-drying 
process by instrumenting multipoint NIR spectroscopy into the process and 
applying a suitable multivariate data analysis tool for the quantitative 
determination of residual moisture. 
 
III Confirmation of suitability of multipoint NIR spectroscopy method for its 
intended use as an in-line moisture content analysis tool in the laboratory scale 
freeze-drying process by validating the multipoint NIR spectroscopy method 
according to the relevant pharmaceutical regulatory guidelines, and by 
establishing a streamlined protocol to allow the calibration transfer between the 
probes of multipoint NIR instrument. 
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4 Microscale Freeze-Drying with Raman Spectroscopy 
as a Tool for Process Development1 
                                                                
1 Reprinted with permission from KAUPPINEN A, TOIVIAINEN M, AALTONEN J, KORHONEN O, JÄRVINEN K, 
JUUTI M, PELLINEN R, KETOLAINEN J: MICROSCALE FREEZE-DRYING WITH RAMAN SPECTROSCOPY AS A 
TOOL FOR PROCESS DEVELOPMENT. ANALYTICAL CHEMISTRY 85: 2109-2116, 2013. Copyright 2013 American 
Chemical Society. 
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5 In-Line Multipoint Near-Infrared Spectroscopy for 
Moisture Content Quantification during 
Freeze-Drying2 
                                                                
2 Reprinted with permission from KAUPPINEN A, TOIVIAINEN M, KORHONEN O, AALTONEN J, JÄRVINEN K, 
PAASO J, JUUTI M, KETOLAINEN J: IN-LINE MULTIPOINT NEAR-INFRARED SPECTROSCOPY FOR MOISTURE 
CONTENT QUANTIFICATION DURING FREEZE-DRYING. ANALYTICAL CHEMISTRY 85: 2377-2384, 2013. Copyright 
American Chemical Society. 
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6 Validation of a Multipoint Near-Infrared Spectroscopy 
Method for In-Line Moisture Content Analysis during 
Freeze-Drying3 
                                                                
3 Reprinted from Journal of Pharmaceutical and Biomedical Analysis, Vol. 95, Kauppinen A, Toiviainen M, Lehtonen M, 
Järvinen K, Paaso J, Juuti M and Ketolainen J, Validation of a Multipoint Near-Infrared Spectroscopy Method for In-Line 
Moisture Content Analysis during Freeze-Drying, pp. 229-237, Copyright 2014, with permission from Elsevier. 
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7 General Discussion and Future Prospects 
The overal aim of the study was to deepen our understanding of freeze-drying product and 
process by implementing noninvasive spectroscopic methods into the process and utilizing 
appropriate MVDA tools for the analysis of the spectroscopic data. Subsequently, the 
established methods could achieve an improvement in the process efficiency. Chapter 7.1 
discusses the main findings of this thesis and compares the results to the previous studies 
on the subject. The limitations of the developed methods and propositions for the future 
studies will be discussed in chapter 7.2.  
7.1 THE KNOWLEDGE GAINED IN THIS WORK 
In general, it was found that the use of MVDA is required to extract relevant information 
from the spectroscopic data and the selection of an appropriate MVDA tool is dependent 
upon the experimental setting and objective of the research. The results clearly showed that 
the spectroscopic methods can elucidate the physical and chemical phenomena occurring in 
the sample during a freeze-drying process. This is valuable information and can be utilized 
to assure the quality of the freeze-dried product and to enhance process efficiency. 
 
In the first part of the study, presented in chapter 4, the possibility of using Raman 
spectroscopy in a microscale freeze-drying set-up was evaluated. The objective was to 
characterize and quantify the different solid-state forms of the model formulation during 
the process and to evaluate the effect of the processing conditions on these solid-state 
forms. Previously, four published studies have investigated the application of Raman 
spectroscopy in the microscale freeze-drying environment (see Table 2.5). Similar to the 
present work, the paper published by Cao et al. investigated the crystallizing behaviour of 
mannitol under different processing conditions (e.g. varying cooling rate) (Cao et al. 2013). 
However, as the main differences with this present study are that they used two different 
Raman instruments (i.e. Raman spectrometer with small spot probe and Raman imaging), 
lower concentration of mannitol and multivariate curve resolution (MCR) as MVDA tool. 
Thus, the comparison between studies can only be conducted at a general level. 
In the present work, it was found out that a single CLS multivariate calibration model 
could be used to estimate the ratios of solid-state forms semiquantitatively throughout the 
rest of the process once the sample was solidified. Similarly, a single PCA model was found 
to be applicable for qualitative characterization of the process trajectory. In accordance to 
the results of Cao et al., the cooling rate was found to be the crucial parameter determining 
the crystallization behaviour of mannitol. Results from both PCA and CLS regression 
analyses confirmed that the ratios of the solid-state forms could be manipulated by altering 
certain processing conditions such as the cooling rate and the secondary drying 
temperature and associated time. In the analysis with a small spot Raman probe, Cao et al. 
observed that the solid-state form of mannitol varied depending on the location of the 
measurement spot. This observation was confirmed by Raman imaging of the whole 
sample which revealed the heterogeneous spatial distribution of mannitol solid-state forms. 
In this respect, the utilization of small spot probe for in-line monitoring produces results 
that do not represent the sample as a whole. Due to this heterogeneity, the measured 
sample area needs to be maximized in order to achieve representative results for the whole 
sample. This conclusion supports the choice to use a large spot Raman probe for in-line 
monitoring of microscale freeze-drying process. In the present work, where a large spot 
PhAT probe (ø 6 mm) was used, the measured sample area was approximately 610  times 
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larger than that in study of Cao et al., covering most of the sample area. Therefore, the 
application of large spot Raman probe enhances the representativeness of the results. 
The results obtained in this work demonstrate that the combined use of the microscale 
freeze-drying set-up, Raman spectroscopy utilizing a large spot probe and a suitable 
MVDA tool can achieve a reliable in-line monitoring of the evolution of the solid-state 
forms in a rapid fashion with a small amount of sample. Furthermore, these results indicate 
that this method can be used to screen and select the optimal process parameters so that the 
pathway of formation of the solid-states is controlled and the end product contains the 
desired stable forms. The present findings offer new insights into fisrst understanding and 
then finding ways for enhancing the freeze-drying process. 
 
Chapters 5 and 6 presented the second part of the study which were concerned with the 
development and validation of the multipoint NIR spectroscopy method for in-line 
moisture content analysis during laboratory scale freeze-drying process. Currently, there 
are no other published reports on the application of multipoint NIR spectroscopy into the 
freeze-drying process at any scale. Previous studies on the subject have investigated the use 
of NIR spectroscopy as a single-vial technique in the monitoring of the freeze-drying 
process (see Table 2.6). Only two of these studies conducted a quantitative analysis of the 
NIR spectroscopic process data (Presser 2003; Zhou et al. 2003). Similar to the present work, 
Zhou et al. also applied PLS as a MVDA tool but their experimental setting differed 
significantly in that study since they monitored an in-house designed filter-dryer freeze-
drying process and examined a formulation containing some undefined drug substance. 
The investigation conducted by Presser bears a greater similarity to the present work as a 
shelf type of freeze-dryer was employed, the NIR probe was placed to measure the bottom 
side of the vial and the studied formulations included aqueous 5%-m/v sucrose solution.  
In the present study, both the PCA and PLS revealed that the water was the major 
contributor of the observed spectral variance and the data was clustered according to the 
sucrose concentration. Subsequently, establishment of a global PLS calibration model of 
moisture content for all sucrose concentrations was unsuccessful. Instead, the chemometric 
validation parameters of the individual PLS models for each sucrose concentration 
indicated good predictive performance of the multipoint NIR method during the latter 
stage of the freeze-drying process. This was a similar observation as found in the previous 
studies on the subject (Presser 2003; Zhou et al. 2003) and was confirmed in the validation 
study (chapter 6). This study revealed the applicability of the multipoint NIR method as a 
technique capable of producing valid in-line RM predictions starting from the end of 
primary drying step until the end of secondary drying. It was also observed that the 
method was robust in withstanding the drastic temperature changes so that the in-line NIR 
predicted RM values corresponded to the values determined by an off-line KF method 
during both conservative and aggressive freeze-drying cycles. One notable observation 
made by Presser was that in-line, single-vial NIR method resulted in significant 
underestimation of the RM values in comparison the samples that were measured using the 
off-line KF method (Presser 2003). The heterogeneous intra- or inter-vial moisture 
distribution was proposed to be responsible for the underestimations. This finding from 
Presser highlights the necessity of simultaneous measurement of multiple samples during 
the freeze-drying process in order to increase the representativeness of the moisture 
predictions based on NIR spectroscopic data. 
This present study found that the workload of calibration could be reduced by 
establishing a calibration model using a single primary probe. By using this protocol, the 
calibration samples do not need to be measured with all of the probes in the instrument. 
The established model was subsequently transferred into the secondary probes of the 
multipoint instrument using the additional sample set containing varying moisture 
contents over the intended analytical range. This sample set was used to correct for the 
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responses of the secondary probes. The established protocol streamlines the calibration 
significantly as the number of probes increase. 
The results obtained in this work demonstrate that it was possible to conduct a reliable 
in-line moisture content quantification in a laboratory scale freeze-drying process using 
multipoint NIR spectroscopy and the appropriate MVDA tool. The major advantage of the 
application of the multipoint NIR instrument over the single-vial approach was the higher 
representativeness of the measurement accounting for the edge vial effect caused by 
heterogeneous heat radiation transfer. Previously, the single-vial feature has been 
considered as a major limitation to NIR spectroscopy becoming an acceptable PAT tool for 
in-line monitoring of the freeze-drying process (Patel and Pikal 2009; De Beer et al. 2011b). 
In addition, the utilization of multipoint spectroscopic methods was postulated as one way 
to overcome the single-vial barrier (De Beer et al. 2011a). As shown in this work, the 
application of multipoint spectroscopic instrument to process monitoring makes it possible 
to characterize the individual samples whose state is being influenced by the heterogeneity 
of the freeze-drying process. Therefore, the multipoint NIR method can be considered as an 
upgraded single-vial technique since it combines the benefits of batch and vial techniques. 
Further, the obtained results clearly reveal the applicability of the multipoint NIR method 
for process end detection to a desired RM level. Moreover, the method could also be used 
to detect possible anomalies across the measured products during the process. 
7.2 LIMITATIONS OF THE METHODS AND FUTURE PROSPECTS 
Despite the demonstrated benefits, the developed methods are yet to be complete. They can 
be viewed as newly established platforms requiring further development in order to be 
seriously considered PAT tools for freeze-drying. Furthermore, neither of these methods 
can be used to provide all of the critical information of the product or process when used 
alone. Therefore, in order to fulfill the quality criteria of a given product, one needs to select 
a suitable combination of process analyzers that can deliver the relevant information about 
the required CQAs and CPPs of the particular product and process.  
 
The Raman spectroscopic method developed for solid-state characterization in 
microscale freeze-drying was evaluated using a simple two-component mixture of water 
and bulking agent at a relatively high concentration. This is highly simplified case 
compared to actual formulations that can contain multiple components at different 
concentrations. Thus, the applicability of the method for the freeze-drying process 
development will need to be validated using formulations with higher degrees of 
complexity.  
In the case of multicomponent formulations, the chemometric method for multivariate 
calibration will need a re-evaluation. For more complex sample matrices, direct CLS 
regression is not likely to be a suitable tool because of the strict requirement to have access 
pure analyte spectra. In such cases, calibration could be performed using indirect CLS 
regression employing spectra of analyte mixtures. Alternatively, a method implicitly 
accounting for all sources of variation (i.e. PLS or PCR) could also be a tool for calibration 
(Beebe et al. 1998; Strachan et al. 2007). 
The scale-up of the produced results is still an open question. Therefore, more studies are 
required to be conducted in order to assess transferability of the results into the larger scale. 
For example, the operator still needs to confirm the equivalence of the obtained solid-state 
form ratios between the scales of operation and to assess how these ratios are affected by 
issues such as the selected container type or the cleanliness level of the production site 
(Rambhatla et al. 2004; Patel and Pikal 2011; Sutton 2012). In addition, the optimal CPPs 
obtained at a smaller scale will still need to be adjusted up to a larger scale (Schneid and 
Gieseler 2011).  
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The current system has some drawbacks related to its engineering. Currently, only one 
sample can be processed and analyzed at one time without the possibility to control 
temperature of nucleation (i.e. degree of supercooling). Therefore, with purely technical 
modifications, microscale freeze-drying stage could be upgraded for higher throughput 
and to control the nucleation process. These upgrades would clearly improve the possibility 
to scale-up of the obtained results. Another issue is related to the presentation of sample for 
measurement and the effective sample volume. The current system utilizes the large spot 
PhAT probe measuring from the top of the sample. Even though a significant portion of the 
upper area of sample is covered, the effective sample volume covers only the most upper 
layer and it does not presumably gather any information from the lower part of the sample. 
Therefore, the current system is unable to deliver physicochemical information that is 
dependent upon the sample thickness. Moreover, the operation of the current set-up is not 
very practical as it combines two technologies that are not specifically designed for this 
purpose. For example, the build-up of the system requires tailor-made instrumentation and 
the complete system is inconveniently operated with two different types of software. 
Should this method ever be developed into a commercial product, certain aspects related to 
the usability and management of the system will need to be improved. Moreover, the 
method should include integrated calibration software of the spectroscopic process data for 
the real-time estimation of the sample state. 
In this work, only one parameter linked to product CQAs was studied. Due to the 
versatility of information obtained by Raman spectroscopy, the method is not restricted 
only to characterization of solid-state forms. For example, it has been shown that the 
combined use of microscale freeze-drying and Raman spectroscopy is applicable for the in-
line monitoring of protein structure (Hedoux et al. 2012, 2013). Future research might 
establish a Raman spectroscopy based in-line method capable of simultaneous prediction of 
multiple CQAs in a product. 
 
Similar to the Raman study, the studies related to development and validation of 
multipoint NIR spectroscopy method for moisture analysis were conducted using a simple 
model formulation. Therefore, the actual performance of the multipoint NIR method still 
requires more evidence and validation using formulations with greater complexicities.  
The main limitations of the current system with respect to its engineering are the small 
effective sample volume, relatively large probes and fragile optic fibers. In the current 
system, the bottom side of the sample vials is measured. Since the information depth of the 
diffuse reflectance NIR measurement is approximately 1 mm, only a small fraction of the 
whole sample volume is captured into the measurement (Olinger et al. 2001). Therefore, the 
method does not account for intra-vial heterogeneity and the reliability of the NIR 
measurement can be compromised if the distribution of an analyte is heterogeneous within 
the sample matrix or the contact between product and vial wall is lost (Patel and Pikal 
2009). In addition, the probes and fibers require manual placement onto the shelves. 
Therefore the current technological state of the system does not allow it to be used in sterile 
freeze-drying process monitoring or in freeze-dryers with automatic vial loading or CIP/SIP 
systems. Furthermore, when placed on the shelf, the probes of the current system create a 
physical obstacle blocking space from the bulk samples and alter the hexagonal packing 
array of the vials. Due to these reasons, the batch size is reduced and the NIR measured 
vials and vials surrounding the probes are subjected to increased heat radiation transfer. 
Consequently, increased radiational heat flux can cause the observed vials to run at a 
higher temperature than the corresponding bulk vials at respective locations on the shelf. 
Therefore, more studies will be required with the current set-up to determine the 
magnitude of the effect of putative altered heat transfer. Thus, in order to overcome the 
above issues, the probes and fibers need to reduced in size and made more robust. The 
future technological improvements of the method could involve integrating the probes and 
fibers into the equipment (e.g. into the shelves) or designing some kind of automatic 
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placement system. Moreover, the developed version of the method would include 
integrated calibration software with a feedback system for process control and an 
automated self-referencing system (Cogdill and Drennen 2006). 
The freeze-drying process developed using the current setting cannot be directly 
transferred to a larger scale. In the scale-up phase, the CPPs are still required to be adjusted 
in order to acquire the desired RM level of the products. Currently, the method is well 
suited for freeze-drying R&D purposes where products with certain levels of RM are 
required. One straightforward application of the method could be the preparation of 
samples with the different moisture contents for stability studies such as assessing the level 
of RM leading to an optimal storage stability of the product. 
The calibration and validation of multipoint NIR methods for quantitative purposes are 
laborious tasks that are required to perform before the method can be applied to process 
monitoring. During the calibration and validation steps, a vast number of samples are 
needed to be produced and analyzed with both the NIR and the reference method. Finally, 
the acquired data is multivariately analyzed with the most suitable calibration method 
being selected. Furthermore, the calibration and validation have an inflexible nature. Once 
the final calibration model is obtained, it is only applicable for that specific formulation 
within those variations in the processing conditions where the calibration and validation 
were conducted. Thus, calibration and validation databases need to be updated in order 
take account of the variation due to a modification of some attribute related to the product 
(i.e. a change in the composition of formulation, the process parameter or type of the 
container). In the worst case scenario, the above protocol is required to be completely 
repeated. Moreover, the validation phase requires a sufficient number of samples 
containing a more or less identical moisture content at each concentration level of interest. 
Even though the sample extractor door of the freeze-dryer used here did permit the NIR 
measurement of the calibration and validation samples in an authentic process 
environment (e.g. at temperatures and pressures typical for the process) and removal of 
these samples at the fixed time points of drying, the aqcuisition of sufficient number of 
samples with similar moisture content is something of a lottery and cannot be controlled.  
In the current study, only one CQA was studied and predicted. As with Raman 
spectrocopy, NIR spectroscopy is capable of acquiring comprehensive amounts of physical 
and chemical information of the sample. Theoretically, it should be possible to upgrade the 
multipoint NIR method to allow the simultaneous in-line estimation of multiple attributes 
related to CQAs of the sample. For example, the in-line assessment of the protein structure 
or solid-state form of the product using NIR spectroscopy has already been demonstrated 
(De Beer et al. 2009a; Pieters et al. 2012b). However, further R&D will be required in order 
to confirm the feasibility of using a multicomponent analysis. 
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8 Conclusions 
Raman and NIR spectroscopic methods were successfully instrumented into microscale and 
laboratory scale freeze-drying processes as in-line process analyzers, respectively. The 
spectroscopic process data analyzed confered added value and increased the 
understanding of the product and process. The following specific conclusions can be drawn 
on the basis of the study: 
 
I Raman spectroscopy is applicable for noninvasive in-line freeze-drying process 
monitoring in a microscale set-up. The evolution of solid-state forms of the sample 
can be semiquantitatively characterized using CLS regression after the 
solidification of the sample. The use of a microscale platform enables rapid 
screening of the effect of process conditions with small amount of sample. 
 
II Multipoint NIR spectroscopy can be applied for noninvasive in-line monitoring of 
the laboratory scale freeze-drying process. The moisture content of the samples 
across the batch can be quantified using PLS regression during the latter stage of 
the freeze-drying process. The multipoint feature enables representative moisture 
analysis accounting for the influence of heterogeneous heat radiation transfer 
within the process. 
 
III In-line moisture analysis applying multipoint NIR spectroscopy and PLS 
regression produces valid moisture estimates from the end of primary drying 
until the end of secondary drying. The multipoint method can be used to detect 
the end point of drying to a desired RM level. Calibration model transfer can be 
streamlined using an additional sample set for correction of the secondary probe 
responses. 
 
The application of Raman and NIR spectroscopic methods for in-line freeze-drying 
process monitoring deepens the product and process understanding. The obtained 
quantitative information can be used to improve product quality and to enhance process 
efficiency. 
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An understanding of both the prod-
uct and the process is essential for 
improving product quality and proc-
ess efficiency. In this thesis, spectro-
scopic methods were implemented 
into a freeze-drying process in order 
to acquire critical product-specific 
information. More precisely, Raman 
spectroscopy was used to determine 
solid-state form and multipoint near-
infrared spectroscopy determined 
the moisture content of the sample 
during a freeze-drying process.
d
isser
tatio
n
s | 273 | A
r
i K
au
ppin
en
